Pathophysiology of the Adult Respiratory Distress Syndrome and Multi System Organ Failure. by Tighe, Derek
Open Research Online
The Open University’s repository of research publications
and other research outputs
Pathophysiology of the Adult Respiratory Distress
Syndrome and Multi System Organ Failure.
Thesis
How to cite:
Tighe, Derek (1992). Pathophysiology of the Adult Respiratory Distress Syndrome and Multi System Organ
Failure. The Open University.
For guidance on citations see FAQs.
c© 1991 The Author
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
Name. Derek Tighe
Title. Pathophysiology of the Adult 
Respiratory Distress Syndrome 
and Multi System Organ Failure
Degree. Bachelor of Philosophy.
msdpime. Faculty of Biological Sciences.
Suhmissian February 22 1991.
date.
ProQ uest Number: 27919353
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent on the quality of the copy submitted.
in the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27919353
Published by ProQuest LLC (2020). Copyright of the Dissertation is held by the Author.
Ail Rights Reserved.
This work is protected against unauthorized copying under Title 17, United States Code
Microform Edition © ProQuest LLC.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106 - 1346
A bstract.............................................................................................................. 1
C hapter 1. Introduction................................................................................... 2
Diagnosis and symptoms........................................................... 2
Prognosis...................................................................................... 6
M echanism .................................................................................. 6
Conclusion....................................................................................10
Chapter 2 ............................................................................................................12
Introduction.................................................................................12
Pneumonia and ARDS................................................................14
Military multi- traum a...............................................................16
The Vietnam w ar........................................................................ 20
Civilian m ulti-traum a............................................................... 21
Multi system organ failure........................................................23
M onitoring................................................................................... 26
Mechanical ventilators............................. ................................. 27
C h ap te r  3 C auses o f ARDS an d  MSOF.................................................... 29
Sepsis, Septic Shock and the Septic Syndrome...................................29
Introduction................................................................................. 29
Clinical manifestation of sepsis................................................ 38
Septic Shock...............................................................................39
Metabolic changes during sepsis.......................................... ^
Animal models of sepsis............................................................43
Conclusion....................................................................................46
T ra u m a ......................................................... .......................................... 48
Pulmonary dysfunction in battle casualties............................48
Civilian traum a........................................................................... 55
Hypoxemia associated with skeletal injury.............................57
Early Bone Fixation.....................................................................58
Historic perspective.................................................................... 61
Experimental multi-trauma on animals.................................62
Conclusion ...........................................................................64
Oxygen Deprivation........................................... ....................................66
Introduction................................................................................. 66
Oxygen metabolism.................................................................... 66
Oxygen extraction ratio in normal patien ts........................... 68
The relationship between D02 and V02.................................. 68
Relationship of D02 to V02 in normal patients...................... 70
Inadequate capillary recruitm ent............................................73
Effective capillary perfusion............................................:..........78
Regional shunting of organ blood flow.................................... .78
Increased Oxygen Consumption.............................................. 79
Supply dependency of oxygen consumption in ARDS
patients..........................................................................................81
Oxygen debt in septic patients................................................... 83
Defective oxygen extraction ratio in ARDS.............................. 86
Optimum values for oxygen metabolism................................. 87
Oxygen diffusion..........................................................................90
Criticisms of the work on oxygen consumption in
understanding MSOF................................................................. 90
Mitochondria................................................................................92
Tissue oxygen utilisation........................................................94
Phosphocreatine/D02 ratio ........................................................ 96
ATP Levels in sepsis................................................................... 100
C hapter 4 Histological features associated w ith  M.S.O.F...................... 104
Introduction.................................................................................104
L u n g  H isto lo g y .................................................................................. 105
Normal pulmonary u ltrastructure.......................................... 105
Pathological pulmonary u ltrastruc tu re .................................. 106
Animal studies of pulmonary ultrastructure in ARDS
like syndrome............................................................................... 108
liv er  histology.......................................................... ............................. I l l
Spleen histology..................................................................................... 113
Renal Histology....................................................................................... 113
H eart h isto logy ...................................................................................114
Muscle histology................................................. ........................... . 114
Conclusion.................................................................................... 114
Chapter 5 Inflanunatory cells..  .........................................................115
Polymorphonuclear leucocytes (neuizophils).. ................... 115
Introduction................................................................................. 115
Two phase response of pulmonary dynamics..........................119
Leukocytopaenia...........................................................................120
Neutrophil role in endotoxin induced endothelial cell
in jury ............................................................................................. 121
Pulmonary leucostasis without damage...............................122
Leukocyte adhesion......................................................................123
Influence of leucostasis...........................................................123
Endothelial-leukocyte adhesion molecule................................125
Neutrophil mediated tissue injury........................................ 126
1 Granular enzymes.........................................................126
2 Reactive oxygen metabolites......................................... 127
3. Membrane phospholipases...................................... 128
Monocytes................................................................................................131
Macrophages........................................................................................... 132
Conclusion.................................................................................... 132
Chapter 6 B iochem istry o f inflam m ation............................................... 134
Introduction................................................................................. 134
P rotein  m ediators o f inflam m ation.............................................. 137
K in in s..................................................................................................... 137
Bradykinin Blockade................................................................ 137
Background to K inins................................................................. 137
Biological actions of bradykinin and related kinins............. 138
Bradykinin receptor s ite s .................................................. ;........ 139
Mechanisms of action of kinins..............................................140
Involvement of kinins in inflammation.................................140
Conclusion.................................................................................... 142
Cytokines: TNF and inteileukin........................................................... 143
Introduction................................................................................. 143
Neutrophil and endothelial activation by IL-1 and TNF
a lp h a ..............................................................................................144
Endothelial leukocyte adhesion molecule (ELAM).................145
Sources of TNF and IL-1........................................................ 146
Tissue receptors of TNF.............................................................. 146
TNF production in vivo in response to LPS or bacteria.......... 148
Shock in response to TNF infusion.............................................153
Prostaglandins and TNF............................................................157
Human TNF................................................................................. 158
Conclusion.................................................................................... 161
Complement........................................ ......... ........................................ 162
Introduction................................................................................. 162
Biological actions of complement cleavage products........... 162
Complement activation via the classical and alternative
pathw ays...................................................................................... 162
Complement activation in haemodialysis.................................163
Neutrophil activation by complement.................................... 164
Cardiopulmonary by-pass activation of complement.............. 165
Anaphylatoxins.............................................................................166
N eutropaenia............................................................................... 166
C5a desaturated arginine..................   167
Complement activation in the development of ARDS 169
Reduction of complement activity.................... 1.........................170
Conclusion...............................................................   170
Lipid m ediators o f inflam m ation............................................... 172
Phospholipids...............................     172
Introduction  ..........................................................................172
P h osp h o lip ase  .......................   174
Introduction.......................................................   174
Clinical significance of serum PLA2 activity........................... 175
A rachidonic acid .................................................................................178
Introduction........................   178
Eicosanoid substrate..................................  178
P la telet activatin g factor................................................................. 179
Introduction.................................................................................. 179
C ydooxygenases..................................  181
Introduction.................................................................................. 181
Lipoxygenases.................................................................................   186
Introduction...................................................................................186
Summary..............................................................................................................188
R eferen ces.....................................................................................................  195
l is t  of Tables
Table L Alternative names for ARDS...............................................12
Table 2. Causes of ARDS.................................................................... 13
Table 3. Pulmonary pathological finding in deceased 
multi-traumatised soldiers who survived shock for at least
18 hours................................................................................................. 18
Table 4. The outcome of 207 patients at risk fi*om
developing ARDS................................................................................ 24
Table 5. The causes of death in the ARDS and non-ARDS
groups.................................................................................................... 25
Table 6. Comparative mortalities of ARDS and non-ARDS
patients from 86 with Gram-negative infection.............................31
Table 7. Outcome of 116 consecutive patients with
bacteremia firom ARDS and shock........................................................31
Table 8. Comparison of the 191 bacteremic and non-
bacteremic patients with septic syndrome........................................... 33
Table 9. Significant differences between the septic shock 
group and the sepsis syndrome alone in the 191 patients
studied.................................................................................................. 33
Table 10. Diagnosis associated with the development of
ARDS in 129 survivors and non-survivors......................................36
Table 11. Clinical and autopsy diagnosis of major sites of
infection in 103 patients with ARDS..................................................... 37
Table 12. Characteristics of infections in 129 patients with
ARDS by blood culture and clinical diagnosis.................................. 37
Table 13. Time of death and positive blood cultures in
experiments A and B.......................................................................... 43
Table 14. Relative mean organ weights of rats in 
experiments A, (normal) and B (germ free), groups 1 and
2.............................................................................................................44
Table 15. The relationship between organ damage and the
presence of bacteria................................................................................ 46
Table 16. Effect of shock on arterial oxygen tension in 148
traumatised patients.......................................................................... 49
Table 17. Per centage of patient suffering hypoxemia
(without shock) in response to fi:acture.................................................50
Table 18. Per centage of patient suffering hypoxemia
(without shock) in response to differing fracture locations............. 50
Table 19. Lung weights of 100 combat casualties........................... 51
Table 20. Comparison of the three groups of seriously
injured patients................................................................................... 52
Table 21. Data from 12 patients suffering from acute 
respiratory distress.................................................................................56
Table 22. Partial pressures of oxygen in arterial blood 
from 100 severely injured patients immediately after
hoi^tal admission..................................................................................57
Table 23. Association of fat in the blood with respiratory
distress in 20 patients......................................................................... 58
Table 24. Comparison of early and late stabilisation in
traumatised patients.......................................................................... 61
Table 25. Effect on lung weight of increasing impact
velocity................................................................................................. 63
Table 26. Haemodynamic parameters associated with a 
DO2 less than and greater than 330 ml/min/m^ in 58
patients.................................................................................................71
Table 27. Action of hypotension alone and in combination 
with either hypoxemia or muscle contraction on muscle of
dogs................................................  74
Table 28. The effect of hypoxemia, on noradrenaline
treated muscle, in dogs....................................................................... 75
Table 29. Distribution of blood flow and oxygen utilisation
in various organs, of control dogs......................................................77
Table 30. Oxygen utilisation dynamics in septic and
nonseptie patirâts.................................................................................. 81
Table 3L Changes in oxygen delivery and consumption in 
patients with septic or hypovolaemic shock, challenged
with volume infusions............................................................................ 84
Table 32. Metabolic changes in the various tissues of rats
with faecal peritonitis.............................................................................101
Table 33. Fractional distribution of labelled TNF in tissue
of mice, 8 minutes after injection......................................................147
Table 34. Haemodynamic and neurohormonal response of
dogs to TNF infusion.......................................................................... 154
Table 35. Attenuation of haemodynamic responses to TNF
infiision, by TNF antibodies, in baboons............................................156
Table 36. Association of serum TNF with clinical outcome
of 79 septicaemic patients.................................................................. 160
Table 37, Diagnostic distribution of 84 patients at risk of
developing ARDS.................................................................................183
Table 38. Plasma concentration of thromboxane and 
prostacyclin in 84 patients, in 3 diagnostic groups, at risk 
of developing ARDS.......................................................................... ...184
List of figures.
Figure 1. Development of MSOF..................................................... 4
Figure 2. Lung section from a pig taken before infection.................105
Figure 3. Neutrophil in a pig pulmonary capillary,
sampled before infection.................................................................... 105
Figure 4. Lung sample from a patient with ARDS  ............ 105
Figure 6. Lung sample from patient with ARDS................................105
Figure 6. Pig lung after 5 hours of infection........................................ 105
Figure 7. Neutrophil in a pig pulmonary capillary after 5
hours of infection................................................................................ 105
Figure 8. Pig pulmonary capillary after 5 hours of
infection................................................................................................. 105
Figure 9. Sinusoid of pig liver section taken before
infection................................................................................................. 105
Figure 10. Pig liver section taken before infection..........................105
Figure IL Sinusoid of pig liver section taken after 5 hours
of infection..............................................................................................105
Figure 12. Pig liver section taken after 5 hours of
infection................................................................................................. 105
Figure 13. Sinusoidal endothelium from a pig liver section
taken befere infection.............................................................................105
Figure 14. Sinusoidal endothelium from a pig liver section
taken after 5 hours of infection......................................................... 105
Figure 15. A swollen Kupffer cell fn>m a pig liver section
taken after 5 hours of infection......................................................... 105
Figure 16. Peripheral blood neutrophil count in sham and
septic rabbits over a five hour period................................................ 117
Figure 17. Number of neutrophils per alveolae in sham
and septic rabbit lung after five hours of peritonitis....................... 118
Figure 18. Summary of possible mechanism of vascular
injury caused by neutrophil activation............................................ 130
Figure 19. Mediator response to tissue damage involved in
MSOF.................................................................................................... 135
Figure 20. Scheme of Kinin generation.......................................... 138
Figure 21. Serum TNF concentrations in human 
volunteers, over 6 hours, challenged with 20 units/kg E.
œli endotoxin...................................................................................... 148
Figure 22. Serum interleukin-1 concentrations in human 
volunteers, over 6 hours, challenged with 20 units/kg E,
coli endotoxin...................................................................................... 149
Figure 23. Serum TNF concentrations, over 12 hours, in 
baboons challenged with a lethal dose of live E. coli................ ..........150
Figure 24. Serum interleukin-1 concentrations, over 12 
hours, in baboons challenged with a lethal dose of live E,
œli........................  151
Figure 26. Serum interferon-g concentrations, over 12 
hours, in baboons challenged with a lethal dose of live E,
œli.........................................................................................................152
Figure 26. lipid cascade in response to tissue damage in
MSOF..........................................................................   .....173
Figure 27. Structure of phosphatides and the action of 
phospholipase..................................................................................... ,174
1
Abstract.
Pulmonary dysfunction in patients with the adult respiratory distress 
syndrome (ARDS) is nearly always associated with damage to other organs, 
although such damage may not be clinically apparent. When non- 
pulmonary in origin ARDS should be considered as an element of midti
i
system organ failure (MSOF). Most patients with MSOF do not die from 
hypoxemia. Major traum a is nearly  always associated w ith some 
pulmonary dysfunction, although often subclinical. Medical conditions such 
as septicaemia, traum a, pancreatitis or bum s cause severe inflammatory 
cascade activation (SICA), which is the most likely cause of MSOF.
Oxygen metabolism is central to the development ofj SICA. Once
established SICA causes redistribution of blood flow to and within vital
1
organs. Organs needing a high oxygen delivery (e.g. heart or brain) are 
deprived of blood by the relatively high flow in less dependan^ organs (e.g. 
skin, kidney, or splanchnic bed). In th is condition, blood flow is 
redistributed, producing a relative ischemia and reduction in the production 
of ATP. This ischemia promotes the formation of super oxides by xanthine 
oxidase, causing further tissue damage.
U ltrastructure studies show tha t leucocytes aggregate in the lungs, 
liver and spleen and tissue damage is greatest in these organs. But, even 
when there is little leucocyte aggregation in the lungs, considerable tissue 
damage is observed. Leucocytes can be induced to aggregate in the lungs 
without causing tissue damage. Leucocytes do not aggregate in significant 
num bers in the heart, kidneys or muscle. Leucocytes are therefore 
important in the inflammatory cascade of MSOF but not essential.
Although there are many biochemical mediators of MSOF, the choke 
point enzyme phospholipase is the m ost important and its  inhibition m ay be 
important in treating the condition.
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Chapter 1.
Introduction.
Single organ failure such as myocardial infarction, with cardiogenic 
shock or renal failure has long been recognised as a cause of mortality^ But 
with the establishment of intensive therapy units (ITU) in the late 1960's, a 
new form of organ failure, involving the lungs, unrelated to the original 
injury, was identified. This condition is referred to as the adult respiratory 
distress syndrome (ARDS). The syndrome originates from a wide variety of 
diffuse injuries, which either directly or indirectly cause damage to the 
lung parenchyma.
In 1967, Ashbaugh et al. first described ARDS. Patien ts had 
pulmonary oedema, lung failure and arterial blood hypoxemia in response 
to non-pulmonary injuries. By the mid to late 1970*s it was understood that 
ARDS was also associated with the sequential failure of liver, kidney, brain, 
blood gastro intestinal tract, vascular tone and heart, and was usually 
followed by death (Tilney et al. 1973, P ratt. 1979). This syndrome of 
sequential multi-system organ failure (MSOF) is now well described. 
Current intensive therapy unit (ITU) technology allows the support of 
patients with single and multiple organ failures who would previously have 
failed to survive the initial insult or its immediate aftermath. Unfortunately 
these patients still die a t a similar rate as in the pre-ITU period.
Diagnosis and symptoms.
The first manifestation of the complex medical syndrome ARDS, is 
the occurrence of breathlessness, in patients who often do not have any 
direct pulmonary ipjury. They develop hypoxemia and cyanosis, th a t is 
refractory not only to nasal oxygen, but also to interm ittent positive pressure 
mochanical ventilation, Those patients have to be mechanically ventilated to 
m aintain adequate arterial blood oxygenation. The partia l pressure of 
arterial blood oxygen should be roughly eqivalent to tha t of atmospheric
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oxygen. But in ARDS patients» the difference between inspired and arterial 
oxygen tension is markedly increased; often 200 to 500 mmHg, representing 
a large shift in the pressure saturation graph from left to right. The chest X- 
ray shows bilateral shadowing over most of the lungs, thought to be due to 
oedema (Ashbaugh et al. 1967), and the heart has a normal cardiac 
silhouette. This pulmonary oedema develops in the absence of any heart 
failure. When pulmonary oedema occurs without heart failure it  is most 
likely due to an increase in the permeability of pulmonary capillaries. This 
so called “low pressure oedema” is typical of the syndrome. The permeability 
change was originally thought to be due to the absence of alveolar 
surfactant» similar to the condition» respiratory distress syndrome» seen in 
small children. Consequently it was called the “adult respiratory distress 
syndrome” (ARDS) by Ashbaugh et al. (1967).
Typical clinical patterns of patients who develop MSOF in the ITU 
have been established and are reported in such work as tha t of Cerra (1987) 
and Siegel and Cerra (1979). The development of MSOF is shown in Figure
i
1. This flow diagram shows th a t after a major insult, protein and lipid 
mediators are released, there is a massive whole body inflammatory 
response and there are pulmonary, peripheral and myocardial responses. 
Shock is seen to develop and there is a severe decrease in systemic vascular 
resistance. Severe myocardial depression occurs and dysfunction develops 
in several organs. If unresponsive hypotension and MSOF occurs, then the 
patient dies.
Figure 1. Development of multi ststem organ Aûlure.
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When many of these patients are admitted to the ITU, they already 
have shock, with low cardiac output. The fall in cardiac output (CO) in the 
megority of cases indicates a fall in venous return due to hypovolaemia. The 
cardiac output can be rapidly increased by blood volume expansion. The 
offoct of fluid loading on left atrial presouro often indicatco the heart has a 
limited reserve and will not function normally. The CO is in fact lower than 
would be expected for a given left atrial pressure, indicating myocardial 
depression. There is httle or no rise of CO when volume expansion therapy 
is associated with a rapid rise in left atrial pressure. When the patient is 
resuscitated and the initiating event controlled» the patients often appears to 
do well. Several days later there is an insidious onset of low grade fever, 
increased heart rate and breathlessness with the appearance of diffuse 
patchy infiltrates of both lungs on the chest X-ray. The patient has some 
alteration in mental status, with normal renal and hepatic function based 
on standard laboratory tests. The breathlessness continues, and intubation 
and ventilator assistance, usually involving positive end expiratory pressure 
is required. The elasticity of the lungs decreases, and its capacity to 
oxygenate blood declines.
The patient usually stabilises haemodynamically and has a relatively 
high urine output and cardiac output (CO). Hyperglycemia, low systemic 
vascular resistance (SVR), lactic acidosis, and raised oxygen consumption 
(V02) are often seen.
The p a tien t subsequently  shows evidence of d issem inated 
intravascular coagulation and renal and hepatic failure develop. The 
hyperdynamic and hypermetabolic states become more pronounced with 
further increases in blood sugar and lactate; there is a further increase in 
V02 and CO with a fall in SVB« There are reduced levels of hepatic proteins 
such as albumin, transferrin, prealbumin, and retinol-binding protein. 
There is a progressive need for drugs to maintain blood pressure and CO, 
and fluid to support blood volume and cardiac preload. The patients can
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survive about 21-28 days, providing they can maintain a high CO, if they are 
unable to sustain such a CO, then death occurs much more rapidly.
Prognosis.
The transition to MSOF is a  significant prognostic event. It marks the 
change in mortahty from the 25%-40% to 40%-60% range in the early stage 
and 90%-100% in the late stage. The differentiation between early and late 
MSOF is primarily the degree of hver and renal failure.
Mechanism.
Scientific interest in ARDS developed because the pragmatic medical 
approach of treating the symptoms of the condition proved to be inadequate. 
A thorough understanding of the disease mechanisms is required to initiate 
adequate patient therapy. Scientific progress in understanding the condition 
rests heavily on the development of animal models showing symptoms that 
resemble ARDS. None of these animal studies truly reflects the condition. 
They are used to investigate specific features of the condition and can oidy 
have lim ited value. Extrapolation to the clinical condition requires 
considerable caution. But these studies have allowed investigation of organ 
u ltras tru c tu re  and the development of the theory of whole body 
inflammation.
Initially, medical treatm ent for ÀRDS was empirical, i t  involved 
treating the symptoms as they arose. The last ten years have witnessed 
progress in strategies for support of patients with ARDS. These strategies 
are nutritional (Driver and LeBrun 1980), application of positive airway 
pressure and the use of high technology ventilators (Petty 1982), 
measurement and manipulation of intravascular pressures, blood volume 
and flow rates (Haynes 1982).
U nfortunately the 40-80% m ortality  from ARDS is v irtually  
unchanged from the earliest reports (Petty 1975, Fowler et al. 1982). Those
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individuals most at risk are often young, previously healthy people, who 
may have been expected to lead productive lives if they had survived ARDS. 
The implication is tha t we have not yet made the first small step in 
preventing or reversing the pathogenic mechanisms of ARDS. I t has 
become d ea r that improved care will not improve the overall mortality from 
this disorder. Progress must come from undiscovered or unapplied basic 
insights of scientific understanding as the disease mechanism becomes 
better understood.
Numerous primary pathological conditions causing lung damage 
and arterial blood hypoxemia, but not initially involving the lungs have been 
known for many years. Lung damage was initially thought to be spedfic to 
the initiating illness and it was not until 1967 tha t the lung damage was 
recognised to be the same, regardless of the initiating illness. This was not 
altogether surprising as the lungs have a limited number of responses to 
the different insults that they sustain. These insults can be air-bome, direct 
injury or blood-bome. The extra-pulmonary insults are varied and include 
sepsis, trauma, shock, bums or pancreatitis. But the end stage of all types of 
acute resp ira to ry  insufficiency are rem arkably  sim ilar in  th e ir 
morphological, functional and clinical features.
In some patients, control of the initiating event and supportive 
measures can lead to recovery. But several clinical settings are assodated 
with the transition from the hypermetabolic state to organ failure. These 
include a persistent unrecognised perfusion defidt; a persistent focus of 
infection; or a persistent focus of inflammation such as pancreatitis or a leg 
fracture tha t has not been debrided and internally fixed within 24 hours.
An analysis of the development of ARDS over time in such patients 
gives an illum inating picture. F irst is  the in d tin g  event COupled with the 
host response. An indting event can be assigned in about 80% of cases of 
ARDS (Fowler et al. 1982, Pepe et al. 1982), into one of nine categories:
i. sepsis.
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ii. multiple trauma,
iii. aspiration of gastric contents or near drowning,
iv. multiple blood transfusions,
V. prolonged hypotension,
vi. bums,
vii. pancreatitis,
viii. focal pneumonia requiring intensive ca re ,.
ix. lung contusion.
In each of these categories mentioned a minority of patients develop 
ARDS (1-30%) raising the question of risk characteristics in the host for the 
development of the condition. It is also unknown why some patients survive 
this condition and others progress to irreversible ARDS and MSOF. Equally 
important is the question of the common features of these nine categories 
allowing the development of ARDS. Are there pathogenic mechanisms 
common to these events?.
Pulmonary oedema is a particularly important feature of ARDS. The 
oedema is not due to cardiac failure, as these patients usually have normal 
left atrial pressure. I t was initially thought to be due to massive fluid 
overload during shock resuscitation with altered capillary hydrostatic and 
protein osmotic pressures. This oedema is now thought to be due to 
increased permeability of the pulmonary vascular bed. By the Starling 
equation (Starling 1896) transduction of fluid across the vascular bed into 
the interstitium  depends on two opposing forces, hydrostatic pressure and 
oncotic pressure, and on the integrity or permeability of the filtering 
membrane. In conditions of increased permeability, more fluid will cross 
the membrane for any given net driving force, and the fluid will have a 
higher protein concentration. Fluid obtained from the airways of patients 
with ARDS has a higher protein concentration than from normals or from 
patients with cardiogenic pulmonary oedema (Newman 1985).
9
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This increased membrane permeability has led to the assumption 
tha t the inflammatory process ts involved in the pathophysiology of ARDS. 
Neutrophils have been implicated as a major mediator of injury because of 
their presence in the lungs of paren ts with ARDS (Schnells et al. 1980) and 
animal models of the condition (Tighe et al. 1989). Neutrophils have been 
found in increased numbers in the lungs of patients dying of ARDS (RatHff 
et al. 1971) and radio labelled neutrophils have been shown by lung scan to 
sequester in the lungs of these patients. In animal models of this condition, 
the peripheral blood leucocyte count decreases to below 50% of baseUne and 
pulmonary leucostasis is seen. The degree of hypoxemia has been shown to 
increase as the peripheral leukocyte count decreases (Snapper et al. 1983). 
In sheep made leucopaenic by nitrogen mustard there was an attenuation of 
pulmonary oedema and capillary permeability (Burford and Burbank 1945).
The mechanism by which neutrophils are activated to take part in 
this syndrome has been thought to be by the action of the complement 
fragment C5a. Neutrophil induced injury is thought to be associated with 
the production of highly toxic oxygen radical molecules. The free radical 
superoxide can participate in several chemical reactions yielding hydrogen 
peroxide and the hydroxyl radical (OH"). These potent oxidising compounds 
can cause injury to a number of enzyme systems and can attack cell 
membranes.
The lungs of patients who die from ARDS reveal variable degrees of 
inflammation and fibrosis, with damage to cells both on the vascular and 
airway side of the alveolae. The alveolar are often collapsed and contain 
hyaline membranes. They are typically airless and will sink when 
immersed in  water, having a similar appearance to liver when cut. 
U ltrastructure studies show leucostasis with capillary endothelial and 
alveolar epithelial damage.
I
The inflammatory cascade involving the production of lipoxygenases 
and cyclo-oxygenases from arachidonic add  by the action of phosphoUpases
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is thought to be partly responsible for the systemic changes associated with 
ARDS. Thromboxane, prostacyclin, p la te le t activating  factor and 
leukotrienes are the individual compounds thought to be involved with the 
local inflammatory response in ARDS.
Tissue ischaemia could be responsible for organic damage and the 
consequent initiation of the inflammatory cascade. During tissue injury 
from what ever cause there is a consequent increase in metabolic rate with 
an increased oxygen need. If this need is not satisfied then the resulting 
oxygen debt can cause tissue ischaemia to develop. Tissue ischaemia results 
in a dramatic fall in systemic vascular resistance (SVR), allowing the CO to 
increase by reducing after-load. This is the system mechanism to increase 
tissue oxygen consumption (V02) by increasing oxygen delivery (D02) 
through an increase in CO. If survival is to occur then the increase in V02 
m ust be sufficient to meet the increased metabolic demands and prevent 
further tissue injury and inflammatory amplification.
Conclusion.
A major difficulty in understanding the condition has been the 
inability to appreciate that it is not only a pulmonary problem. It involves 
damage to other organs such as liver, kidneys, heart, pancreas and the 
gastro-intestinal tract. Most patients do not in fact die from hypoxemia, as 
had been previously thought: only 20% developed terminal hypoxemia. The 
name ARDS has become a major problem in attem pts to elucidate the 
pathophysiology, as it concentrates the attention too firmly on the lungs. 
Pulmonary dysfunction in this condition is only the pulmonary aspect of a 
larger syndrome. ARDS would have been better named multi-system organ 
failure.
This thesis will initially describe the clinical signs of the MSOF, 
giving an  historical review, and a description of ultrastructural changes. 
The importance of sepsis, traum a and oxygen metabolism, will be
11
considered to show their common characteristics in the development of 
MSOF. It will follow the development of MSOF as shown in figure 1. The 
inflammatory process will be considered, involving cell bodies, especially 
neutrophils and monocytes and their interaction with endothelium. The 
action of the protein mediators, complement, the kinins and the cytokines 
will be examined, as will the lipid mediators, the cyclo-oxygenases and the 
lipoxygenases.
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Chapter 2.
Historical Background 
Introduction
ARDS is a common cause of acute respiratory failure, called by many 
different names shown in Table 1, they are associated with the insult 
preceding the pulmonary dysfunction. They reflect the numerous unrelated 
conditions from which an understanding of this syndrome developed.
!
Table 1. Alternative names for ARDS.
Adult hyaline membrane disease 
Bronchopulmonary dysplasia 
Congestive atelectasis 
DaNang Lung 
Haemorrhagic atelectasis 
Haemorrhagic lung syndrome 
Hypoxic hyperventilation 
Noncardiogenic pulmonary oedema 
Oxygen toxicity 
Post-perfusion lung 
Post-transfusion lung 
Post-traumatic pulmonary insufficiency 
Progressive respiratory distress 
Pulmonary contusion 
Pulmonary microembolism 
Pump lung
Respiratory insufficiency syndrome
Septic lung syndrome
Shock lung
Stiff lung syndrome
Transplant lung
Traumatic wet lung
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Wet lung
White lung syndrome
Table 2, shows tha t acute lung injury can develop from a wide variety of 
causes, either directly or indirectly involving the lungs. In 1967 Ashbaugh 
et al. established the name “adult respiratory distress syndrome". Until that 
time it  was thought th a t all these differing names reflected separate 
pulmonary conditions.
Table 2. Causes of ARDS.
Shock of any cause
Septic
Hypovolaemic
Infection
Pulmonary
pneumonia 
Non-pulmonary sepsis
Bacterial (Gram negative or positive)
V iral
Fungal infection
Traum a
Fat embolism 
Lung contusion 
Non thoracic traum a 
Head injury
Haemorrhagic hypotension 
Abdominal surgery 
Battlefield trauma 
Fluid aspiration 
Gastric juice
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Near drowning 
Hydrocarbon fluids 
Drug toxicify or sensitivify 
Heroin 
Methadone 
Propoxyphene 
Barbiturates 
Paraquat 
Bleomycin 
Inhaled toxins 
Oxygen
Smoke (containing hydrogen cyanide or carbon 
monoxide)
Corrosive chemicals (nitrous oxide, chlorine, 
ammonia, phosgene, or cadmium)
Haematological disorders
Disseminated intravascular coagulation 
Massive blood transfusions 
Metabolic disorders 
Pancreatitis 
Uraem ia 
Others
Post cardiopulmonary by-pass
Pneumonia and ARDS.
Both pneumonia and ARDS involve severe pulmonary tissue damage 
and although the definition of ARDS is very specific, its association with 
pneumonia has lead to considerable confusion. The distinction between 
pneumonia and ARDS may require sophisticated monitoring and tests to 
distinguish between them th a t are not always available. Patients with
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pneumonia often die from ARDS. Historically deaths from ARDS were most 
likely recorded as pneumonia. Records of the cause of death contain an over 
estimation of pneumonia cases and an under estimation of ARDS. The 
problem arises over the historic position of pneumonia in medical practice. 
It has been a feared disease with a high mortality, presenting as an 
infection of one or more lobes of the lung by bacteria, virus or fungus. It is 
an infection of the alveolae, forming a solid mass with the production of 
purulent sputum, but little oedema. On X-ray, unlike ARDS it may only 
involve several lobes, but unfortunately it may also involve both lungs when 
it is indistinguishable from ARDS and is referred to as broncho pneumonia. 
Additionally when pneumonia involves only one lung, the infection can 
cause ARDS to develop in both lungs. Before ARDS was described, all deaths 
from hypoxemia were called pneumonia. Pneumonia can also cause MSOF, 
as many patients with pneumonia have renal failure and hepatic problems. 
Despite the use of antibiotics, the fatality rate in pneumococcal bacteraemia 
rem ains high. A ustrian and Gold (1964) described 529 adults with 
bacteraemic pneumococcal pneumonia who despite appropriate antibiotic 
therapy had a mortality of 25%. Fruchtman et al. in 1983 described 10 
patients with pneumococcal pneumonia who developed ARDS. Elderly 
patients who died from pneumococcal pneumonia usually did so without 
developing ARDS. But 10 young patients, with a median age of 33 years, 
developed the syndrome and 5 died. The most likely cause of death among 
this group of patients was the development of ARDS and MSOF as a 
complication of pneumonia.
The development of ARDS and MSOF is likely to arise from the 
inflammatory focüs provided by the tissue damage resulting from lung 
infection. The dam aged pulm onary tissu e cannot be rem oved or drained 
and therefore the cascade of events resulting in septic shock and death 
cannot be stopped. The use of antibiotics, when given early, could stop the 
spread of the disease and by containing the damage to pulmonary tissue.
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prevent the development of a large persistent focus which initiates the 
inflammatory response. But, when ARDS is established they are unlikely to 
reverse the course of the syndrome.
Military multi- trauma.
The history of ARDS has been seen more in connection with traum a 
especially when associated with the battlefield. When a soldier dies from 
pulmonary dysfunction several days after successful surgical repair of leg 
traum a the problem is quite apparent. Unfortunately battlefield traum a was 
often associated with infection, whether real or assumed, and was thought 
to be the cause of death. Only since the end of the second world war has the 
distinction between infection and trauma been easily and clearly made.
Pulmonary damage in response to battlefield injuries has been known 
for many years. Descriptions of the condition in response to traum a without 
sepsis during World War 1 are very uncommon. Mayo-Robson in 1918 stated 
"virtually all war wounds, with the exception of some bullet wounds, are not 
only septic but virulently septic; this is due to contamination of the skin and 
clothing, as well as the fragments of shell and other foreign bodies driven 
into the tissues, by the germ saturated soil of the highly cultivated lands of 
France and Belgium."
Pasteur (1913) is often quoted in current literature as describing 
ARDS in wounded soldiers during the first world war. He is supposed to 
have described pulmonary dysfunction as' acute massive collapse," in 
response to battlefield injuries. His work was in fact produced in 1913, a 
year before the outbreak of the war, and was concerned with pulmonary 
problems occurring after abdominal surgery. The "acute massive collapse," 
he described was rarely fatal and did not resemble ARDS. Most patients 
developed this condition after surgery but recovered from it.
Soldiers of World War 1 did not receive fluid replacement therapy and 
arrived a t hospital for surgical treatm ent at least 72 hours after injury.
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Thus most of the severely injured patients who may have developed MSOF, 
died before arrival a t the hospital from their original injuries or shock. 
Those who did arrive at the institution would be shocked and cyanotic, their 
deaths recorded as due to either infection or the original trauma.
During World War II, although the wounded were hospitalised at an
increased speed, Burford et al. in 1945 showed that although most patients
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were first seen more than 72 hours after injury, about 30% were seen within 
24 hours and treated rapidly. They were shocked and cyanotic before 
undergoing surgery and received some fluid replacement. Unfortunately 
their life expectancy was only extended several days. An accurate way of 
m easuring fluid volume was not available, and the fluid replacement 
therapy was usually inadequate. Consequently the patients continued to 
suffer from shock, hypotension, and usually died from renal failure. There 
was little mention of sepsis in these traumatised subjects.
Although Burford (1945) further described "traum atic wet lung" 
among his wounded patients, examination of his published chest X-rays 
show that the patients were suffering from lobular pulmonary oedema as a 
result of contusions of the lung. This "traumatic wet lung" is not the low 
pressure bi-lateral pulmonary oedema associated with ARDS, and the 
patient usually recovered.
Mallory et al. (1950) described pulmonary lesions in tissue taken from 
patients who died from shock during World W ar 11. They originally 
examined tissue a t necroscopy from battle casualties dying up to 12 hours 
after injury and found little evidence of histological changes specifically 
associated with shock. However when they extended their investigation to 60 
patients who survived injury more than 18 hours they found a constant 
pattern of specific pulm onary changes. The lungs were never normal and  
had a variety of pathological features. It can be seen in Table 3 that all lungs 
examined were congested, and most showed oedema, collapse and 
haem orrhage.
_________________________________________________ IS.
Table 3. Pulm onary  pathological finding in  deceased m ulti-traum atised  
soldiers who survived shock for a t least 18 hours. (Mallory et al. 1950)
Symptoms_________________ % of symptoms present
congestion_______________________ 100
oedema 86
atelectasis 70
intra-alveolar haemhorrage_______ 55
interstitial haemhorrage__________ 25
pneumonia______________________ 30
Mallory et al. (1950) established that pulmonary oedema was never a 
cause of shock, but developed as a result of the shocked condition, often in 
association with sepsis and acute renal failure. They claimed tha t the 
oedema was not due to fluid overload as infusions of volume expanders or 
blood were strictly controlled, although they did not report how the latter 
was achieved. It is likely tha t these patients were shocked due to this fluid 
restriction. The importance of the work of Mallory et al (1950) is that it 
established for the first time the relationship between shock in traumatised 
patients and the development of lung damage. Secondly that it  only occured 
in those patients who survived the initial injury for a t least 18 hours. Death 
earlier than  this period was usually due to the original injury. They 
additionally found no correlation between fat embolism, shock and 
pulmomary dysfunction
Jenkins et al. in 1950 were the first group to understand tha t they 
were dealing with an unfamiliar pulmonary condition. They named the 
condition "congestive atelectasis". They described the clinical course of 8 
patients with "congestive atelectasis" and presented the autopsy reports of 
the 7 who died. All the patients had abdominal surgery for a variety of 
reasons from gunshot wounds and ruptured appendix to perforated ulcers. 
On x-ray they could see that some of the patients had pulmonary oedema.
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thought to be associated with left heart failure. Although, they gave 7 of 
their patients digitalis, none showed any improvement and all died. From 
these observations they deduced th a t the oedema was unlikely to be 
cardiogenic in origin, as some patients should have improved with 
treatment. They also noted that, unlike obstructive atelectasis described by 
Pasteur in 1913, the congestive type always effected both lungs and was 
nearly always fatal. They referred to autopsy reports showing tha t 6 patients 
having abdominal surgery for gunshot wounds or gastric problems had 
evidence of non-cardiac pulmonary oedema and capillary congestion, 
symptomatic of ARDS.
They also performed some studies on dogs to elucidate the aetiology of 
the condition. Blood was radio-labelled with phosphorous 32 and a plexiglas 
window was inserted in the chest to view the lungs. When a leg tomiquet, 
previously fastened for 90 minutes was released, there was a threefold
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increase in pulmonary blood volume and haemorrhagic patches developed. 
The lungs became very stiff showing a loss of compliance when the left 
atrial pressure fell. The opposite would have been expected if the oedema 
was due to heart failure. They had shown, for the first time, the presence of 
low pressure permeability oedema in the lungs. On autopsy, lung tissue 
appeared similar to liver, it was congested and oedematous. In their radio­
labelling studies, they observed a threefold increase in emissions from the 
lungs. They thought it represented an increase in pulmonary blood volume 
as they considered tha t only labelled red blood cells. I t undoubtedly also 
labelled leucocytes, and most likely represented the discovery of the now well 
known pulmonary leucostasis occurring in ARDS.
Unfortunately, in 1950 they did not understand the findings described 
in  their work from either the p atien ts or anim al experim ents. In the 
patients they thought tha t the oedema and congestion was caused by the 
over administration of fluids. This thinking confused the understanding of 
the syndrome and lead to a fruitless argument about the relative values of
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giving crystaloids or colloids to patients for many years. It also reflected the 
poor understanding of adequate volume therapy in these shocked patients. 
This attitude was to be maintained until relatively recent times.
It is interesting to note the rudim entary equipment Jenkins et al. 
were working with in 1948. Ventilators were not in use a t th a t time. 
Pressure measurement of the left atrium involved opening the thorax of his 
experimental animals to insert a left atrial catheter. This la tter procedure 
demonstrates the difficulty of measuring patients left heart pressures and 
consequently the realisation that low pressure oedema even existed.
Interestingly, there were no reports documenting awareness of 
respiratory failure after traum a or shock during the Korean war in the 
early 1950's.
The Vietnam war
The Vietnam war in the 1960's brought about a complete change in 
the treatm ent of multi-traumatised soldiers. They were given vigorous field 
resuscitation, rapid evacuation to a hospital and prompt surgical treatm ent 
of their injuries. The improved intra-vascular volume expanders, renal 
dialysis, ventilators and early surgery prolonged the lives of seriously 
wounded personnel. The period of hypovolaemic shock suffered by the 
soldiers was shortened and the incidence of renal failure reduced. But it 
was discovered th a t soldiers who were initially resuscitated from their 
battlefield iiyuries went on to die of severe respiratory dysfunction. Soldiers 
subjected to severe shock and tissue traum a were more than  usually 
susceptible to pulmonary dysfunction and death in the post operative period.
Simmons et al. in 1969 showed that of 96 patients who died with and 
without thoracic wounds, only 3 had norm al lu n g  w eights. Pulm onary  
oedema and congestion were present in 80% of cases. When they looked at 
314 combat casualties suffering non-thoracic wounds, Simmons et al. found 
tha t the great majority had some degree of hypoxemia and 20% had severe
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respiratory distress. Even in the absence of shock most of the wounded had 
respiratory dysfunction. Martin et al. in 1969 studied autopsy reports and 
published their findings from 100 patients. They were able to show that 62% 
of deaths occurred after a week, but in most patients, this was not due to the 
initial injury. The lung weight of 94 patients was in excess of 1000 g, 
suggesting considerable pulmonary congestion. Proctor et al. (1970) during 
the Vietnam war studied three groups of multi-traumatised soldiers: bed 
rest controls w ith minor injuries, massively traum atised  w ithout 
respiratory failure and a similar traum atised group with respiratory 
failure. They were able to show that all three groups had respiratory failure, 
but to different degrees. Those patients described clinically as having 
respiratory failure were the most severe cases, but all the patients had some 
degree of failure in response to their trauma. This data suggests tha t tissue 
damage, especially when associated with shock, caused the development of 
respiratory dysfunction, often with fatal outcome.
I
Civilian multi-traiima
Ashbaugh et al. (1967) were the first to describe this syndrome after 
traum a in civilians as a separate entity in clinical practice. They thought 
the condition was due the lack of alveolar surfactant as in infant respiratory 
distress syndrome and used the term “adult respiratory distress syndrome”. 
This nomenclature was la ter shown to be erroneous, as the lack of 
surfactant was a result of acute lung injury not its cause. This work drew 
attention to the presence of a syndrome manifest by pulmonary dysfunction 
th a t is distinct from pneumonia. Many of these patients died from acute 
respiratory failure in the first 48-72 hours.
Petty and Ashbaugh in 1971 showed th a t with vigorous treatm ent 
including the use of ventilators using positive end-expiratory pressure 
(PEEP), fluid restriction, diuretics and salt-poor albumen, most patients
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survived the early phase of respiratory distress. But unfortunately many 
still died at a later stage.
Ashbaugh and Petty in 1972 looked at a group of patients to determipe 
the causes of death after they had received the therapy described in their 
1071 study. They wcro able to show that patients rarely died from hypoxemia 
in the early stages, but went on to die from the failure of several other 
organs as well as the lungs or from sepsis. Autopsy results always showed 
severe lung damage, that was not necessarily the cause of death.
In this group of 51 patients, 21 survived, but 30 died. Nine of these 
patients did not have respiratory failure and died from other causes. Six of 
these 9 died from sepsis. All the remaining 21 patients had some degree of 
respiratory failure, and 16 had sepsis as a major cause of death. Other 
contributing factors were renal failure in 11, central nervous system injury 
in 7, disseminated intravascular coagulation in 5, cardiac failure in 4 and 
other causes in 8. Twenty seven of 31 patients had autopsies performed at 
the time of death. The lung of all those patients were heavy and airless, This 
important work suggests th a t although better therapy eould prevent the 
patients from dying from aeute respiratory failure in the first 48-72 hours, it 
merely allowed the development of more severe injury to the lungs and 
multi-organ damage to occur.
In fact MSOF was almost non-existent as a distinct syndrome before 
ARDS patients were ventilated. Most died from hypoxaemias before MSOF 
could develop as a distinct syndrome. ARDS is a clinical term  expressing 
the most apparent feature of MSOF; hypoxemia and pulmonary X-ray 
pictures showing opacity. The failure of other organs such as the liver, 
kidney, blood and heart are not as obvious. ARDS appears to be the 
pulmonary aspect of the developing multi-system organ failure.
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M ulti system  organ failure
Tilney et al. in 1973 published the first detailed study of MSOF. They 
reported a retrospective study in 15 patients who underwent surgery for 
aortic aneurysms, showing th a t organ failure developed in the pancreas, 
lungs, liver, heart, kidney, brain or gastrointestinal tract. Fourteen patients 
subsequently died. The pulmonary failure th a t developed was typical of 
ARDS, and the organ failure was typical of that la tter recognised as MSOF. 
All the patients were ventilated on a mechanical respirator and the authors 
considered tliat the majority of patients died from respiratory failure. This 
paper was based on analysis of data extracted from the files of past patients. 
Although it shows the existence of MSOF it tells little of its relevance to 
surgery for aortic aneurysms. We do not know the occurrence of this 
condition in the total population of such surgical cases. We do not know why 
it developed or how many patients did not develop MSOF.
There was an implicit assumption tha t patients who die from ARDS 
do so from respiratory failure. They were thought to be unable to oxygenate 
arterial blood sufficiently, causing inadequate oxygen consumption by the 
body. Consequently it was assumed that if the blood could be oxygenated 
artificially then the patient could survive.
P ratt (1979) of the American National Heart, Lung and Blood Institute 
reported on a multi-centre randomised prospective study using extra- 
corporeal membrane oxygenation to support patients with severe ARDS 
between 1975 77. Half the patients wore supported by oxygenator, the other 
half did not receive such support. They hoped to reduce mortality by giving 
respiratory support to these patients. But, the optimistic expectations were 
unfortunately not realised.
The investigators showed that membrane oxygenation had no clinical 
benefit, 90% of patients in both treatment groups died. It was the first mqjor 
study of a large number of ARDS patients, meticulously studied before and 
after death. The study showed that survival could not be related to initial
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lung function. Surprisingly, they found tha t death could be attributed to 
hypoxemia in only 17% of patients. Most patients with ARDS did not die 
from respiratory failure: They died from multi-system organ failure; renal, 
hepatic or cardiac or from their initial medical problem. I t was also 
demonstrated that, although patients did not die from pulmonary changes, 
they showed pathological changes in up to 3 weeks that had previously been 
thought to take months to develop.
Important work in showing MSOF in patients previously thought to 
have ARDS was performed by Montgomery et al. (1985), shown in Tables 4 
and 5. This work showed tha t most deaths from ARDS are not caused by 
hypoxemia.
T able 4. The outcom e of 207 p a tien ts  a t  r isk  from  develop ing  ARDS.
(Montgomery et al. 1985)
ARDS group num ber of patients
survivors
deaths 32
total 47
Non-ARDS group
survivors 105
deaths 55
total 160
They either died from their original presenting illness or injury, sepsis or 
the failure of other organs. They looked at 207 patients prospectively as being 
at risk of developing ARDS. Forty seven per cent (87 of 207) of the patients 
having risk factors for ARDS died. Sixty eight per cent (32 of 47) of the 
patients developing ARDS died, compared to 34% (55 of 160) of the patients 
with similar risk factors who did not develop ARDS.
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Patients who died were classified into early, up to 72 hours, and late, 
after 72 hours from the time of their injury, are shown in Table 5. Early 
deaths were usually caused by the original presenting illness or injury, 8 
out of 10 in the ARDS group and 24 of 25 in the non ARDS group.
T ab le  5. T he c a u se s  o f  d e a th s
groups.(Montgomery et al. 1985)
in  th e  ARDS a n d  non-ARDS
ARDS group Non-ARDS group
early death late death early death late death
n=10 n=22 n=25 n=30
organ failure as a  cause of death
sepsis 3 8 3 15
cardiac 1 5 1 1
respiratory 1 4 0 2
brain 3 4 13 10
haemhorrhagic 2 1 8 1
hepatic 0 0 0 1
The cause of late death in both groups was from complications tha t 
developed after entry into the study, 19 of 22 in the ARDS group and 20 of 30 
in the non-ARDS group. Sepsis syndrome was the primary cause of late 
deaths of 8 patients in the ARDS group (36%), and was a contributing factor 
in a further 8 patients. Cardiac dysfunction (23%) was the next biggest 
cause of death. But surprisingly, irreversible respiratory failure was 
responsible for only 5 of the 32 ARDS deaths (16%), 4 of these 5 patients had 
sepsis syndrome a t the time of death. Most of the patients with ARDS at the 
time of death had multi-system organ failure and sepsis syndrome.
Montgomery et al. (1985) concluded from this study that patients with 
ARDS do not usually die from respiratory failure. Some died early from the 
underlying illness or injury, but most late deaths, with and without ARDS,
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were a result of the sepsis syndrome. Most ARDS patients who died, had the 
failure of three or more organs.
Monitoring
The importance of monitoring, in the diagnosis, understanding and 
treatm ent of ARDS, cannot be overstated. From the early days of this 
century up until the mid 1950's, a suitable method of measuring a patient’s 
blood volume, left atria l pressure or cardiac output was unavailable. 
Measurement of the central venous pressure (CVP), left atrial pressure 
(LAP) or reflected LAP, the pulmonary capillary wedge pressure (PCWP) 
indicates a patients' blood volume and allows control of fluid replacement
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therapy. Fluid replacement therapy did not s ta rt until early in the fifth 
decade, and did not become common place until the late 50's. Pulmonary 
oedema caused by (left ventricular) heart failure is diagnosed by the 
presence of high LAP or PCWP. When associated with a low LAP, it 
signifies an increased pulmonary capillary permeability. Cardiac output 
(CO) is a measurement of the blood volume ejected by the heart in 1 minute 
and is im portant in determining the patients haemodynamic status. 
According to Starlings' law (Starling 1896, 1918), CO increases with the 
raising of left atrial pressure. Measurement of CVP, by inserting a catheter 
into the right atrium via the internal jugular vein started in the mid 195(j's, 
but was not in widespread use until the early 1960's. Although CO and left 
atrial pressures could be measured in the 1960's they were cumbersome 
techniques, not appropriate for bedside use with very sick patients.
Swan et al. in 1970 developed the use of a triple lumen balloon catheter 
tipped with a thermistor, easily floated into the pulmonary artery via the 
femoral or brachial vein, allowing blood sampling, the measurement of 
PCWP, pulmonary artery pressure and CO. When measurement of these 
param eters became more accessible, the presence of ARDS became more 
apparent. '
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The understanding of ARDS and MSOF during sepsis, unlike 
trauma, developed in the late 1960's and early 1970's with the widespread 
use of the Swan-Ganz catheter. The acceptance of thermodilution flow 
directed pulmonary artery catheters in the intensive care unit made the 
m easurem ent of PCWP, CO and mixed venous oxygen saturation  
commonplace. Clinicians could characterise pulmonary oedema as either 
"permeability oedema" or "hydrostatic oedema ". These values permitted the 
rapid calculation of the systemic and pulmonary vascular resistances, 
intrapulmonary shunt fraction, oxygen delivery to tissue and the oxygen 
consumption by the tissues.
Mechanical ventilators.
A ventilator is a machine that delivers pulses of gas to a patient a t a 
controlled rate, volume and pressure. Although these machine have been 
used for nearly 80 years it  was not until the Copenhagen poliomyelitis 
outbreak in 1951 th a t they gained widespread use. Polio damages the 
breathing mechanism, ultimately leading to the death of the patient unless 
artificial ventilation is applied. Teams of medical students were employed to 
pump bags filled with oxygen and nitrous oxide, and later air into the lungs 
of such patients to sustain life in those affected with bulbar paralysis. Some 
patients were hypoventilated and others hyperventilated on the wrong 
volume of air by over or under enthusiastic medical students. Two Danish 
anaesthetists designed and mass produced machines th a t delivered the 
correct volume of gas, a t the required pressure, and desired rate.
Patient ventilation prior to 1951 was very poor, relying on spontaneous 
breathing. Thus when a patient developed a respiratory problem his demise 
would be fairly rapid. Under these circumstances it  can be seen tha t 
patients who might have developed ARDS would die before the gross 
pulmonary changes could occur. Although ventilators were used widely in 
the operating theatre, it was not until the mid 60 s that they began to be used
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in intensive therapy units. Since the aggressive use of ventilation by Petty
and Ashbaugh in 1971, few ARDS patients die purely of hypoxemia.
!
Unfortunately, they usually go on to develop and die from multi-system 
organ failure.
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C hapters.
Causes o f ARDS and MSOF.
Section 1. Sepsis, Septic Shock and the Septic Syndrome.
Section 2. Trauma.
Section 3. Oxygen Deprivation.
Section 1.
Sepsis, S ^ tic  Shock and ihe Septic Syndrome.
Introduction.
Infection is considered the greatest risk factor from which ARDS is 
likely to develop. The terms in common use when discussing infection 
should first of all be defined. B a c te ra e m ia  indicates the presence of 
potentially pathogenic bacteria in the blood with few signs of infection. 
Endotoxemia  denotes the presence of measurable amounts of endotoxin or 
lipopolysaccharide in the systemic circulation. Sepsis denotes infection due 
to a variety of microorganisms or their toxins, associated with fever and 
toxic reactions. Sepsis syndrome  is defined as the systemic response to 
sepsis as shown by hypo- or hyper-thermia, tachycardia, tachypnea and 1 of 
the following; altered mental status, hypoxemia, lactic acidosis or oliguria. 
But there may not be a positive blood culture. S ep tica em ia  is a clinical 
syndrome commonly considered to be caused by gram negative or positive 
bacteria. Such a condition is usually associated with fever, hyper or 
hypodynamie circulatory shock, oliguria, lacticacidosis and pulmonary 
oedema, and has a positive blood culture. Septic shock describes a condition 
of cardiovascular collapse due to septicaemia.
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N um erous papers have been published  show ing the association  
between sepsis, especially gram negative bacteraemia, and ARDS. The most 
frequently isolated micro-organisms are E. coli (30-40%) K le b s ie l la ,  
Pseudomonas and Serratia. Only 25-35% of patients with bacteraemia wiU
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develop septicaemia (Ellner 1983). A study (Dupont and Spink 1969) of 172 
children with gram-negative bacteraem ia, showed th a t septic shock 
developed in only 25%, but they had a mortality rate of 98%. Over the past 20 
years there has been a twenty-fold increase in the incidence of Grain- 
negative sepsis in the U.S.A. (Cavanagh et al. 1982), There are over 300,000 
cases per year, 25% of whom develop septic shock (Ellner 1983) with 70,000 
deaths.
Septic shock rarely presents itself as a community acquired disease. 
It is associated with hospitalised patients, especially those in intensive care 
un its w ith indwelling catheters or undergoing abdominal surgery. 
Approximately 1% of hospital admissions in the U.S.A. are complicated by 
gram negative sepsis, the genito-urinary tract is the most common site of 
infection, followed by the gastrointestinal tract and the respiratory tract. ^
Clowes in 1974 showed by an analysis of 8000 consecutive admissions 
to the surgical departments of 2 hospitals in Boston, U.S.A. that there was 
an overall mortality of 2.1%. Respiratory failure alone was responsible for 
58% of these deaths, rising to 75% when present with severe sepsis. Thus it 
was apparent tha t sepsis played the single greatest role in the induction of 
fatal pulmonary lesions.
Kaplan et al (1979) identified 20 cases of ARDS from 86 cases of Gram- 
negative bacteraemia, an incidence of 23%, as shown in Table 6. The 
m ortality of patients with ARDS was 90%, and w ithout ARDS 55% 
respectively. Shock (systolic blood pressure less than 90 mmHg) was present 
in 13 patients with ARDS and in 5 patients without ARDS.
S i
Table 6. Com parative m ortalities of ARDS and  non-ARDS patients from 86 
w ith Gram-negative infection.(Kaplan 1979)
ARDS Non-ARDS
n % n %
Number of patients 20 23 66 76
Shock 13 65 5 8
Mortality 18 90 36 55
Postmortem of 7 patients diagnosed as having ARDS revealed 5 
patients as having pathological findings, typical of ARDS. In the non-ARDS 
group oil of the 12 patients examined postmprtom showed either completely 
normal lungs or pathological findings not usually associated with ARDS.
Table 7* Influence of shock on 116 consecutive bocteraemic patients w ith nn<^
w ithout ARDS. (Fein 1983)
ARDS Non-ARDS
n % n %
Number of patients 21 18 95 82
Died 17 81 33 34
Survived 4 19 62 65
Shock present 21 100 12 15
Died in shock 17 81 11 12
Died without shock 0 0 21 22
Class of micro-organism found in the blood
gram -ve 17 81 58 61
gram +ve 3 14 36 39
fungal 1 4 1 1
Fein et al. (1983) reported 116 consecutive patients with documented 
septicaemia. His data, shown in Table 7, found tha t ARDS occurred in 21
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patients and of the 17 of whom died, 12 or 60% had gram negative infection. 
The original medical problem was usually the cause of death in non-ARDS 
patients who died without shock.
The work of Kaplan in 1979 and Fein in 1983 dem onstrate the 
increased risk of developing ARDS when infection was present. There was a 
further increase when shock developed. Both factors developing together 
produce a very high risk of death. It should also be pointed out tha t there is 
an increased risk of shock developing in ARDS patients.
These two pieces of work unfortunately leave several questions 
unanswered. From what did the non-ARDS patients die? W hat was the 
nature of the shock both groups were suffering from, and was it the same 
type of shock? Did patients from either group suffer from the failure of 
organs other than the lungs? Did the heart and arterio venous system 
respond in a similar manner in both groups?
The most recent large study involving sepsis and MSOF was the 
placebo data from the Veterans Administration study of steroid treatm ent in 
septic shock. This study by Bone et al. (1989) describes patients with the 
sepsis syndrome in a group of 191 prospectively evaluated patients. 
Bacteraemia was defined as the presence of one positive blood culture 
obtained within 48 hours of entry into the study. Shock was defined as a 
sustained decrease in the systolic blood pressure of a t least 40mm Hg from 
baoelino or a systolic BP of <90 mmHg after adequate volume replacement. 
The data presented in Tables 8 and 9 is tha t recorded in the first 24 hours of 
the study. Forty-five percent (84/191) of the patients were bacteraemic and 
would fill the traditional definition of sepsis. The other 107 patients were 
non-bacteraemic. ;
___________________________________________________________________________________ m .
Table 8. Com parison of the 191 bacteraem ic and  non-bacteraem ic patients
variable Bacteraemic non-bacteraemic
num ber 84 107
systolic BP (mmHg) 103 103
diastolic BP (mmHg) 57 59
temperature °F 101.5 101.6
bicarbonate (mEq/L) 21 22
Table 8 shows th a t there is no significant difference between the 
bacteraemic and non-bacteraemic groups in the variables shown.
Table 9. Significant differences between septic shock and sepsis syndrome in  
the 191 patients studied. (Bone et al. 1989)
variahle sepsis syndrome alone septic shock
num ber 122 69
systolic BP (mmHg) 114 83
diastolic BP (mmHg) 65 47
temperature °F 102.0 100.8 ;
bicarbonate (mEq/L) 23 20
Shock was noted in 69 (36%), patients. Temperature, systolic and 
diastolic blood pressure, p la telet count and bicarbonate were all 
significantly lower in the septic shock group compared to the sepsis 
syndrome alone. A comparison of Tables 8 and 9 shows th a t the patients 
cannot be divided by the presence or absence of bacteria. The division 
between the groups is better shown by comparing the presence or absence of 
shock.
The occurrence of septic shock was slightly higher in the bacteraenpc 
than non-bacteremic patients (47% compared to 30%). But there was no 
significant difference between the Gram-negative and positive bacteraemias 
regarding the development of shock. There was also no significant
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differences observed in the time to develop shock between the bacteraemic 
and non-bacteraemic patients.
Total mortality for all patients was 26% (49/191). Patients with sepsis 
syndrome died a t significantly lower rate than those with septic shock. 
Bacteraemic and non-bacteraemic patients did not differ in their mortality 
rates.
Data relative to the development of ARDS in this study is available in 
162 patients. ARDS developed in 38 patients, reversal occured in 23 (63%) 
and 15 (37%) died. Unfortunately this study does not show in which groups 
the ARDS patients were found. But it does show tha t the sepsis syndrome 
does not require the presence of a positive blood culture or hypotension 
which is integral to the diagnosis of bacteraem ia and septic shock 
respectively. The septic syndrome is defined as the systemic manifestation 
of presumed sepsis. It could equally be defined as the systemic response to
V
tissue injury th a t does not require the presence of micro-organisms. When 
only 84 out of 191 patients with septic syndrome could demonstrate a positive 
culture for micro-organisms then, either the test is very poor, giving a very 
high false negative count, or there were no micro-organisms present. The 
other possibility is tha t the patients systemic response was to tissue damage, 
not the presence of micro-organisms. If this is true then ARDS m ust be 
considered to develop from the systemic response to tissue iiyury.
These three studies show one of the major problems in studying 
ARDS. There is an assumption tha t sepsis has the greatest risk for the 
development of ARDS. This is partly due to the large number of papers 
coming from hospital medical departments who naturally report on sepsis. 
There are no studies in the literature describing a prospective analysis of a 
large number of consecutive patients entering a hospital developing ARDS 
and describing the precipitating cause of the condition, from all the 
departments of a general hospital. All of the studies are selective, they are 
from one departm ent of a hospital, or only include a selected group of
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patients. It is necessary to perform a study including consecutive patients 
with positive and negative blood cultures, in addition to the other causes of 
ARDS.
Two aspects of the definition of sepsis are an identified source of 
infection and a systemic response to tha t infection. The systemic response 
includes both the hyperdynamic and hypermetabolic aspect. Those patients 
having a systemic response are defined as having hypermetabolism or 
sepsis*' syndrome. Only some of these patients have identifiable micro­
organisms, as shown by Bone et al. (1989). Septicaemia is a systemic 
response to infection usually characterised by a toxic picture of fever. This 
infection classically produces an acute inflam m atory reaction, often 
associated with bacteraemia. Bloodbome cytotoxic mediators appear to elicit 
the septic systemic response to infection and inflammation. In addition, a 
sim ilar clinical picture can be evoked in catastrophic injury which is 
associated w ith tissue inflam mation and necrosis, such as multiple 
trauma, massive bums, pancreatitis or tissue hypoxia.
Many cases of gram-negative bacteraemia originate from an obvious 
infectious site, e.g. peritonitis, intra-abdominal abscess, pyelonephritis or 
pneumonia. The majority of cultures taken from a septic patient are 
negative. This finding can be due the presence of antibiotics in the blood, the 
difficulty of finding micro-organisms in the 5 ml of blood taken for culture or 
the effectiveness of the reticulo-endothelial defense system in clearing the 
invading organisms. However, quite often and especially in cases of severely 
impaired host defense, no primary focus can be detected. These patients 
have septic syndrome. They have a systemic and metabolic response 
typically seen with infection, but without any apparent source. Even post 
mortem examination can fail to identify a septic focus.
Seidenfeld et al. described (1973) the prospective study of 129 intensive 
therapy unit (ITU) patients who developed ARDS, 108 of whom were 
infected, described in Table 10. They examined the organism responsible.
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the body sites involved and the outcome of therapy. Table 10 shows the 
primary causes of ARDS in their patients and clearly demonstrates that 
infection was the principal cause. Although 73 patients had an infection as 
the primary cause, 108 patients developed what was thought to be an
j
infection.
T able 10. D iagnosis associa ted  w ith  th e  developm ent o f ARDS in  129
survivors and  non-survivors. (Seidenfeld et al. 1973)
Survivors non-survivors
n = 37 n =92
Cause
Sepsis 10 36
Pneumonia 8 19
Traum a 3 6
GI bleed 2 7
Pancreatitis 3 3
Carcinoma 0 8
Postoperative 6 5
Miscellaneous 5 8
Pneumonia associated with the development of ARDS occurred in a 
high percentage of survivors who had it as a persistent complication (7 of 8).f,-’
Only 19 non-survivors presented with pneumonia. However, 49 had it  as a 
complication from other non-septic causes of ARDS. Tables 11 and 12 show 
in more detail the patients described in Table 10. Table 11 shows tha t the 
non-survival rate was far higher in patients in whom there was lung and 
thorax involvement.
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ az
Table 11. Clinical and  autopsy diagnosis of m igor sites of infection in  lOZ 
patien ts w ith  ARDS. (Seidenfeld et al. 1973)
Survivors
n = 33
Non-survivors
n =70
Sînglp site.
Lung 6 45
Abdomen 10 7
Soft tissue 1 3
Other 1 4
Table 12 shows tha t when patients had no infection the survival rate 
was greater, although 33% died. But most importantly Table 12 shows when 
there was a positive blood culture and the site of sepsis was unknown, and
■' JTable 12. Characteristics of infections in  129 patients w ith  ARDS by bloo^ 
cu lture and  clinical diagnosis. (Seidenfeld et al. 1973)
- Survivors
n
Non-survivors
n
num ber of patients 37 92
No infection 14 7
Positive blood culture
site known 11 18
site unknown 0 9 if*
Negative blood culture
site known 8 45
Clinical sepsis 4 13
Antibiotic therapy
Adequate 20 49
Inadequate 3 10
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therefore could not be physically removed, the mortality rate was 100%. 
Table 12 also shows th a t of 108 patients thought to be infected, 53 had 
negative blood cultures. When the blood culture was negative, a common 
finding in clinical medicine, and the site unknown, the death rate was also 
very high. When the patients had clinical sepsis the mortality rate was 75%. 
The death rate was exactly the same regardless of adequate or inadequate 
antibiotic therapy.
These data suggest tha t some patients who were considered to be 
infected or septicaemic may never have been infected. The condition called 
septic shock may be a syndrome reflecting the body's response to tissue 
damage from many causes including bacteria. Sepsis is often associated 
with gram negative infection. Endotoxin is therefore thought to be the 
principle stim ulator of this response. But gram positive infection was 
present in 30% of patients, consequently endotoxin was not present.
When the infection was established antibiotic therapy had little effect 
on mortality in this syndrome. The syndrome appears to be a devastating 
whole body secondary response to the damage caused by bacteria or other 
insults.
The importance of this work is in showing th a t a focus of tissue 
damage, whether infected or not, or containing dead bacteria, can produce 
the whole body inflammatory reaction th a t is overwhelming and causes 
further extensive tissue destruction.
Clinical m anifestation o f sepsis.
In 1888 Roux and Yersin described abnormal regulation of blood flow 
following an intravenous ipjection of live diphtheria bacilli into rabbits. 
Multiple haemorrhages and microthrombi were found in kidneys, lungs 
and adrenals. Welch and Flexner (1891) injected live diphtheria bacilli and 
subsequently observed thrombi occluding the lumina of the glomerular 
capillaries.
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Mammals infected with gram-negative bacteria often develop a state of 
shock characterised  by hypotension, d issem inated  in trav ascu la r 
coagulation, and organ dysfunction. These descriptions of the effects seen 
after the administration of bacteria, such as changes in blood coagulation, 
the occurrence of microclots and haem orrhages, are the earliest 
oboervationo on the offbcto of bacterial producto in organ dysfunction and its 
consequences.
In 1948 Spink et al. found th a t on adm inistering antibiotics to 
bacteraem ic patien ts, they became fevered, hypotensive and had 
tachycardia. They suggested th a t endotoxin from Brucella  m elitensis  
induced the shock like syndrome. Waisbren in 1951 further described the 
clinical picture of septic shock. He described two patien t groups with 
clinically distinct characteristics. The first group was classified as toxic and 
consisted of animated patients with hot, dry, flushed skin, and called, 
"warm shock". The second group were hypotensive, lethargic and 
apprehensive with cold clammy skin, and referred to as "cold shock". These 
two groups are now recognised as the hyperdynamic and hypodynamie 
phases of septic shock. The term bacterial shock was not introduced until 
1963 by Shubin and Weil who considered that the patients were suffering 
from distributive shock, so named because of the defect in blood volume 
distribution.
Septic Shock
The term shock (choc) was first used by the French physician LeDran 
in 1773 to describe the clinical sequence seen in patients after severe 
gunshot trauma. Clinically, shock is a syndrome th a t is a manifestation of 
circulatory failure. I t is often recognise by the onset of hypotension, but does 
not necessarily start with it, as in septic shock. Shock is a maldistribution of 
the microcirculation, resulting in a reduced oxygen consumption (V02) 
relative to metabolic needs. It can be cardiogenic, which is a maldistribution
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due to inadequate blood supply to the microcirculation, arising from poor 
cardiac function. Haemorrhagic shock is similar to cardiogenic shock but jis 
due to inadequate blood volume circulated to the microcirculation. Both 
cardiogenic and haemorrhagic shock result in  vasoconstriction of certain 
organ beds as an adaptation to maintain blood flow to vital organs such as 
brain and heart. But shock associated with traum a or sepsis is a distributive 
shock, associated with inadequate blood supply to the microcirculation, that 
might be considered high compared to cardiogenic or haemorrhagic shock, 
or even the basal state. But the blood is not distributed to organs and tissues 
in appropriate volumes relative to its needs. I t is differentiated from the 
other types of shock by the reduction in systemic vascular resistance, 
producing vasodilatation. This dilatation is not fully compensated for by an 
increase in cardiac output, consequently the blood pressure falls.
The typical clinical picture of shock in septic patients is fever, 
confusion, shortness of breath and eventually hypoxemia and hypotension. 
At first the blood pressure responds to fluid administration and the patient 
shows evidence of a hyperdynamic circulation with an increased metabolic 
rate. This phase is followed by protein wasting, peripheral oedema and 
deteriorating function of the brain, lungs, liver and the kidney. Finally, the 
falling blood pressure is unresponsive to fluid administration and if cardiac 
stim ulants (inotropes) are unable to support the circulation, the patient 
dies.
The in itia l stage of septic shock is characterised by fever, 
h yp erven tila tion  and respiratory alkalosis. These m anifestations are 
associated with an increased cardiac output and pulse pressure, with a 
striking decline in systemic vascular resistance and narrowing of the 
arterio venous oxygen difference. Oxidative metabolism is compromised 
and the oxygen debt is thought to be reflected by the development of lactic 
acidosis. This hyperdynamic state is thought to be mediated by endogenous 
vaso-dilators such as endorphins, kinins, prostaglandins and histamine
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and is characterised by warm extremities, often referred to as "warm 
shock".
However, progression of the shock state is followed by the more 
fam iliar "cold shock", with progressive hypotension, cooling of the 
extremities and anurea. These clinical features are associated with a 
decreased cardiac output and pulse pressure, increased systemic vascular 
resistance and marked lactic acidosis. Although it should be emphasised 
th a t the concept of "cold shock" is becoming discredited, patients who 
develop a protracted period in this condition are more likely to be 
hypovolemic i.e. reduced effective blood volume. When given adequate 
volume resuscitation, warm shock develops. Cold shock only occurrs just 
prior to death, due to myocardial depression and its consequent reduction in 
cardiac output.
Several factors may play a p art in  the transition  from the 
hyperdynamic to hypodynamie septic shock. A substantial portion of the 
blood volume appears to be pooled in the venous capacitance vessels 
producing a relative hypovolaemia, such that the effective circulating blood 
volume is decreased. Fluid loss secondary to fever, diarrhoea, vomiting, 
sequestered th ird  space fluid (in terstitia l) or increased capillary 
transduction may also contribute to the hypovolaemia and inadequate fluid 
administration.
Critical decreases in the venous return and consequent reduction of 
cardiac output produce a hypodynamie circulation. Release of endogenous 
catecholamines and vaso-constrictors such as vasopressin, angiotensin, 5- 
hydroxytryptamine, and thromboxane mediate increased sympathetic tone 
and systemic vascular resistance. Cardiac dysfunction secondary to 
myocardial ischemia or the m yocardial d ep ressan t factors m ay also 
contribute to the hypodynamie state.
Although Mohr et al. (1969) showed tha t fluid challenge in septic 
shock patients failed to increase V02 despite haemodynamic improvement.
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Kaufman et al. (1984) reported a significant increase in V02 with reversal of 
lactic acidosis, when patien ts were volume expanded. The volume 
expansion caused an increase in  oxygen delivery in  patien ts with 
hypovolaemic shock. Abraham et al. in 1983 showed th a t increases in 
cardiac output, D02 and V02 occurred in surviving patients with septic 
shock. These studies suggest that increases in oxygen consumption reflects 
increases in nutrient capillary blood flow. There is a greater need for oxygen 
as tissue repair, production of mediators and clearance of toxins is 
associated with an increased metabolic rate.
M etabolic changes during sepsis.
Gump et al. (1970) showed that oxygen requirements are 50% greater 
than  normal during septic shock. The increased V02 in septic shock 
reflects the greater oxygen requirem ents due to hypertherm ia and 
hyperm etabolism . The hypermetabolic response is associated with 
byperglycaemia, hypertriglyceridaemia and hyperuricaemia. Although 
sepsis is characterised by an insulin resistance, glucose oxidation is 
actually increased. The hyperglycaemia is primarily caused by accelerated 
endogenous glucose production in  the liver (gluconeogenesis). 
Hypoglycaemia secondary to hepatic failure occurs very late in the course of 
sepsis. Fat is increasingly oxidised as a major fuel substrate during septic 
shock and lipolysis is associated with increasing blood free fatty acid levels. 
As metabolic failure worsens, there is decreased triglyceride clearance. 
Proteolysis leads to an excessive loss of body protein as amino acids arc used 
to supply alternative energy sources. Protein catabolism is reflected by an 
increased ureagenesis and u rinary  nitrogen excretion. Progressive 
multiple organ failure appears to follow these catabolic derangements, most 
especially pulmonary and hepatic failure. Muscle protein destruction 
appears to be flow independent and oxygen delivery at th is late stage is no 
longer the primary determinant of survival.
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A nim al m odels of sepsis
Goris et al. (1986) performed one of the most important studies to 
investigate the significance of micro-organisms in the development of ARDS 
and MSGF. They investigated the effects of a non-bacterial, non-endotoxic, 
local inflammatory stimulus on the functional and microscopic changes in 
distant organs on rats. They performed 3 groups of experiments, A, B. and 
C over a 12 day period, as shown in Table 13 and 14. Zymosem was used as it 
is a  potent inflammatory agent, activating the complement cascade.
In experiment A, 30 male W istar rats, (300-400g) were randomised 
and divided into 2 groups. Group 1 (20 rats) received an aseptic intra- 
peri toneal injection of zymosan, suspended in paraffin. Group 2 (10 rats) 
received an aseptic intra-peritoneal injection of the vehicle, paraffin.
Table 13. Time of death and positive blood cultures in  experiments A and B.
(Goris et al. 1986)
positive cultures of bacteria are in brackets ( )
Time of death
Group n 0-3 days 9-11 days 12 days
Experim ent A (normal rats)
Izp 20 7(7) 3(0) 10(1)
2p 10 0(0) 0(0) 10(0)
Experiment B (germ free rats)
Izp 10 1(0) 0(0) 9(0)
2p 10 0(0) 0(0) 10(0)
Experiment C (normal rats)
control 10 0(0) 0(0) 10(0)
z=zymosan. p=parafïîn
In experiment B, 20 germ free male Wistar rats, (300-400g) were kept 
under germ free conditions and randomly divided into 2 groups. Group 1,
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received an aseptic intra-peritoneal injection of zymosan, suspended in 
paraffin, and group 2, received an aseptic intra-peritoneal injection of 
paraffin. In experiment C, 10 male W istar rats killed after 12 hours, (300- 
400g) served as controls. Positive blood cultures were obtained from the 
peritoneal fluid. All 7 experiment A, group 1, rats that died early and also in 
1 tha t died after 12 days were positive. Bacterial cultures of peritoneal fluid 
remained negative in all other rats of both group A and B. Cultures of faecal 
material in the germ free rats showed no bacterial growth.
The histological findings were normal in all rats fn>m group 2 in both 
experiments A and B. In group 1 rats of experiments A and B, an extensive 
fibroblastic peritonitis was found with massive adhesions. The lungs 
showed extensive hyperemia with haemorrhagic spots and occasionally 
extensive haemhorragic infarction.
Table 14. Relative m ean organ weights of ra ts  in  experim ents A, (normal) 
and  B (germ free), groups 1 and 2. (Goris et al. 1986)
Organ weight/body weight XlOO)
G roup 1 (zymosan)
Group AX Group B1 Omfrol
Lungs 1.42 0.99 0.45
liv e r 4.69 4.93 3.77
lÜdneys 0.84 0.94 0.66
Spleen 0.24 0.34 0.15
G roup 2 (paraffin)
Group A2 Group B2
Lungs 0.60 0.46
liv e r 4.14 4.11
IGdneys 0.69 0.70
Spdeen 0.15 0.20
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Microscopically, the lungs showed in terstitia l and intra-alveolar 
oedema and greatly increased numbers of intracapillary granulocytes. The 
liver showed congestion and oedema and an increased num ber of 
granulocytes in the sinusoids and space of Disse. The kidney and spleen 
also showed signs of damage. Acute peritonitis was found in those animals 
that died early, but in none of the other animals.
Groups 1 and 2 were always significantly different, in  experiments A 
and B. Although there was a qualitative similarity in  histological changes 
in A1 and B1 there was a greater increase in organ weights in B1 compared 
to Al. The increase in organ weight was greater in the bacteria free 
animals except for the lungs.
The vital importance of this work cannot be overstated. Goris et al. 
(1986) have shown tha t bacteria free animals can develop similar organ 
damage to those animals with normal gut flora. Liver, kidney and spleen 
had a greater weight in the germ free animals than similar organs of the 
normal rats. The conclusion must be tha t organ damage results from the 
large area of inflammation occurring when sterile peritonitis is induced.
We (llghe et al. 1989) examined vital organs in rabbits with peritonitis 
by electron microscopy and cultured the micro-organisms in those organs, 
our data are shown in Table 15. We demonstrated a lack of correlation 
between the presence of micro-organisms in an organ and tissue damage 
within th a t organ. The rabbits' hearts showed no structural changes 
whereas the lungs demonstrated considerable damage, but both organs 
produced few colonies of bacteria. The liver, spleen and kidney produced 
high colony counts with damage to the two former organs, but no damage to 
the latter. This evidence suggests that the presence of bacteria in an organ 
is not necessary for it to suffer damage. But their absence does not prevent 
damage to that organ.
LUNG HEART BLOOI LIVER SPLEEN KIDNEl
Enierdbacter
aeelomercma + + + + + +
Strept, fiMecaUn — — — + + +
Bacteriodes — — + + + +
Gram -ve anaerobic 
rods — — + + +
1 D egranulating
N eutrophils +
- -
+ +
-
E ndothelial
D am age + - - + -
—
F ibrin D eposits - - - + + -
D ie - - + - - -
Disseminating intravascular coagulation (DIG)
Conclusion.
ARDS and MSOF in association with generalised sepsis accounts for 
the death of 60% of patients dying in an ITU. As MSOF was almost non­
existent before ARDS patients were ventilated mechanically, it seems that 
the ITU has created its own disease. There is a consensus th a t bacterial 
overgrowth in these immunolpgically compromised patients is the cause of 
this highly lethal syndrome. i
But the evidence for such a causal relationship is weak:
i). MSOF develops in patients with primarily nonbacterial problems such as 
severe pancreatitis or severe trauma before bacterial invasion is obvious.
ii). Positive blood cultures are not present in many of these patients.
iii). No single study could reliably demonstrate elevated levels of circulating 
endotoxin preceding MSOF.
iv). The drainage of pus or administration of antibiotics or decontamination 
of the gastro intestinal tract does not prevent or suppress MSOF.
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v). A MSOF like syndrome can be induced aseptically in ra ts  by 
intraperitoneal inoculation of zymosan.
Generally the therapeutic concern about the patient with sepsis has 
been related to choosing the proper antibiotic therapy or to deciding the 
optimum time for surgical drainage or excision of an organ tha t has become 
the focus of a life threatening septic process. The preoccupation is with the 
specific nature of the infectious agent and its progress, rather than  the 
more general nature of the host response and support of the host defence 
m echanism .
The common denominator in the development of ARDS and MSOF 
appears to be tissue iiyury regardless of whether it be caused by physical 
trauma, lack of perfusion as in shock, or fulminating invasive sepsis.
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Section 2.
Traum a
Multi-trauma had not usually been associated with ARDS and MSOF, 
as such patients usually died from the original injury, shock or infection. 
During the first world war more soldiers are thought to have died from 
shock and infection than  from the original wound. The Vietnam war 
brought about an understanding of the involvement of traum a alone in 
causing ARDS and MSOF. Wounded soldiers were quickly airlifted to 
hospital, where they received immediate corrective surgery and blood 
replacement, were ventilated and received renal dialysis when necessary. 
But they still died from unexplained causes. Intensive investigations were 
carried out to find the reason for these deaths, although the mechanisms 
involved remained a mystery.
Pulmonary dysfunction in  battie casualties.
A (Simmons et al. 1969) report on over 800 autopsies performed from 1966 to 
1968 was published by the U.S. army in Vietnam.
Criteria for the report was;
1). AU patients had combat wounds from missiles or blast.
2). None had been burned.
3). AU were quickly evacuated to hospital, received resuscitative care, 
survived the initial operation and died during the post operative period.
4). AU patients were studied prior to the initiation of therapy.
Of 96 patients who died from wounds, after resuscitative surgery, 80% 
had pulmonary oedema, 60% had pulmonary congestion, and 28% had 
pulmonary haemorrhage. Only 1 patient had a normal lung weight and 
only 2 had lung weights less than 1200 g. Thoracic and non-thoracic wOunds 
produced the same pulmonary dysfunction and was a common cause of 
death.
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In 314 combat casualties breathing room air, an arterial p02 of less 
than  80 mmHg was found in 33% and less than 60 mmHg in 8.5% of 
patients. Although most patients with penetrating chest wounds had 
hypoxemia, 17% of 148 patients with extremities and soft tissue injuries also 
had hypoxemia.
The possible influence of shock was considered as a contributing 
factor of pulmonary dysfunction, defined as a systolic pressure of less than 
60 mmHg, an arterial pH less than 7.30 or an arterial blood lactate higher 
than  20 mg%. Where these param eters were measured in patients with 
extremity and soft tissue wounds 112 patients had an arterial p02 of 90 or 
less. Although 27 had shock, surprisingly, 85 did not. Although Simmons et 
al. (1969) showed tha t there was a significant relationship between the 
degree of hypoxemia and the presence of shock, it was found tha t patients 
without shock still suffered pulmonary dysfunction, as seen in Table 16.
Table 16. E ffect o f shock on arterial oxygen ten sion  in  148 traum atiseJ  
patients. (Simmons et al. 1969)
shock present shock absent
arterial p02 (mmHg) n % n %
>100 7 20 29 25
80-90 16 47 72 63
60-79 7 21 10 9
40-59 2 6 3 3
<40 2 6 0 0
total 34 114
Table 17 shows th a t in the absence of shock, there was a statistically 
significant relationship between the degree of hypoxemia and the presence 
of fractures in patients. In the absence of fracture or shock no patient with 
extremity or soft tissue injury developed hypoxemia on admission to the
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hospital. These data suggest that in patients with tissue iigury insufficient 
to cause bone fracture, hypoxemia was less likely to develop.
Table 17. P e r  centage of p a tien t suffering hypoxem ia (w ithout shock) in 
response to fracture. (Simmons et al. 1969)
a rte ria l p 0 2  (mml%) Fracture (67) No fracture (47)
>100 22 28
80-99 60 70
60-79 13 2
40-59 5 0
Table 18 shows the site of the fracture was im portant in  the 
development of hypoxemia. Foot and femur fractures were associated with 
profound hypoxemia or shock but fibula tibia and arm fractures were not.
Table 18. P e r  centage of p a tien t suffering hypoxem ia (w ithout shock) in 
response to differing frracture locations. (Simmons et al. 1969)
p02(mmHg) F em ur (26) Tlbia-fibula (28) Foot (9) Arm  (4)
>100 12 39 0 25
80-99 62 54 67 74
60-79 19 7 22 0
40-59 8 0 11 0 ;
The important feature of these wounds was that they were associated with 
high energy traum a. All the foot injuries were caused by mines. Femur 
iiyuries were caused by high energy bullets. Tibia and fibula injuries were 
associated with lower energy blast and consequently less tissue contusion. 
Sepsis is not mentioned in this study so its absence must be assumed.
This work shows tha t pulmonary dysfunction is in proportion to the 
degree of tissue traum a suffered by the subject. When the mass of tissue
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suffering contusion increased, the degree of pulmonary hypoxaemia 
increased.
Martin et al. (1969) studied 800 autopsy reports from the U. S. Army 9 
medical laboratory in South Vietnam between 1966 and 1968 from which 100 
were selected for analysis. Selection of data was made on the following 
criteria;
1). All patients had received combat wounds.
2). None had been burned.
3). AU were rapidly evacuated to hospital.
4). The autopsy reports were sufficiently detailed with microscopic 
studies to permit detailed analysis.
All patients were men aged 18-47 years who had a mean survival time 
foUowing injury of 6.5 days. Thirty three per cent of deaths occurred during 
the first 24 hours and 62% in the first week.
There was no correlation between lung weight and duration of illness 
or site of injury. Table 19 shows tha t most patients at autopsy had lungs 
much heavier than the normal 800 g.
Table 19. Lung weights of 100 com bat casualties. (Martin et al. 1969)
No. of patients lung w t in  g
5 <1,000
64 1,000-2,000
31 >2,000
Pulmonary oedema, congestion and alveolar hemorrhage were found in 89 
of the 100 patients. The pulmonary dysfunction was rarely caused by fat 
embolism, only being found in 4 of the 100 patients. Septicaemia, usuaUy 
associated with abdominal injury, occurred in 18 patients and was seen 
after the first week. These data show that the majority of patients had severe 
lung damage as a result of non-thoracic tissue injury. Most of these patients
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died from lung failure. The majority of patients studied by M artin et al. 
(1969) who died of m ulti-trauma without infection had lungs typical of 
ARDS.
Proctor et al. (1970) studied 52 patients who were wounded soldiers 
from the U.S. Navy hospital in Da Nang, South Vietnam. They were divided 
into 3 groups and studied until death or survival 120 hours after injuiy, 
shown in Table 20.
Table 20. C om parison o f the  th ree  groups of seriously  in ju red  patien ts.
(Proctor et al. 1970)
Group 1 2 3
massive abdominal and/ 
limb injuries. 33 0 4
minor traum atic 
injuries. 0 15 0
SABP< 80 mmHg 33 0 4
Respiratory problems 0 0 4
Pa02 <60 mmHg 0 0 4
SABP Systolic arterial blood pressure.
Similar massive soft tissue injuries and fractures were common to all 
patients in groups 1 and 3, but no patients had thoracic injuries. In group 1, 
were 24 patients who had limbs traum atically am putated by exploding 
mines. Eight patients had only abdominal injuries and 4 had both traumatic 
amputations and abdominal injuries. In group 2, were 15 bed rest controls 
who sustained only minor injuries, with no fractures or wounds requiring 
only local debridement. In group 3, were 4 shock lung patients with injuries 
similar to those of group 1. Their chest X-rays were consistent with shock 
lung and had clinically apparent signs of respiratory insufficiency.
Although 3 deaths occurred in group 1 they could not be attributed to 
pulmonary causes and a t autopsy their lungs were unremarkable. Whereas
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the lungs of patients in group 3, were wet, heavy and congested, typical of 
that seen in patients with ARDS. ‘
Group 1 patients showed an altered pattern  of respiration when 
compared to normal subjects. They had a decrease in tidal volume and an 
increase in respiration rate, resulting in very little alteration in minute 
volume. There was a small decrease in pulmonary compliance. Although 
there was an increase in resistive work per breath, there was very little 
change in total work per breath. When comparing normal subjects to group 
1, the total work per breath was similar. But, as group 1 patients were 
respiring a t a faster rate than normal, the total work to move a similar 
volume of air in group 1 patients was higher than  th a t found in normal 
patients. According to the data of Proctor et al (1970) these patients were in 
fact working harder to move an equivalent volume of air. There was a very 
large increase in pulmonary A-V shunting.
This altered pattern of respiration for all the group 1 patients was 
compared w ith normal values. Tidal volume and compliance were 
significantly lower than normal while respiration rate, minute volume, 
total work per breath, total work per litre, resistive work per breath, 
resistive work per litre and pulmonary shunting were all significantly 
higher than normal values. But surprisingly, when the bed rest controls, in 
group 2, were compared to normal controls it was discovered that they also 
had a similar pattern of significant differences as in group 1 patients. Thus 
group 2 patients also showed abnormal pulmonary function, albeit a t a 
better level than group 1 patients. In fact when group 1 patients were 
compared to group 2 patients it was seen th a t although they were 
significantly different, group 2 patients were also significantly worse than 
would be expected from normal subjects.
The investigation of group 1 patients characterised the respiratory 
p a tte rn  found in  those surviving m assive non-thoracic injury, 
haemorrhagic shock and resuscitation. Comparison of group 2 patients
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with normals revealed unexpected alterations th a t could not be easily 
explained.
Comparison of the limited data collected from group 3 patients with 
the data from group 1, indicates tha t the two groups are qualitatively 
identical, but that alterations in group 3 are quEmtitatively more severe. As a 
result of this increased severity, the group 3 patients had clinically apparent 
symptoms of respiratory failure. On the basis of clinical evaluation alone, 
they may be set apart from group 1 patients with apparently similar 
injuries, and diagnosed as having shock lung. Proctor et al (1970) 
considered tha t on the basis of the measurements made, the singling out of 
clinically apparent cases and labelling them shock lung was not justified. 
Whatever the factor responsible for the alteration in respiratory function, it 
appeared to operate in all three groups of patients studied.
When Proctor et al (1970) calculated the oxygen consumption for 
group 1 patients, he found it to be high on admission, gradually decreasing 
to normal over the 120 hour investigation period. Proctor et al (1970) showed 
tha t a basic abnormality was an increase in oxygen requirement in the face 
of a  ventilation perfusion m ism atch, requiring increased alveolar 
ventilation. Because of this defect and the reduced pulmonary compliance 
there was an increase in the work of breathing. Proctor et al (1970) assumed 
that the major difference between group 1 and 3 was the inability of group 3 
patients to produce enough oxygenated blood to satisfy their metabolic needs. 
This assumption was most likely correct but Proctor et al (1970) did not take 
the idea to its logical conclusion. The inadequate oxygen consumption that 
occurred in group 3 patients produced tissue hypoxemia and further tissue 
damage. If an attem pt had been made to produce high oxygen delivery in 
these patients then their m ortality may have been reduced. These data show 
that any tissue traum a will cause arterial blood hypoxemia. When severe, it 
is termed ARDS, but when less severe, producing subclinical hypoxemia it 
remains undiagnosed and unnamed.
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It should be noted that both group 1 and group 3 were both severely 
iiyured, but group 1 were mostly traumatic amputations. Whereas group 3 
patients still retained their damaged tissue. Group 1 patients had little 
damaged tissue to initiate a major inflammatory response, unlike group 3 
patients.
Civilian trauma.
Ashbaugh et al. in 1967 described ARDS in their patients, their data 
are shown in Table 21. They were the first to recognise ARDS as a specific 
clinical entity, separate from the condition that precipitated its development.
I
Ashbaugh et al. (1967) looked a t 12 patients with hypoxemia and loss 
of pulmonary compliance after a variety of insult. Seven patients had severe 
trauma, 4 had viral pneumonia and 1 had acute pancreatitis preceding the 
respiratory distress. Pulmonary dysfunction occurred from 1-96 hours after 
the precipitating insult. Although all 12 patients developed hypoxemia, 
hypotension was present in only 5 patients and acidosis (pH<7.34) in 5 
patients before the onset of respiratory distress.
When pulmonary compliance falls, it reflects a decrease in  the 
elasticity of the lungs and is estimated by dividing the lung volume by the 
maximal breathing pressure in paralysed ventilated patients. All patients 
were ventilated and showed reduced compliances to between 0.009 and 0.019 
1/cm of water, (normal is about 0.05-0.125 1/cm of water).
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Table 21. D ata from 12 patien ts suffering from acute resp ira to ry  distress.
(Ashbaugh et al. 1967)
illness Hypotension acidosis Sa02
multiple traum a +  4- 85
multiple traum a 4- 4- 4- 4- 4- 72
multiple traum a 4- 78
abdominal gunshot 4- 4- 4- 4- 73
blunt chest injury 4- 4- 85
acute pancreatitis 4- 4- 4- 4- 85
viral pneumonia 79
viral pneumonia 41
viral pneumonia 4- 4- 84
multiple traum a 87
viral pneumonia 74
chest gunshot 72
Sa02= oxygen saturation of arterial blood
Gross inspection of the lungs of the 7 patients who died showed them to be 
heavy and deep reddish-purple with an average weight of 960 g for the left 
and 1150 g for the right. Cut section resembled liver tissue. Microscopy 
revealed all major pulmonary vessels to be patent and free of thrombus. 
In terstitial and intra-alveolar haemorrhage and oedema were common. 
Alveolar macrophages were numerous and alveolar hyaline membranes 
were found in all but one patient.
Although they do not make such a claim, this work demonstrated the 
very important finding tha t pulmonary dysfunction occurred in the absence 
of shock or sepsis. While shock may be a precipitating factor for pulmonary 
dysfunction in some patients it was not necessary for the development of 
respiratory distress in the majority of patients. The correction of shock had 
no effect on overall mortality. Multiple traum a alone was the cause of a 
lethal outcome in 50% of these patients.
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Hypoxemia associated w ith skeletal ipjury.
Hypoxemia associated with fractures was originally described by 
Sproule et al. (1964). Since that time many authors have emphasised the 
importance of arterial hypoxemia in relation to fat embolism. They consider 
that the broken bone releases fat into the circulation, subsequently becoming 
trapped in the lungs. In the m ajority of cases the hypoxemia is 
unrecognised clinically and is thus termed unapparent hypoxemia (as 
mentioned in military trauma). Typical of these studies is tha t of Wrobel et 
al. (1974), described in Table 22. They undertook a prospective analysis of 100 
adults with non-thoracic traum a. The partia l pressures of oxygen in 
arterial blood (Pa02) were obtained on admission from patients breathing 
room air. :
Table 22. P a rtia l p ressures of oxygen in  a r te ria l blood from  100 severely 
ipjured patients immediately after hospital admission. (Sproule et al. 1964)
P a0 2  mmHg Number of patients
>100 30
80^100 30
7080 27
<70 13
Patients with the highest risk of hypoxemia were those with fractures 
of the lower extremity (femur, tibia and fibula). The majority of patients did 
not show clinical hypoxemia as even with low partial pressures, down to 60 
mmHg, blood exhibits 98% saturation.
Although most studies of post-traumatic hypoxemia suggest it is 
caused by fat embolism, the diagnosis is usually based on clinical criteria, 
such as confusion and skin petechiae, with little attem pt to show the 
presence of fat in the blood stream.
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Hutchins and Macninol (1985) studied twenty males with one or more 
long bone fractures in the lower limbs. They looked for fat globules by 
micropore filtration and microscopic examination. They assigned patients 
to 2 groups and reported on the presence of fat macroglobules in the blood, 
as shown in Table 23.
Table 23. A ssociation o f fat in  the blood w ith  respiratory d istress in  20 
patients. (Hutchins and Macninol 1985)______________________________.
profound hypoxem ia m üd hypoxem ia
patients _________________ 6__________   14
presence of blood fat
Although all the patients became hypoxemic, only six developed profound 
respiratory distress with significantly lower arterial oxygen tension, these 
patients were assigned to group 1. The other 14 patients appeared to have 
better pulmonary function and were assigned to group 2. Circulating fat 
macroglobules were identified in four cases, only one was in group 1. The 
other three were associated with only mild respiratory distress.
The test for fat embolism was therefore thought to be of little 
prognostic value. This finding casts doubt on the role of fat embolism in 
traum atic respiratory distress and unapparent hypoxemia. There is every 
likelihood that the role of fat embolism in traum a is much exaggerated. The 
cause of hypoxemia is more likely to be due to some lung damage, resulting 
from the initiation of the inflammatory process in response to tissue 
traum a.
Early Bone Fixation.
In Germany in 1942 Kuntscher started the procedure of internal 
fixation of fractured weight bearing limbs. This procedure was adopted to 
increase the speed of recovery and reduce the incidence of permanent
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damage. In 1958, Allgower (Allgower 1977) in Sw itzerland, became 
dissatisfied with the poor results from the therapy for bone fractures. It was 
an unsatisfactory mixture of conservative and operative treatment, with the 
conservative treatm ent prevailing. Conservative treatm ent was traction for 
3-4 weeks, followed by a long term leg plaster or external fixation of up to 20 
weeks and late weight bearing. He found that a large number of his patients 
had some form of long term  disablement. The Swiss national accident 
insurance had to pay com pensation for p a rtia l d isablem ent to 
approximately one third of patients with tibial firactures, two thirds of those 
with femur fractures, and to nearly all those with fractures of the weight 
bearing joints. He decided tha t the method of fixation was a t fault, and 
considered that early pain free mobilisation might prevent the disablement 
th a t was occurring. He started  a programme of immediate surgical 
internal fixation by “plate” or “nail” of fractures to improve the results of 
fracture care, together with, anatomical reduction, tha t is the realignment 
of the broken bones, reffered to as osteosynthesis. This therapy was 
associated with early pain-free active mobilisation, especially during the 
first 10 days of injury in those patients studied. He noted an immediate 
improvement in operative complications and a reduction in pulmonary 
failure. Unfortunately the results of this study made little impact in the 
Anglo-Saxon world, as the details of such studies were published in his 
native German (Mueller et al. 1963), and not in English. In Germany, 
Austria and Switzerland a group was establish in 1958 to study early 
osteosynthesis. As a result of this work, immediate internal fixation of 
femoral fracture was undertaken in several centres in the late 60 s and 
early 70 s. This practice was usually carried out in opposition to the 
traditional or “conservative” surgical authorities. Although these workers 
undertook early osteosynthesis to prevent permanent bone injury, they had 
in fact established a system of preventative action to reduce the incidence of 
respiratory failure and MSOF. Those workers who continued with the
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conservative method of bone fixation unwittingly allowed ARDS and MSOF 
to develop.
The first such centres to practice early osteosyntesis were in Basel, 
Helsinki and Seattle. Ruedi and Wolff in 1975, Riska et al. in 1976 and Wolff 
e t al. in 1978 reported th a t adding immediate internal fixation of femur 
fractures to the traditional surgery drastically reduced problems of 
traumatic pulmonary failure and post operative care. Unfortunately none of 
these early reports used an injury severity score as a method of grading the 
total body traum a to match the different study groups.
Meek et al. in 1980 in abstract and in a full paper in 1986 and Goris et 
al. in 1982 started grading the severity of injury with the injury severity 
score (HTI-ISS). More importantly, they showed tha t late septic deaths 
occurred in one of twenty one from the group with early internal fixation of 
fractures. Fourteen of forty nine patients who had conservative fracture 
management died of late septicaemia.
In 1985 Johnson et al. and Seibel et al. published similar findings but 
in better matched groups with more statistical evaluation of the basic data. 
Both of these studies showed that MSOF and late septic death occurred only 
in the group with conservative management. They especially showed that 
deaths from traum a were not related to the magnitude of the original iiyury 
as judged by HTI-ISS but to the initial method of management of the 
injuries.
All of these studies have one critical defect, fracture management 
was not prospectively randomised with injury severity scores. The study of 
178 patients by Bone et al. in  1989 rectified these faults. They were 
prospectively randomised to either an early stabilisation group, the first 
twenty four hours, or a late stabilisation group, more than forty eight hours 
after injury, summarised in Table 24. All urgent surgical procedures were 
done imm ediately with only the femoral fracture being randomised 
according to early or delayed fixation. There were two deaths in the early
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treatm ent group, one from brain injury and the other ARDS. The ARDS 
patient had an HTI-ISS of 66. There was one death in the late treatm ent 
group from ARDS with an HTI-ISS of 26. An ISS of 66 is very severe 
whereas th a t of 26 is considered to be only moderate. This work showed 
unequivocally tha t early debridement and fixation of the broken bone, 
especially the femur, considerably reduces the risk of complications.
Table 24* Comparison of early and Into stabilisation in  tranniatised patients*
(Bone et al. 1989)
Treatm ent group n HTI-ISS ITU days Average cost $
Early stabilisation 46 31.8 2.8 19,854
Late stabilisation 37 31.3 7.6 32,915
Historic perspective
Civilian practice in the United Kingdom has adopted a more 
conservative approach to bone fixation. Three methods of stabilising 
fractures were employed, on what appears to be a random basis, internal 
plating, external fixation or traction. Traction and plaster is, and has been, 
the moot popular method of reootting a broken bone. It avoids the neceooity 
of an operative procedure if the bone was plated or pinned. Consequently 
when the femur is broken, with its high risk of associated MSOF as a 
complication, it  is also often put into traction and plastered.
The work of Smith and Sage (1957) in the USA concluded that the 
time and method of fixation was unimportant. This work was then cited as 
evidence supporting conservative therapy. But it should be emphasised that 
their work was on the forearm, not the femur. So the work's relevance to 
ARDS and MSOF is inappropriate.
In 1959, Smith published evidence tha t a delay in fixation actually 
reduced the incidence of non-union of fractures. Reports by Chamley and 
Guindy in 1961, Smith in 1964 and Lam in 1964 also showed that late fixation
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(greater than 7 days) allowed better union of the fractured bone than early 
fixation. Standard therapy then became traction of the limb from 7-35 days 
followed by internal fixation. These reports never addressed the problem of 
respiratory insufficiency and predate the description of ARDS. I t was 
considered that, a t the time of admission, the multiply traumatised patient 
was too sick for any additional surgery beyond the immediate life and limb 
saving surgery. Because of the multiple organ systems involved in trauma, 
most surgeons relegated the care of the fractured limbs to a low priority. 
Except for debridement of the open wound, definitive fixation of fractures 
was delayed un til the patien t's  overall condition was stabilised. 
Debridement of closed fractures was rarely performed.
This early work on fracture stabilisation is highly suspect. I t was 
never randomised and the groups were never matched for severity of injury. 
P atien ts receiving early fixation were usually  the most severely 
traumatised, and the period of so called early fixation was between 24 hours 
and 6 days after the injury. Consequently in the UK there is presumably a 
greater risk of MSOF in traumatised patients than on continental Europe 
where early stabilisation and fixation is practised.
Experimental multi-trauma on animals.
Ingvar Jansson, (1982) when working on missile traum a in pigs at 
the Swedish army research centre, discovered a direct relationship between 
tissue damage and pulmonary dysfunction.
He divided pigs into 3 groups.
Group 1: 12 pigs were subjected to missile traum a (impact velocity of 
450 m/s) in a hind limb. The wound was debrided and the shaft of the tibia 
and fibula cut with a surgical saw. The fractures were left untreated and 
not immobilized.
Group 2: 10 pigs were treated in the same way, but the fractures 
immobilised by internal fixation with a compression plate.
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Group 3: 4 pigs were prepared in the same way but no traum a was 
inflicted.
All the animals were anaesthetised and monitored, and sacrificed 
after 72 hours. In group 1, 10 pigs developed x-ray changes similar to those 
seen in patients with ARDS, none of group 2 or 3 showed these changes. 
Microscopic examination of postmortem tissue showed changes only in 
group 1. They had in terstitia l and alveolar oedema, leucostasis and 
occlusion of capillaries, similar findings to those seen in ARDS. The lungs 
of group 1 pigs weighed 30% more than those of groups 2 and 3 (16.4 g/kg 
compared to 10.5 g/kg body weight).
Aseptic conditions were maintained throughout the study and no 
signs of sepsis were seen. This work shows tha t ARDS can develop as a 
result of tissue traum a in the absence of any infection. Tissue damage over 
a period of hours appears to be necessary to provided a focus upon which the 
cascade of events can occur, resulting in the ultim ate destruction of 
pulmonary tissue.
They (Jansson et al. 1982) also studied the effect of shooting missiles of 
differing impact velocities into the legs of 3 anaesthetised pigs. The fracture 
was left untreated and the study terminated at 72 hours, as shown in Table
25.
Table 25. Effect on Inng w e i^ t  of increasing im pact velocity. (Jansson et al.
1982)
Impact vdociiy Ekiergy uptake lung weight Platelets
(m/s) (J) (g/kg) (10^/L)
945 233 10.2 172
1276 439 12.9 96
1500 617 14.4 50
J= joules
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The broken leg was neither debrided or fixed resulting in pulmonary 
damage similar to th a t Jannson et al. (1982) previously described. The 
degree of pulmonary damage was proportional to the amount of energy 
imparted to the tissue. The weight of the lungs increased, due to pulmonary 
oedema, with the increasing impact velocity. Blood platelet count also fell in 
a similar manner.
The work of Jannson showed th a t although multi-system organ 
failure was commonly attributed to bacterial infection, inflammation and 
tissue damage may be the initiators of this condition.
Thorne et al. (1989) studied neutrophil sequestration in  an 
anaesthetised pig traum a model. Autologous neutrophils from 10 pigs were 
labelled with radio-labelled Indium-oxine. They were subjected to traum a by 
striking both hind limbs 100 times with a 10 pound mallet. Although there 
was a significant fall in blood pressure it was not profoundly hypotensive 
and quickly returned to normal levels. This fall in blood pressure was 
insufficient to cause bacterial egress from the intestinal lumen. Within 1-3 
minutes of trauma, the radioactivity over the lungs increased dramatically, 
indicating pulmonary neutrophil sequestration. This was followed by a 
small decrease after 90 minutes, but the levels remained significantly 
raised. Liver neutrophils sequestration also showed a significant increase, 
but there was marked reduction in neutrophil activity in the heart. This 
work shows unequivocally tha t neutrophil aggregation occurs in the lung 
and liver in the absence of any infection or endotoxic stimulus. Damaged 
tissue in the hind limb provides sufficient inflammatory response to initiate 
a whole body response.
Conclusion.
Trauma is an important cause of ARDS and MSOF, especially when 
associated with fracture of the femur. The high energy level required to 
break the femur causes considerable damage to the muscle. The tissue
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mass of the contused quadraceps provides an inflammatory focus large 
enough to initiate whole body inflammation. If the femur is not set and 
debridement performed within 24 hours, then secondary tissue damage 
resulting from the inflammatory response can occur. The septic syndrome 
can then develop without the involvement of infection, although infection 
may develop as a complication. In these circumstances ARDS and MSOF 
are almost inevitable.
Unfortunately the early fixation of broken bones and debridement of 
damaged tissue is not a common practice. More popular is to wait and see. 
Another popular treatm ent of multi-traumatised patients is to wait for them 
to improve before fixing their broken bodies.
All m ulti-traum a produces respiratory distress although it might 
often be sub clinical. F at embolism is not a very common cause of 
respiratory distress.
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Sections.
Oxygen Deprivation.
Introduction.
The concept of oxygen deprivation as a cause of ARDS and MSOF is a 
relatively new one. Major injury such as sepsis, traum a, pancreatitis, 
bum s or major surgery, all cause a significant increase in  the metabolic 
rate. Those patients who are unable to raise their metabolic rate could be at 
risk of developing MSOF. This increased rate must have a higher oxygen 
consumption than the basal level would allow. The purpose of this increased 
V02 is to allow an increased production of ATP. Unfortunately these major 
injuries are often associated with a reduced V02, partly due to the decrease 
in oxygen delivery to the tissues. Additionally these injuries can cause a 
redirection of blood flow away from certain organs causing tissue ischemia. 
Although oxygen delivery may appear normal or even raised it is in fact 
lower than that necessary to maintain the integrity of certain tissues.
The functional tissue ischemia can prevent the adequate formation of 
ATP and allow the production of hypoxanthine. Hypoxanthine via the 
enzyme xanthine oxidase can allow the production of super oxides and 
hydroxyl ions. These compound are widely known to cause tissue damage. 
Such tissue damage would cause the inflammatory reaction to commence, 
and if substantial enough could lead to the development of whole body 
inflammation.
Oxygen metabolism 
Introduction
Oxygen transport by arterial blood is defined in terms of the total 
oxygen delivered to the tissues, oxygen delivered (DOg). The total am ount of 
oxygen consumed by the tissues is the oxygen consumption (VO2 ) and the 
ratio between the two, the oxygen extraction ratio (OgER). Oxygen delivered
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is the product of the volume of oxygen carried by arterial blood, the arterial 
oxygen content (CaOg) and the cardiac output (CO):
D02 = (C0)x(Ca02)
To compare different patients, this is usually indexed to the body surface 
area (BSA) to give the oxygen delivery index (DO2I):
D 02l = ^ ° B & -
The units are ml/min/m^.
The oxygen consumption index (VO2 I) is the difference between the arterial
and the venous oxygen content (Cv02) multiplied by the cardiac output:
_  ,  C 0x(C a02-C v02)
V O 2 I  =  B S Â -------------
The arterial oxygen content is usually derived from the arterial oxygen 
saturation (Sa02) the haemoglobin (Hb) concentration and 1.34, the number 
of ml of oxygen carried per gram of haemoglobin per 100 ml of blood:
Sa02 X Hb X 1.34
So that:
___ _ CO X (Sa02 -Sv02) x Hb x 13.4 
VO2I------------------- BSÂ
The oxygen extraction ratio is the ratio of the delivery to the consumption:
0 2 E R = ^
and is usually expressed as a percentage.
The basic determ inant of hum an life is the ability of cellular 
metabolism to m aintain oxidative phosphorylation. The body has to 
distribute oxygen according to need because a prerequisite to its utilisation 
is the transport of oxygen to the cell,
Uptake = Delivery X Extraction 
(organ) (resistance vessels) (exchange vessels)
If the whole body is used to assess oxygen consumption (VO2 ), then a 
form of the Pick equation is easy to apply (reverse Pick principle):
VO2 = (CO X Ca02) ({Ca02-Cv02}/Ca02)
(oxygen consumption) (delivery) (extraction)
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Oxygen extraction ratio in normal patients
Under normal circumstances, a reduction in DO2 or an increase in 
VO2 is accompanied by an increase in the amount of oxygen extracted from 
the blood, resulting in a widened arterio venous oxygen difference. Patients 
with a variety of acute illnesses are unable to increase their O2ER despite 
marked reductions in DO2 . The cause of this is unclear.
A poor O2 ER has been ascribed to several circulatory defects, the 
peripheral shunting of blood flow through arterio venous connections in an 
organ, the inability to recruit enough capillaries to utilise delivered oxygen, 
the inappropriate distribution of blood flow to organs, poor oxygen diffusion 
to the cell finm the capillaries or damage to the mitochondria.
The relationship between DO2 and VO2.
In healthy subjects, normally those performing vigorous exercise, 
VO2 is maintained despite a drop in oxygen delivery (DO2 ) as the O2ER 
increases proportionately. However, below a critical DO2 , any further 
decrease in DO2 produces a proportionate decrease in  V02, and lactic acid 
accumulates. This critical DO2 threshold has been estimated as about 
8ml/kg/min. At this point the O2ER is about 70%.
Historically, ie. before ITU measurements of DO2 and VO2 became 
commonplace, it was assumed th a t VO2 was mdependent of DO2 . It was 
thought tha t the metabolic rate was the primary determinant of VO2 , not 
the rate of oxygen supply. It is now appreciated tha t VO2 is dependent on 
DO2 to the organs of the body, the distribution of CO to those organs, the 
density of capillaries within those organs and the metabolic needs of those 
organs. The oxygen delivery to any organ will depend on its share of the 
cardiac output. The extraction of oxygen from that delivered is determined 
by the needs of cellular metabolism and the ability of the organ to change the 
number of capillaries being perfused. Vaso-regulation controls distribution.
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and resistance vessels must dilate to increase flow, possibly in response to 
oxygen need.
When oxygen requirements are high, increased demand can be met 
by increased delivery, through increased CO, and increased extraction 
through increased capillary density. Increases in cardiac output can be 
accommodated by altered resistance. When the oxygen content of arterial 
blood is low, either flow must be increased or extraction must be increased 
yet further. In pathological states there may not be an appropriate match 
between oxygen supply and oxygen demand, tha t is those organs with the 
greatest need may not receive an adequate supply. Those organs with lower 
needs may have an inappropriately high flow. There may also be an 
inability of the body to extract the required oxygen.
The arterial/venous oxygen difference is dependent on the relative 
distribution of blood to the various organs and the eflective capillary density 
of the organ. Skin, gut, kidney and muscle are considered flow independent 
organs; they have high blood flows that are not primarily for the delivery of 
oxygen. Flow dependent organs are the brain and heart in which the blood 
flow is primarily for the delivery of oxygen. Blood flow in the skin, gut or 
kidney is not as important in ATP production and VO2 as flow to the heart 
or brain. If there is a high blood flow to the skin or muscle in a moribund 
patient, then less oxygen will be consumed than if there is a high flow to the 
heart or brain. If the effective capillary density of an organ is low then the 
O2 ER of th a t organ will be reduced. The capillary density of an organ 
changes according to its need, by activating pre-capillary sphincters that 
are sensitive to hypoxemia and its metabolites eg. exercising muscle has a 
higher effective capillary density than resting muscle. When the capillary 
density of an organ is increased the oxygen extraction ratio can be raised, 
and a greater proportion of the oxygen delivery to the organ will be 
consumed.
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Relationship of DO2 to VO2 in normal patients.
In healthy persons VO2 is independent of DO2 . Any reduction in DO2 
results in  compensatory mechanisms to satisfy tissue demand. These 
adaptations include increased O2ER, increase in local capillary perfusion 
and shifts in the oxyhaemaglobin dissociation curve.
Shibutani et al. (1983) studied 58 patients undergoing coronary artery 
by-pass graft operations. The relationship between DO2 and VO2 was 
studied in each patient.
They produced data sets for each patient and found tha t there was a 
critical value for DO2  of 330 ml/min/m^ when VO2 was 109 ml/min/m^. 
Below th is value VO2 decreased proportionately showing a linear 
relationship between DO2 and VO2 , demonstrating tha t VO2 was supply 
dependent. At higher values of DO2 , VO2 showed no further increase, and a 
plateau was reached when it became supply independent.
In 15 patients DO2 levels less than 330 ml/min/m^ wero observed and 
the plasma lactate concentration showed lactic acidosis. Whereas those 
patients having a DO2 higher than 330 ml/min/m^ had normal lactate 
levels. The decrease in VO2 seen during surgery was previously attributed 
to decreased metabolic demands, caused by anaesthetic agents (Ngai and 
Papper 1962), but now a reduction in DO2 below 330 ml/min/m^ is  
interpreted as evidence of tissue oxygen deprivation. Waxman et al (1982) 
reported an association of decreased intraoperative VO2 with increased 
post operative lactic acidosis, showing th a t the reduced VO2 during 
anaesthesia and surgery reflects inadequate tissue oxygenation. Patients 
who are supply dependent, exhibit an oxygen deficit, as can be seen in Table
26.
This important piece of work by Shibutani et al. (1983) was considered 
to show the relationship between DO2 and VO2 It reflected the normal 
relationship between DO2 and VO2 and could be extrapolated to normal
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subjects. Oxygen consumption is independent of D02 until a critical low 
point is reached when V02 becomes flow dependent.
Table 26. Haemodynamic param eters associated w ith  a  DO2 less than  and 
greater than  330 ml/min/m^ in  58 patients. (Shibutani et al. 1983)
Param eter DQ2<330 DQ2>330
MABP 85 85
Cl 1.7 2.5
DO2 273 450
VO2 86 109
02EEI 31 24
Lactate mMol/1 14.9 10.9
Pv02 38 42
Sv02 70 75
MABP mean arterial blood pressure, Cl cardiac index, Pv02 oxygen partial 
pressure in venous blood, Sv02 oxygen saturation of venous blood
The basal VO2 during surgery was previously reported by Guedel 
(1924) to be 138 m l/m in/m ^. The work of Shibutani et al. (1983) showed a 
plateau value of 109 m l/m in/m ^ and is therefore 78% of basal level. The 22% 
reduction in the mean value of VO2 was thought by Shibutani et al. (1983) to 
reflect the reduced oxygen requirement produced by anaesthesia and the 
lower temperature seen in these patients during surgery.
The data shown in Table 26 show th a t when D O 2 was below the 
critical value of 330  m l/m in /m ^, then there was a compensation in the 
O2 ER, which rose from 24% to 31% to maintain its VO2 . The reduced oxygen 
partial pressure and saturation in the venous blood shows th a t there has 
been a greater extraction of oxygen.
Pepe and Culver (1985) performed studies on 21 dogs to measure the 
relationship between DO2 and VO2 . They divided the dogs into three groups
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to reduce the DO2 : group 1 had DO2 reduced by increased positive end 
expiratory pressure (PEEP), group 2 had flow reduced by venous obstruction 
and group 3 had DO2 reduced by increasing PEEP and initiating lung 
damage. In all three groups, VO2 was independent of DO2 above a critical 
value of 13ml/kg/min. (workers using animals adopt body weight as an 
index of flow instead of body surface area). Below this critical value VO2 was 
linearly dependent on DO2 .
These two important studies show th a t in the whole body, VO2 is 
dependent on DO2 when below the critical value, but is independent, 
forming a plateau when DO2 is above this value. In studies of individual 
tissue beds this relationship does not occur. This was shown by the work of 
Stainsby and Otis (1963) on skeletal muscle in dogs.
Stainoby and Otio (1963) looked at the effect of changes in blood flow on 
oxygen consumption, of the in situ  gastrocnemius-plantaris muscle group, 
in dogs. When perfusion pressure was reduced, the flow decreased. The 
reduction in blood flow was matched by an equivalent increase in the 
arterio venous oxygen difference. As a result the calculated VO2 was 
unchanged. Some remarkably low levels of venous oxygen content were seen 
during the period of reduced flow. Even though the venous oxygen 
saturation fell as low as 10%, representing a venous PO2 of about 10 mmHg, 
there was no decrease in VO2 . When blood flow was increased to high levels 
there was still no change in VO2 . Stainsby and Otis (1963) concluded that 
VO2 was independent of DO2 except at very low, minimal or critical levels. 
They thought tha t the rate of oxygen uptake of resting skeletal muscle in 
these experiments, was regulated by some factor other than the amount of 
oxygen delivered by the blood. Stainsby and Otis (1963) also subjected the 
skeletal muscle to contraction and showed an increase in the O2ER. They 
applied the Krogh equation to estimate capillary density in these studies. 
The resting muscle was calculated to have a capillary density of 40/mm^. 
The resting muscle with reduced blood flow was estimated to have an
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increased capillary density of 150/m m ^. Contracting skeletal muscle during 
progressive hypoxemia had a considerably increased density of about 700  
capillaries/mm^. Capillary density for this group of muscles has previously 
been estimated histologicaly (Schmidt-Nielsen and Pennycuik 1961) and 
found to be about 750/mm ^.
Inadequate capillaiy recruitment
Extensive studies were performed by Granger et al. (1975) on the 
control mechanisms of capillary blood flow and oxygen extraction. In 36 
dogs they looked a t the effects on hind limb vasculature, in the whole 
animal, of the following interventions:
a) Arterial hypotension of 80 mmHg.
b) Thigh muscle contraction by electrical stimulation.
c) Arterial hypoxia by respiring 6% oxygen.
d) Adrenergic stimulation by noradrenaline to increase vascular tone and 
reduce blood flow and venous oxygen levels.
In Table 27, under the column headed "control B", are data recorded 
before hypotension was induced, whereas "control A" shows data recorded 
when reducing the blood pressure by 20 mmHg. There was a fall in blood 
flow of 50%, but in spite of the reduction, normal VÜ2 was maintained, 
suggesting tha t the O2ER increased twofold. Associated with this increase 
in O2ER was a doubling of the capillary filtration coefficient, suggesting a 
doubling in the number of perfused capillaries. With hypoxemia, in column 
B, before hypotension was induced, the blood flow was higher than  
corresponding control column B. This suggests th a t autoregulation was 
occurring to m aintain VO2 . But when hypotension was introduced, as seen 
in column A, there was a small fall in blood flow, accompanied by an 
increase in O2ER as shown by the rise in capillary density.
With muscle contraction, before hypotension, in column B, there was 
an increase in blood flow accompanied by a rise in capillary density and A-V
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oxygen difference, compared to control value, in column B. The large 
increase in VO2 from 4.4 to 18 reflects the increase in ATP production. 
Hypotension causes a further increase in capillary density to 0.033, this is a 
150% increase in capillary density as reflected by Krogh's coefficient.
Table 27. A ction o f hypotension  alone an d  in  com bination  w ith  e ith e r
hypoxemia o r muscle contraction on muscle of dogs. (Granger et al. 1975)
Control Hypoxemia Contraction
B A B A B A
BP mmHg 100 80 100 80 100 80
A-V O2 (vol%) 4 9 3 4 10 12
Flow ml/min 100 50 130 115 140 135
VO2 4.4 4.0 4.2 4.2 18 17.6
Pv02 45 30 32 28 24 22
Kf .013 .020 .020 .032 .026 .033
B = before hypotension, A = after hypotension, Kf = Kroghs' capillary 
filtration coefficient (capillary density)
In Table 28, hypoxemia alone, was found to increase blood flow and 
raise the capillary density, suggesting an increase in O2ER, so tha t V02 
could be maintained. But when noradrenaline was added to the preparation 
there was a precipitous fall in blood flow tha t was compensated for by a 
large increase in the capillary density. When hypoxemia was initiated in 
these conditions there was a large increase in blood flow and capillary 
density.
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Table 28. The effect of hypoxemia, on noradrenaline treated  muscle, in  dogs.
(Granger et al. 1975)
Control Noradrenaline
B A B A
BP mmHg 100 100 100 100
A-V 02  (vol%) 6 2 13 2
Flow ml/min 80 200 35 160
V02 3.5 3.7 3.7 3.3
Pv02 42 21 24 20
Kf .008 .018 .027 .036
B = before hypoxemia, A = after hypoxemia
Although blood flow decreased during hypotension and contraction 
via electrical stimulation, effective capillary density consistently increased, 
suggesting an unexpected relaxation of the vascular structures involved in 
the regulation of exchange activity. These findings suggest th a t the 
resistance vessels escape from the adrenergic constrictor action, when 
tissue oxygenation was lower than normal. Although muscle cell PO2 was 
maintained within narrow limits despite a variety of local stresses, nervous 
control of vascular resistance in skeletal muscle is of major importance for 
the reflex regulation of systemic arterial pressure.
When m uscular blood flow was reduced by the vasoconstrictor, 
noradrenaline, oxygen delivery to the exchange vessels was reduced. The 
low level of oxygen delivery to the tissues stimulated the metabolically 
sensitive sphincters to dilate, overriding the adrenergic constrictor effect. 
The effective capillary density rose and maintained the VO2 . This increase 
in diffusion capacity compensated for the reduction in  blood flow and 
increased the O2ER. Thus there was an interaction of local and nervous 
control to regulate arterial pressure and D02- Oxygen metabolism appears 
to exert the greatest influence on capillary density.
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Cain (1978) looked at the whole body effect of oxygen metabolism. He 
demonstrated a reduced O2ER in hypoxic dogs when treated with the alpha- 
blocking drug phenoxybenzamine. He studied the effects of vasoconstrictor 
tone on oxygen extraction in 2 groups of anaesthetised dogs, by ventilating 
them on 9% oxygen. Group A were given phenoxybenzamine to produce 
alpha blockade, group B were left untreated as controls. He measured DO2 , 
VO2  and pulmonary artery oxygen saturation. Alpha blockade prevents the 
venoconstriction tha t would normally occur in hypoxemia. Group A with a 
low systemic vascular resistance were never able to take up as much oxygen 
as group B. The venous blood from group A always contained more oxygen 
than group B. In group A, the oxygen delivery and uptake systems became 
less efficient as a result of the loss of vasoconstrictor tone. He was able to 
show that group B were better able to use the low volume of oxygen delivered 
to the tissues. The VO2/DO2 curve was much steeper in group B than group 
A. Group A had a lower VO2 than group B for the same DO2 . It was thought 
tha t local vasoconstriction allowed the diverting of blood flow from tissue of 
low oxygen demand to those of high demand. Cain was also able to show 
that in group B, VO2 considerably improved after 10 minutes of hypoxemia, 
this characteristic was never seen in group A.
He considered (Cain 1978) th a t flow independent organs like the 
kidney, skin and gut would normally vasoconstrict to redistribute blood to 
those flow dependant organs such as the brain and heart. This, of course, 
could not occur in alpha receptor blocked animals. Higher venous blood 
saturation and low SVR seen in group A is also seen in ARDS and MSGF.
Cain’s work shows that differing organs have individual responses to 
oxygen shortage. When they are forced to behave in a similar manner by 
drug therapy, such as alpha receptor blockade, the whole body becomes less 
efficient a t extracting oxygen.
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Table 29. Distribution of blood flow and oxygen utilisation in  various organs, 
of control dogs. (Taylor et al. 1987)
Q CO Q/kg VO2 Q/VO2 A-V
Brain 840 14 600 52 16 6.2
H eart 300 5 1000 34 9 11.4
Splanchnic 1680 28 646 83 20 4.9
Itidney 1380 23 4600 19 72 1.4
Skeletal
muscle 960 16 31 57 17 6.0
Skin 480 8 133 12 40 2.5
All param eters are expressed as ml/min, except CO which is the per 
centage of CO going to the particular organ.
Q = blood flow
VO2 = oxygen consumption
Q/VO2 = oxygen utilisation ratio
A-V O2 = arterio-venous oxygen content difference
Table 29, published by Taylor et al (1987), shows the different blood 
flows and oxygen ultilisation patterns in various organs. Note the large 
difference between the oxygen utilisation ratio in different tissues relative to 
flow (Q/VO2 ). The heart has a ratio of only 9 whereas the kidney's ratio is 72. 
The heart utilises most of its available oxygen, while the kidney has an 
abundance of blood flow relative to utilisation. The heart will need an 
increase in blood flow if its oxygen needs increase (supply dependant), while 
the kidney can simply extract more oxygen from its abundant blood supply, 
without requiring a change in flow (supply independent). Measurement of 
differing organ needs demonstrates tha t the total body oxygen consumption 
is a poor indicator of actual requirements in individual tissue beds.
The inappropriate distribution of cardiac output with excessive flow to 
tissues of low metabolic demands (eg. kidney gut and skin), reducing the
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flow to those organs with high demands (brain or heart) would result in a 
reduced O2ER. A fall in VO2 for any given DO2 would occur. This fall in 
VO2 is also seen in septicaemia and MSOF.
Effective cap illa iy  perfusion
The local microvascular tone or systemic vascular resistance is 
controlled a t two levels. The first are the small muscular arterioles, the 
major systemic resistance vessels, controlling overall blood flow into the 
tissue bed. They appear to be most active a t low tissue PO2 , dilating to 
permit increased DO2-
The second, but major focus of control, a t more modest levels of 
hypoxemia, are the precapillary sphincters which regulate the number of 
open capillaries and thus the capillary density, optimising the conditions for 
gas diffusion, allowing changes in the O2ER.
Regional shunting of organ blood flow.
When a low 02ER or low oxygen uptake is seen clinically, there is an 
assumption tha t blood is by-passing the capillary bed of an organ via an 
anastomosis of the arterioles and venules, preventing the perfusion of 
nutrient capillaries. This arterio-venous blood flow, by-passing the organ's 
capillary bed, is referred to as shunting. But the evidence for the existence of 
an A-V shunt is very limited. Archie (1976) looked at shunting by injecting 
radio labelled microspheres into three groups of dogs: controls, animals 
infused with endotoxin, and animals made septic or developed septic shock. 
Mean shunting was 7.7% in control dogs, 7.3% and 4.3% respectively in the 
endotoxic and septic animals. Regional shunting in the brain, heart and 
skeletal muscle were not significantly different. However mean shunting in 
the splanchnic circulation was 36.5% in the septic animals and 18.6% in the 
control group, a significant difference. Renal shunting in the endotoxic 
group was 15%, but 4% in the controls and septic group. Regional shunting
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is therefore considered to be of little consequence, except in the splanchnic 
region during sepsis.
Increased Oxygen Consumption
Patients a t risk of developing ARDS or MSOF from infection, multi­
trauma, bum s, major surgery and other insults would be expected to have 
an increased metabolic ra te  and oxygen consumption. Much of the 
increased oxygen consumption is in the splanchnic circulation. It is likely 
as Shoemaker suggests that unless this increased need is met, perfusion of 
other organs will suffer and hypoxic damage may result.
Cuthbertson as long ago as 1932 measured the VOg of patients 
suffering leg traum a and found th a t oxygen consumption was 20-25% 
higher than tha t found in patients in the basal condition.
Critically ill patients often have an increased temperature even in the 
absence of infection. Hyperthermia would be expected to increase the 
metabolic rate and oxygen consumption. Bums patients have been studied 
extensively and have a considerable increase in metabolic rate. The degree 
of increase is proportional to the percentage of the skin surface bumed. The 
increase in basal metabolic rate ranges from 25% for a 10% bum  to 115% for 
a 75% bum  (Wilmore et al. 1974). Patients with fractures have an increase 
in basal metabolic rate of 20-25% (Cuthbertson 1932), peritonitis patients, 5- 
25%, and severe infection and multiple trauma 30-50% (Duke et al. 1970).
Regional oxygen consumption in 15 patients with intraperitoneal 
infections was investigated by Gump et al. (1970) They looked a t cardiac 
output, splanchnic bed blood flow, V02 and splanchnic bed oxygen 
consumption. Resting VÜ2 was within normal limits in 6 patients, but was 
raised by 19-44% in 9 others. In those 9 patients, oxygen consumption by the 
splanchnic bed was 26% of total VÜ2, and 51% of the increased VÜ2. They 
showed tha t 42% of the extra CO was accounted for by the splanchnic bed. 
Increased VÜ2 was associated with increased CO in all patients, there was
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no tendency to increase O2ER to meet the additional oxygen needs, as can 
often be seen in exercising athletes.
Similar findings were reported by Wilmore et al. (1980) when they 
looked a t bum s patients. Hepatic blood flow increased by 150% and hepatic 
VO2 increased by 30%, while lactate uptake increased by nearly 200%. These 
patients did not show lactic acidosis. Splanchnic VO2 normally 22% of VO2 
rose to 30%. These data show that the hepatic metabolic rate had increased 
to maintain homeostasis by increasing blood flow and oxygen consumption.
Dahn et al. in 1987 looked at splanchnic and total body VO2 in 12 septic 
and 7 nonseptic but injured patients, shown in Table 30. Patients with sepsis 
had a splanchnic VO2 tha t was 42.9% greater than patients without sepsis. 
Splanchnic VO2 was 30.2% of total VO2 in nonseptic patients and 43.8% in 
septic patients. Cardiac index was 27% higher in septic patients compared 
to nonseptic. The septic group had a splanchnic blood flow index 22% 
greater than nonseptic patients. The proportion of cardiac index flowing to 
the splanchnic bed was similar in both groups.
The proportion of splanchnic VO2 to total VO2 for septic patients is 
disproportionately large compared to nonseptic patients. Forty four percent 
of total VO2 is consumed by the splanchnic bed compared to 30% in the 
nonseptic patients. Although the cardiac index and DO2 is significantly 
higher in the septic group, VO2 is lower, showing an impaired extraction 
ratio. But the extraction fraction in the splanchnic bed was not significsntly 
different when comparing the two groups.
Si
Table 30. Oxygen u tilisa tion  dynam ics in  septic  an d  nonseptic patien ts.
(Dahn et al. 1987)
Nonsepsis (n=7) sepsis (n=12)
Total body oxygen consumption 
ml/kg/min.
4.39 4.34
Splanchnic oxygen consumption 
ml/kg/min.
1.33 1.90*
Cardiac index L/min/m2 3.91 4.98*
Splanchnic flow index L/min/m2 1.11 1.35
Systemic extraction fraction % 32 23*
Splanchnic extraction fii'action % 32 39
Mixed venous oxygen tension 34 38.7
Hepatic venous oxygen tension 33.7 29.9#
Haematocrit % 34.9 33.9
Arterial lactate (mEq/L) 0.87 0.59
Splanchnic lactate uptake (pEq/kg/min) 10 18
* difference significant a t p<0.05 compared to nonseptic,
# difference significant at p<0.01 compared to mixed venous.
Supply dependency of oxygen consumption in ARDS patients.
In  humans and animals previously described, the level of oxygen 
uptake was shown to be independent of oxygen delivery, down to a critical 
level of delivery, below which there exists a direct relationship between these 
two variables. This relationship was further evaluated by looking a t patients 
sufferings from ARDS.
Danek et al. (1980) looked at the relationship of DO2 to VO2 in 20 ARDS 
and 12 non-ARDS patients. In 11 ARDS patients, group la , they 
m anipulated DO2 , by altering the pressure of inspiration on the PEEP 
ventilator, until a maximum level was achieved, and DO2 reduced. The data 
was collected over 2-6 hours with 30 minute stabilisation periods. In the
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other 9 ARDS patients, group lb, data was collected during the acute phase 
of their illness, which was a longer period than group la , 3-9 days. But it 
became apparent to Danek et al. (1980) tha t DO2 and VO2 patterns were 
similar in the two groups. The 12 non-ARDS patients were critically ill and 
had D02*8 that would be expected to vary. Eight of these patients were 
mechanically ventilated, but none required PEEP. M easurements were 
made twice daily for 2.5 -7 days.
In the ARDS patients there was an increase in VO2 with DO2 over the 
whole range of values, suggesting a direct relationship between DO2 and 
VO2 The D02 did not reach a critical point or plateau and the O2ER when 
calculated from these data was a constant 22%. Danek et al. (1980) suggested 
there were two im portant conclusions from these finding; The first that 
even at low DO2 , the O2ER does not increase to maintain VO2 and secondly, 
th a t even a t high levels of DO2 , VO2 continues to rise i.e. VO2 is flow 
dependent a t all levels.
Observation of the data presented by Danek et al. (1980) on the 
relationship between DO2 and VO2 shows most of the data points to be quite 
high. Only 5 points are below a D02 of 8 ml/kg/min. The other 28 points are 
between 8-30 ml/kg/min. Consequently it is impossible to observe if there is 
an increase in O2ER at a low level of DO2 . Cardiac output in ARDS patients 
was 8.2 1/min, whereas in non-ARDS patients it was 5.6 1/min. Although the 
CO in both groups are relatively high, the venous blood oxygen saturation in 
ARDS patients of 39% and 17% in non-ARDS, are low in ARDS patients and 
extremely low in non-ARDS patients. Normal subjects should show about 
70% saturation. The conclusion from this set of data m ust be tha t although 
the ARDS patients are receiving a high DO2 , it is not yet high enough. The 
ARDS patients show supply dependency because of their very high demand. 
The non-ARDS patients showed no relationship between DO2 and VO2 .
Mohsenifar et al. (1987) studied 10 patients with ARDS to determine 
the relationship between VO2 and DO2 , by modifying the pressure of
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inspiration during PEEP ventilation. Mohsenifar et al. (1987) did not make 
any measurements on a control population of patients, so we do not know 
what variations are due to their techniques of data collection.
Below a critical DO2 of 21 ml/kg/min, VO2 was linearly related. The 
CO averaged at 7 .11/min with a venous blood oxygen saturation of 32%. This 
shows that although the CO was reasonably high, the saturation was low, 
suggesting th a t the CO was not high enough. This again suggests tha t 
ARDS patients have a far greater oxygen heed than is normally seen. 
However at a  higher DO2 they were unable to show any correlation with 
V O 2 or the development of a plateau. It should be mentioned th a t 
Mohsenifar et al. (1987) only showed 8 data points higher than a DO2 of 21 
ml/kg/min. There were about 90 data points, mostly below 21 ml/kg/min. 
Conclusions based on 8 data points from 10 patients seems to be stretching 
credibility. The O2ER calculated from the numerical data, below their 
critical point, was 27%, but from the graphical data was 33%. It should be 
mentioned tha t the O2ER seen in ARDS patients is similar to tha t seen in 
normal subjects.
Annat et al. (1986) failed to observe a supply dependency of VO2 in 
ARDS patients, the reason for this was most likely the high DO2 seen in 
most of his patients. This was reflected in the normal blood lactates observed 
in his patients. Similar flow independency was also found by Pepe and 
Culver (1985) in experimental ARDS in dogs, also due to the high level of 
DO2 .
Oxygen debt in  septic patients.
Kaufman et al. (1984) treated 8 patients with septic shock and 5 with 
hypovolaemic shock. They used fluid resuscitation to increase CO and DÔ2 » 
giving a fluid challenge of 250 ml every 15 minutes until the pulmonary 
capillary wedge pressure (PCWP) reached 15 mmHg, usually lasting about
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70 minutes. Measurements were obtained every 30 minutes during the fluid 
challenge.
Kaufman et al. (1984) showed in Table 31 the changes in DO2 and VO2 
in these groups of patients.
Table 31. Changes in  oxygen delivery and  consum ption in  patien ts w ith 
septic o r  hypovolaemic shock, challenged w ith volume infusions. (Kaufinan 
et al. 1984)
septic shock hypovolaemic shock
PE AE PE AE
DO2 ml/min/m2 315 424 239 386
VO2  ml/min/m^ 134 151 96 135
Cl l/min/m^ 2.34 3.48 1.56 2.54
Pv02 mmHg 42 44 31 35
SVR dyne/s/cm 1207 835 1368 1167
O2ER % 45 36 42 37
Lactate mg/dl 78 68 64 52
PE pre-expansion. AE after expansion '
The increases in DO2  and VO2 seen in both groups were significant. There 
was no significant difference between the increase in DO2 or VO2  seen in 
the septic group or the hypovolaemic group. Increasing DO2 by fluid 
resuscitation increases VO2 in both septic and hypovolaemic shock. Even 
though there was a significant rise in the CO, the partial pressure of oxygen 
from venous blood of both groups, although improved, remained low, 
suggesting th a t the patients were still extracting a higher than normal 
volume of oxygen. The lactate levels were also raised in both groups, and 
although they fell, they were still higher than normal. These data suggest 
tha t the raised CO was still too low to meet the oxygen requirements.
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This therapy revealed an oxygen debt in both groups of patients. These 
results also show flow dependency of VOg on DOg, in both groups of 
patients. Unlike the findings of Shibutani et al. (1983) flow dependency 
continues to be seen throughout all the values of DOg obtained. The OgER, 
even after therapy was still high, in the septic group at baseline it was 45% 
falling to 36% and 42% falling to 37% in the hypovolaemic group. If fluid 
therapy had been maintained to a higher PCWP, then greater DOg and VOg 
may have been seen with a further fall in OgER. Equally, if the therapy had 
been maintained for a longer period then benefit to the patients may have 
been seen. Clearly the therapy caused vasodilation as can be seen by the fall 
in SVR, but there was a fall in capillary recruitment, reflected by the fall in 
OgER.
The DOg and VOg obtained after fluid therapy were still lower than 
those recommended by Shoemaker et al. (1973) and 12 of the 13 patients still 
died. These patients did not have their DOg and CO maintained by this fluid 
therapy, it was curtailed after the peaks had been achieved. This study 
shows tha t there is little pathological difference between the two groups of 
patients. They were both suffering from hypovolaemia, low CO and DOg. 
These data suggest that there is unlikely to be any cellular malfunction in 
the septic group, different to the hypovolaemic group, such as mitochondrial 
im pairm ent.
The work of Mohr et al. (1969) was especially interesting as they 
studied VOg in different groups of septic shock patients when given fluid 
therapy. They showed a group of patients who did not increase their VOg 
when given fluid. Close examination of their data shows tha t these patients 
started with VOg of 200 ml/min/m^. Whereas the patients who increased 
their VOg with fluid challenge had in itia l VOg of 154 increasing to 217 
ml/min/m2. This suggests that at lower DOg, VOg has a direct relationship. 
But at the higher levels a plateau is reached when VOg is independent of 
DOg.
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Bihari et al. (1987) suggested th a t inadequate oxygenation of 
peripheral tissue may be unrecognised in critically ill patients and may 
worsen their prognosis. Although they observed the patients before their 
study they did not optimise their treatm ent. They measured the oxygen 
delivery, tissue oxygen uptake and oxygen extraction ratio during a 30 
minute infusion of the vasodilator prostacyclin, in 27 critically ill patients 
with acute respiratory failure. Prostacyclin increased significantly the 
indexed DOg, from 376 to 492 ml/min/m^ in the 14 patients who survived and 
in the 13 who died. This increase in oxygen delivery was accompanied by a 
significant 19% increase in VOg by the patients who died, but only 5% in the 
survivors. The survivors OgER fell by 17%, but in the patients who died, it 
rose by 11%. These data suggest the presence of a substantial oxygen debt in 
those patients who subsequently died. I t also suggests an increase in 
capillary recruitment allowing the tissue to increase its OgER. There was 
an increase in OgER uncovered in those patients who had been inadequately 
treated. This work shows the importance of the relationship between 
cardiac index (Cl), DOg, VOg and OgER in ARDS and MSOF.
The work of Bihari et al. (1987) further established the importance of 
tissue oxygen in the development of MSOF. They showed tha t the level j of 
VOg can differentiate the survivors from the non-suryivors.
Defective ozygien extraction ratio in ARDS.
Duff et al. in 1969 studied 22 patients with septic shock. The cardiac 
index was frequently normal or raised despite symptoms of shock. Systemic 
vascular resistance and V02 were low. When DOg increased, venous 
oxygen content rose, showing an inability of the patient to increase his 
oxygen consumption.
In septic shock in man, a paradox exists with patients having normal 
or raised Cl, raised lactate and narrowed arterio-venous oxygen content. 
Raising the DOg merely increases the venous saturation, showing that
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something has happened to the tissue's ability to utilise available oxygen, 
i.e., an extraction defect exists as compared to a supply defect. In normal 
patients, sufficient oxygen can be extracted until delivery decreases to below 
approximately 8-10 ml/kg/min, but in ARDS patients an oxygen delivery of 
below 21 ml/kg/min is associated with a decreasing oxygen utilisation.
Optimum values for oxygen metabolism.
Investigation of oxygen metabolism as a mechanism of the pathology 
of ARDS and MSOF was carried out by Shoemaker et al. (1973). They studied 
the sequential physiological variables in surgical patients who were in 
danger of developing complications. They measured many data sets from 
patients every 30 minutes during surgery and up to 96 hours postsurgery.
Circulatory problems were studied in surgical patients, as this group 
of patients could have measurements of their numerous parameters made 
before their surgery occured. Measurements could also be made during 
surgery. Unlike other patients who develop ARDS and MSOF, coming into 
an ITU, surgical patients could have measurements made a t known time 
intervals from the time of insult. Haemodynamic and oxygen transport 
patterns were observed to characterise the effects of surgical trauma. The 
patients underwent operations for massive gastro-intestinal bleeding, bowel 
obstruction and rupture, severe multiple traum a as well as other 
conditions, but all were high risk, critically ill patients.
They studied 98 patients, 67 of whom survived while 31 died. Arterial 
blood pressure was found not to be a good indicator of survival, but those 
parameters associated with volume and oxygen transport, ie. cardiac index, 
DO2 and VO2 , were better indicators. In 1985, Bland in Shoemaker's group, 
performed a sim ilar study in  220 critically ill surgical patients. They found 
tha t the DO2 in  survivors was significantly greater than normal, and much 
greater than the values found in non-survivors. The non-survivors' were 
unable to achieve these values, while survivors achieved these DO2 values by
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the second post operative hour. Unfortunately, these higher DO2 values 
required greater work by the heart, those patients unable to achieve this 
higher myocardial performance had a poor likelihood of survival. The non­
survivors had a lower cardiac index than survivors a t similar left atrial 
pressures, showing reduced myocardial performance.
Shoemaker et al. (1973) considered th a t the cause of death was 
circulatory deficiency, best described as inadequate DO2 leading to an 
inadequate VO2 , with failure to m aintain cellular metabolism. Those 
patients with impaired myocardial performance were unlikely to maintain 
the high level of DO2 necessary to survive.
Shoemaker et al. (1973) considered that as patients who survived had 
higher cardiac index (Cl), DO2 and VO2 than non-survivors, patients at 
risk should have these parameters optimised to the values obtained by the 
survivors.
He performed a study (Shoemaker et al. 1982) of first optimising fluid 
therapy to correct the underlying blood volume deficit. Then he directed 
therapy to not ju st restore normal values but to achieve optimal values. 
These optimal survivors values were,
a) 01 50% greater than normal (4.5 IVmin/m^),
b) DO2 30% greater than normal (600 ml/min.m^),
c) VO2 30% greater than normal (170 ml/min.m^),
d) blood volume 500 ml in excess of the norm (3.2 L/m^ for males, 2.8 L/m^ 
for females).
These increments supply the increased metabolic needs associated 
with fever and tissue repair. Severely traum atised and septic patients 
required much greater increments. This hypothesis was tested on 100 
consecutive critically ill post-operative patients. Normal values were used as 
the therapeutic goals in the control patients, while the values obtained from 
the survivor group were used as goals in the protocol group. The mortality 
was significantly less in the protocol group (13%) than the control group
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(48%). The number of life threatening complications was also greater in the 
control group.
It should be emphasised that this therapy of Shoemaker et al. (1982) 
has only been shown to prevent the complications of surgery of which ARDS 
and MSOF are included. It has not been shown to reverse the condition once 
it has started. But in preventing the establishment of ARDS and MSOF it 
does give an insight into the mechanism of the development of the 
syndrome.
i
considered that five basic principles had been established;
1) Reduced or inadequate VO2 leading to tissue hypoxemia was the primary 
pathogenic mechanism of the shock syndromes, providing a focus for the 
inflammatory response.
2) DO2 , the supply side of the equation, limits VO2 by either low flow as in 
haem orrhagic shock or m aldistribution of flow, particularly  a t the 
microcirculatory level from inappropriate vasoconstriction or dilatation 
caused by neurohormonal mechanisms and the various inflammatory 
mediators, as occurs with traum a and sepsis.
3) There is an increased metabolic need (demand) in ARDS and MSOF 
patients that exceeds the basal transport function of the circulation (supply), 
that must be satisfied if the patient is not to suffer hypoxemia.
4) VO2 represents the sum of all oxidative reactions and therefore reflects 
the body's metabolic activity; when VO2 is not rate limited by blood flow, it is 
a measure of metabolic demand.
5) In reduced circulatory function, VO2 is the regulatory mechanism; 
decreases in VO2 stimulate the compensatory increases in DO2 , heart rate, 
myocardial contractivity, cardiac output and ventilatory function, in an 
attempt to increase th  VO2 . '
In essence the problem is a disparity between supply and demand of 
oxygen and the various nutrients transported by the circulation. The
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common denominator in each of the shock syndromes associated with the 
development of ARDS or MSOF is reduced VO2 . I t is the earliest 
pathological event occurring a t or before the initial hypotensive crisis 
signalling the shocked condition. Reduced or inadequate VO2 is greater and 
more prolonged in patients who die than  those who survive. Reduced or 
inadequate VO2 is not just associated with development of shock, but the 
degree of VO2 deficit is the major pathogenic factor in the development of 
shock syndrome and a major determinant of the outcome.
Oxygen diffusian.
The critical level of oxygen required for oxidative phosphorylation to 
proceed normally in vivo is unknown. Chance and Williams in 1955 showed 
in preparations of isolated mitochondria there was no significant decrease 
in the respiration of these organelles, as measured by the oxidation of 
cytochrome c, until the PO2 in the perfusing media fell bellow 0.5 torr. In an 
isolated perfused lung preparation, the cellular PO2 required to maintain 
aerobic function was studied by lowering the PO2 in both the perfusate and 
the ventilating gas. A fall in ATP content and decrease in ATP/ADP was 
seen only when the PO2 was reduced to 0.7 torr, a value not very different 
from the results seen in isolated mitochondria. This supports the concept 
tha t there is a very low resistance to oxygen diffusion within the cell. It is 
unlikely that the poor oxygen utilisation seen in ARDS and MSOF patients is 
due to problems of diffusion across the capillary and cell membrane.
Criticism s o f the work on oxygen consumption in  understanding MSOF.
A dose examination of the work of Shibutani et al. (1983) does not 
show w hat was originally claimed. F irst of all the VO2  value of 109 
ml/min/m^ is very low, the basal value during surgery previously reported 
by Guedel (Guedel 1924) was 138 m l/m in/m ^. The work of Cain (1978), 
previously mentioned shows that an O2ER of about 60% should be reached
91
before the critical point forces the VO2 to fall. Calculating the O2ER from the 
work of Shibutani et al. shows tha t the O2ER was 24% when above the 
critical point and only 31% when below. Athletes can easily achieve 02ER of 
70%. Shibutani et al. (1983) patients appear to have an oxygen extraction 
problem and they do not have ARDS, sepsis or MSOF.
There is also a major difference between the work of Cain (1978) and 
th a t of Shibutani et al. (1983). Although they both demonstrate changes in 
DO2 , these changes are achieved by very different methods. Shibutani et al. 
(1983) showed changes in DO2 as a product of changes in the CO. Changes 
in the CO would change the blood flow to the various sites and the volume of 
blood to a particular organ. But most importantly it would be associated with 
a reduction in capillary density. Cain on the other hand, reduced DO2 by 
producing hypoxemia, this reduced the volume of oxygen in the blood but 
maintained the CO. This had the effect of maintaining blood flow to the 
organs and within the organs. The number of capillaries perfused in Cain’s 
work should remain the same after he produced hypoxemia. This would 
allow for a more efficient extraction of oxygen by maintaining the capillary 
density. This effect is seen by the high O2ER in Cains work.
Shibutani et al. (1983) , measured the effect of differing CO, and saw 
the results of a redistribution of blood flow, both higher and lower in 
modifying the blood flow within an organ. When CO fell it caused a fall in 
capillary density and a reduction in O2 ER. This action would prevent an 
increase in 02ER.
The prindple criticism of the work presented on oxygen metabolism is 
th a t  i t  is alm ost exclusively concerned w ith whole-body oxygen 
consumption. The relationship of blood flow, DO2 and VO2 in differing 
Organs determ ines total blood flow, total DO2 and total VO2 Flow 
independent organs such as the kidney, splanchnic bed, skin and muscle 
have low oxygen extraction rates. Whereas flow dependent organs such as 
heart and brain have very high oxygen utilisation. In principle, decreased
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blood flow in flow independent organs does not reduce the ir oxygen 
consumption but reduced blood flow in a dependent organ will reduce its 
oxygen consumption. Although all organs can increase the capillary 
coefficient, so that they can extract more oxygen from that delivered, there is 
a critical point of about 60% OgER, over which, additional oxygen cannot be 
extracted.
Mitochondria
The reduction in O2ER seen in patients with septic shock or ARDS 
and MSOF could be due to an inability of the mitochondria to utiHse oxygen. 
Although oxygen is delivered to the tissue, a blockage in mitochondrial 
function might occur. Damage to the mitochondria, with the inevitable 
inhibition of mitochondrial respiration would result in a decrease in VO2 
regardless of DO2 , sim ilar to th a t seen in  ARDS. The defect in 
mitochondrial function appears to correlate with the progressive systemic 
circulation failure seen in sepsis.
Endotoxin has been shown to have a variety of deleterious effects on 
isolated mitochondria, in vitro. These effects include the loss of respiratory 
control (Hift and Strawets 1961), the inhibition of succinate, glutamate, and 
malate oxidation (Lardy 1969), the inhibition of mitochondrial ATP-ase 
(Nicholas et al. 1972), the uncoupling of oxidative phosphorylation (Fonnesu
1960), and the deterioration of mitochondrial integrity (Hift and Strawets
1961).
The two mitochondrial reactions responsible for efficient ATP 
synthesis, the ATP-ase ATP synthetase reaction and the adenine nucleotide 
translocase function can be severely damaged in circulatory shock 
(Nicholas et al. 1972). The ATP-ase activity drops to about 30% of the control 
values 45 hours after the onset of haemorrhage or endotoxic injection. 
Adenine nucleotide translocase, an enzyme th a t transports adenine 
nucleotide across the inner mitochondrial membrane is inhibited by in vivo
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endotoxin (Jones and Kramer 1978). A decrease in adenine nucleotide 
translocase activity could result in an accumulation of ATP inside the 
mitochondria which in turn would suppress the biosynthesis of ATP.
In haemorrhagic or endotoxic shock, the mitochondria of the liver, 
kidney and brain become functionally damaged a t differing time intervals. 
Because of the extreme sensitivity of the brain to inadequate perfusion, brain 
mitochondrial metabolism is affected early in circulatory shock (Mellor et 
al. 1979, Baue and Said 1970).
Liver mitochondria, from rats, showed a reduction in ATP synthetic 
capacities (Mellor et al. 1971). Studies of liver mitochondria, from dogs, ini'
endotoxic, septic or haemorrhagic shock have revealed severe deterioration 
of respiratory activity and structural integrity (Hift and Strawets 1961). 
These studies of hepatic mitochondrial energy functions in shock, from rats 
and dogs, indicate loose coupling of mitochondrial respiration after a delay 
of about one hour in haemorrhagic and two hours in endotoxic shock. 
Uncoupling of oxidative phosphorylation occurs, allowing oxygen to be 
consumed by hydrogen ions to produce water but no ATP. This effect is 
similar to th a t of the uncoupler, bromophenolbromine. The respiratory 
control ratios therefore drop progressively with time.
S tructural studies of liver mitochondria performed by Hift and 
Strawets in 1961 have shown that lethal endotoxaemia and haemorrhage 
induce a heterogenous mix of hepatic mitochondrial changes ranging from 
grossly swollen profiles with loosened or disrupted matrices to forms with 
dense matrices and cristae. These are dilated but have normal external 
profiles. Although tissue hypoxia is present in shock, it alone is not 
responsible for the functional and structural changes of mitochondria in 
shock.
Changes of cardiac and skeletal muscle mitochondria in shock 
rem ain controversial. Some investigators have dem onstrated normal 
mitochondrial respiration with adequate generation of ATP at the time of
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cardiac failure (Mellor et al. 1974). After endotoxin induced cardiac failure, 
heart mitochondria do not show morphological damage, even in the 
presence of morphological evidence of inter-fibrila swelling.
Similarly no deleterious alterations in the capacity of dog cardiac or 
skeletal muscle mitochondria to synthesise ATP were observed after 
endotoxaemia when liver and kidney mitochondrial ftmctions were severely 
damaged. But in cardiac failure induced by endotoxaemia in the rat, 
impaired cardiac and skeletal muscle mitochondrial function and altered 
morphology was demonstrated by Schumer et al. (1971).
Unfortunately, mitochondrial alterations occur simultaneously with 
other sub-cellular defects caused by shock. No evidence exists to indicate 
w hether the mitochondrial defects are prim ary or secondary to other 
intracellular alterations. Lysosomal enzymes released in shock have been 
shown to induce cell injury by Rangell et al. (1970).
Criticism of the concept of mitochondrial damage causing impaired 
oxygen uptake in shock was demonstrated by the work of Geller et al. (1986). 
They employed an endotoxic shock model in rats to determine the function of 
skeletal muscle mitochondria. No significant alterations in the parameters 
measured were observed in the endotoxic state. They also investigated 
bacterial peritonitis in the ra t model in both liver and skeletal muscle 
mitochondria for possible alteration in liver metabolism. Neither muscle 
nor liver mitochondria exhibited functional impairment during sepsis and 
they concluded th a t neither endotoxaemia nor peritonitis selectively 
damages the mitochondria as had previously suggested. But this is only one 
paper among many opposing viewpoints. i;
Tissue oxygen utilisation.
W hen th e re  is insuffic ien t oxygen to su s ta in  oxidative 
phosphorylation, increased rates of glycolysis provide for anaerobic 
production of ATP. Pyruvate acts as the proton acceptor from NADH2 and
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lactate is formed. If the dissociated proton from lactate exceeds the body's 
buffer capacity, metabolic acidosis will develop.
Lactate may either undergo oxidation or serve as a substrate for 
gluconeogenesis. Oxidation of lacta te  is accomplished through the 
tricarboxylic acid (TCA) cycle and is an oxygen dependant process. It takes 
place in the liver, renal cortex, heart and skeletal muscle. The rate of 
gluconeogenesis in the liver depends on hormones such as glucagon, 
insulin and glucocorticoids, in addition to the blood lactate level. The energy 
dependant process of gluconeogenesis also depends on the adequate 
oxygenation of the liver.
Tissue hypoxaemia is thought to be the most im portant cause of 
increased lactic acid level in the critically ill patient. When aerobic 
metabolism can no longer be maintained some tissues rely on glycolysis for 
energy production. Since this normally occurs only a t very low oxygen 
levels, it represents very severe tissue hypoxaemia.
Plasma lactate levels are considered to reflect tissue hypoxemia and 
reduced or inadequate VO2 . This concept is an over simplification, as 
plasm a lactate levels are dependant on its production, clearance and 
excretion. The kidney excretes and clears lactate, but the greatest clearance 
is by the liver.
Recent work performed in pigs (Tighe et al. 1989) has shown plasma 
lactate levels in sepsis to be more dependant on liver blood flow and oxygen 
delivery to the liver, than the total body VO2 . Septic pigs treated with the 
drug pentoxifylline showed sim ilar w hole body oxygen consum ption as 
untreated  pigs. Lactate production from the femoral muscle bed was 
similar in both groups of animals. But hepatic blood flow and oxygen 
delivery was significantly higher and arterial lactate significantly lower in 
the drug treated animals, than the untreated septic animals. Whole body 
VO2 could not predict plasma lactate levels.
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These studies strongly suggest tha t the rate of lactate clearance is a 
most important factor in the development of lactic acidosis in septic shock. 
Patients with septic shock who develop lactic acidosis may show a reduced 
hepatic lactate clearance rather than an inadequate VO2 .
Additionally, Lang et al. (1983) have shown th a t in rats with faecal 
peritonitis, VO2 rises by 40% at the same time as a 50% increase in plasma 
lactate occurs. They also presented histological evidence of liver leucostasis 
and congestion as well as renal congestion. This again suggests th a t 
inadequate clearance of lactate is the cause of the high serum lactic acid.
According to the work of Cain (personal communication), VO2 can 
rise a t the same time as blood lactate levels in dogs infused with endotoxin. 
Pyruvate levels also rise. This is considered to be due to the inactivation of 
pyruvate dehydrogenase, preventing the entry of pyruvate into the 
m itochondria by stopping the form ation of acetyl co-A. Pyruvate 
dehydrogenase exists in  two forms, the active and inactive. Sepsis or 
endotoxin can cause the conversion of active PDH into inactive PDH.
Pho^hocreatine/D02 ratio
Energy production can be divided into aerobic metabolism producing 
36 molecules of ATP per molecule of glucose through oxidative 
phosphorylation, or anaerobic metabolism producing 2 molecules of ATP 
per molecule of glucose through glycolysis, the creatine kinase (CPK) 
reaction or the adenylate kinase reaction. Glycolysis increases cytosolic 
hydrogen ion concentration reducing the intracellular pH. Consequently, 
glycolysis is not the preferred source of ATP during hypoxemia.
ATP formed in the mitochondria is freely available to the cell by 
diffusion across the mitochondrial membrane or by the action of 
phosphocreatine (PCr) energy shuttle. The ATP molecule is large and 
diffuses into the cytoplasm with difficulty, therefore it is thought to stay 
within the mitochondria. The PCr molecule is quite small and freely
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diffuses w ithin the cytoplasm. According to the PCR-energy shuttle 
hypothesis, ATP phosphorylates PCr in the mitochondrial membrane by the 
creatine kinase reaction. PCr carries the high energy phosphate from the 
mitochondria to the various energy consuming portions of the cell, where it 
phosphorylates ADP to form ATP and creatine. The PCr reaction also has
I
the advantage of consuming hydrogen ions during the formation of ATP. 
The creatine kinase reaction has been shown to occur in many tissues, but 
the highest concentration of creatine kinase is found in the tissues of high 
energy requirem ents, the heart, skeletal muscle and brain. But the 
beneficial effects of this reaction are short-lived because of limited tissue 
concentrations of PCr. The adenylate kinase reaction helps maintain ATP 
by sphtting 2 ADP in to one AMP and one ATP. 
adenylate kinase 
2 ADP -> AMP + ATP 
AMP diffuses from the cell into the microvasculature where it binds 
to receptors on blood vessels to cause potent vasodilatation.
Oxygen dehvery and consumption are the two parameters judged to be 
of clinical importance in measuring the adequacy of tissue oxygenation. 
Nuclear magnetic resonance studies on cellular metabolism reveal how 
insensitive, and a t times misleading, these indices can be. Measurement of 
tissue ATP, phosphocreatine, and inorganic phosphate (Pi) can correlate 
with DO2 , VO2 , or lactate, or all of them (Clark et. al. 1987)
Studies using magnetic resonance spectroscopy (MRS) in hypoxic ra t 
heart preparations revealed that ATP concentrations were maintained by 
depleting high energy PCr stores. There is an accumulation of Pi, with 
depletion of PCr stores after 5 minutes ischemia and a gradual decrease of 
ATP levels. Similar responses have also been found in brain and heart by 
Sapega et al. (1985).
The decrease in PCr and the increase in Pi provide a convenient 
index of tissue hypoxemia: the PCr/Pi ratio. In fully aerobic tissue, the
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PCr/Pi is high, about 7-10. With hypoxemia, it  declines progressively to 
levels less than 1, and further decreases result in a fall of ATP. ^
Re-perfusion after 3 hours of ischaemia resulted in a rapid and 
complete reversal of these changes. Phosphocreatine re synthesis was 
detected within 10 seconds after reperfusion and complete recovery required 
approximately 1 minute for every preceding hour of ischaemia. The oxygen 
debt did not have to be repaid. It should be emphasised tha t these studies 
were not done in septic animals and the findings may not be applicable to 
humans suffering from ARDS.
The work of Idstrom et al. (1985) represents the only study published 
where changes in cellular bioenergetics correlated with changes in DQ2 
and VO2 Idstrom et al. (1985) found a linear correlation in the PCr/Pi ratio 
with DO2 and VO2 in a ra t hind limb preparation. When VO2 began to 
decline as a function of DO2 , ATP turnover rate was maintained constant at 
the expense of energy stores in the form of phosphocreatine and the use of 
anaerobic metabolism.
The studies of Idstrom et al. (1985) involved perfusing the ra t 
hindlimb with Krebs-Henseleit bicarbonate buffer without erythrocytes. The 
perfusate was equilibrated with gas containing 5% CO2 and fractions of 
oxygen varying from 95% to 20% with the rem ainder nitrogen and the 
preparation perfused a t a constant flow.P^^-MRS spectra were obtained 
from the ra t leg a t different levels of DO2 , with the limb at rest, during 
stimulation and finally during recovery. The relationship between DO2 and 
VO2  obtained during these experiments was a linear function. Likewise, the 
authors found a linear relationship between the PCr/Pi ratio and D02.
Gutierrez and Pohil (1989) performed experiments on the isolated 
hindquarter of rabbits with normal DO2 , hypoxemia and reperfusion. The 
data showed that there were 2 distinct groups, group A with a biphasic DO2 - 
VO2  relationship and group B with a linear relationship having a higher
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resting VO2 . The reason for the spontaneous development of two differing 
groups remains unclear.
Throughout the experimental procedures in both groups ATP 
concentrations were maintained at near control levels. During hypoxemia 
the D02“PCr/Pi in group A showed a biphasic relationship similar to tha t of 
DO2-VO2 , seen in normal subjects. In group B, the D0 2 -PCr/Pi association 
was nearly linear, as DO2 fell so did PCr/Pi.
After the hypoxic phase, some anim als showed th a t during 
reoxygenation, despite a return of DO2 and VO2 to control level, the PCr/Pi 
ratio remained low in both groups, and did not return  to control levels 
during the allotted time for the recovery phase of the study. When the 
perfusion was continued past the recovery time, almost invariably there 
resulted a relentless fall in ATP, with a decrease in VO2 . These events 
signaled irreversible cellular damage. Although this phenomenon remains 
unexplained, it appears likely tha t irreversible cellular damage occured 
during hypoxemia.
Control lactate concentration in group A was always lower than  
Group B; when DO2 fell, there was only a small rise in plasma lactate in 
group A , but a large rise in group B.
Group A had a lower control O2ER corresponding to a lower resting 
VO2 . These animals were able to increase their O2ER from a control value 
of 20% to approximately 60%. Additionally by increasing the O2ER only to 
40%, they could maintain control VO2 a t half the control DO2 . The lower 
control VO2 and the ability of the microcirculation to triple the O2ER allow 
group A to maintain their control level of metabolic activity by generating 
ATP exclusively from oxidative phosphorylation. This results in a constant 
VO2 ,with a reduced DO2 , preservation of the PCr stores and avoidance of 
anaerobic glycolysis as a source of ATP. This is confirmed by the stable 
plasma lactate concentration. When the extraction limits were reached, 
VO2 began to decline and ATP was generated via PCr.
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The group B, animals had difficulty increasing the fraction of oxygen 
extracted from capillary blood. They had a high control O2ER of nearly 40%, 
giving the animals a disadvantage as the maximum O2 ER for skeletal 
muscle is 60%. Consequently these animals could not increase their O2ER 
sufficiently to supply their greater ATP requirements. When DO2 began to 
decrease, VO2 also fell. Oxidative phosphorylation could no longer satisfy 
tissue requirements for ATP and the PCr stores were used, the PCr/Pi ratio 
declined with the VO2 . When PCr was nearly depleted, with a PCr/Pi ratio 
of nearly 1, the lactate levels started to rise.
It must be assumed that the apparent inability to increase the O2ER 
in the face of a falhng DO2 , so lethal to the outcome of the illness, is due to 
the inappropriate perfusion of supply independent organs and the failure to 
recru it sufficient capillaries in  an  organ. The reason why th is 
inappropriate lethal response occurs remains to be investigated.
ATP Levels in  sepsis.
Chaudry et al. (1979) investigated the concentrations of ATP, AMP, 
lactic acid, and the hepatic blood flow in rats with faecal peritonitis over 18 
hours, shown in Table 32. The rats were divided into 3 groups, sham 
operated served as controls, "early sepsis" killed after 10 hours and "late 
sepsis" killed after 18 hours. Tissue was taken from the kidney, liver, 
gastrocnemius muscle (intermittently working muscle) and the diaphram 
(constantly working muscle). Values in the early sepsis group were similar 
to the sham group.
ADP is the degradation product of ATP and should rise as the latter 
falls. But when hypoxemia deprives the cell of oxygen, ATP can be produced 
in some organs by two molecules of ADP forming one molecule of ATP and 
one AMP. In these organs the cellular AMP concentration will rise, when 
the relevant enzyme is not present, the cellular concentration of AMP will 
remain stable. Pyruvate is converted to lactate for glycolysis to proceed, so
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tha t lactate is an indicator of anaerobic metabolism. An equal lactate to 
pyruvate ratio indicates that pyruvate cannot enter the mitochondria and is 
converted to lactate as its concentration rises. If the lactate level rises 
without an increase in pyruvate then it suggests that there is an inadequate 
supply of oxygen preventing the oxidative phosphorylation process from 
proceeding, (NADH converts pyruvate to lactate in the absence of oxygen).
Table 32. M etabolic changes in  th e  various tissues o f ra ts  w ith  faecal
peritonitis. (Chaudry et al. 1979)
liv e r Kidney Gastro Diaphragm
ATP
Sham 1.99 1.23 5.07 3.39
Late septic 0.71* 0.77* 5.10 3.35
AMP
Sham 0.50 0.64 0.06 0.14
Late septic 1.00* 0.64 0.04 0.12
I^ruvate
Sham 0.17 0.23 0.18
Late septic 0.12 0.10* 0.21
Lactate
Sham 1.79 2.45 4.75
Late septic 6.29* 5.12* 9.15*
Lac/E’yr Ratio
Sham 10.5 10.6 26.3
Late septic 44.0* 51.2* 43.5*
Blood Cow
Sham 23.9
Late sepsis 15.5*
* P< 0.001 compared with sham operated animals
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In late sepsis, liver ATP fell by 65% and blood flow decreased, AMP 
and the lactate to pyruvate ratio increased. This conversion of ADP to ATP, 
and lactate production suggests effective cellular hypoxemia. Renal ATP fell 
by 45%, a smaller amount than in the liver. But unlike liver AMP, which 
rose, renal AMP level did not change, showing that it cannot convert ADP to 
ATP, Also, the pyruvate concentration fell and lactate production rose with 
a bigger increase in the lactate to pyruvate ratio than liver, indicating that 
unlike the liver, glycolysis was developing in kidney to maintain ATP levels.
The change in  diaphragm  and gastrocnem ius muscle differ 
markedly from those of the liver and kidney. The ATP and pyruvate levels 
showed no change. But lactate and the lactate/ pyruvate ratio showed a 
considerable increase in anaerobic metabolism to maintain ATP levels.
Although increases in anaerobic metabolism would be expected to be 
associated with falling levels of ATP, this did not occur. The maintenance of 
ATP is probably due to the highly active glycolytic system of skeletal muscle 
and their mobilisation of high energy phosphocreatine to resist effects of 
reduced blood flow and hypoxemia.
There is a decrease in the energy available to liver and kidney but not 
skeletal muscle during late sepsis. This could reflect a more critical fall in 
blood flow to the liver and kidney or the metabolic differences of the various 
organs.
A further m arker of inadequate tissue oxygenation involves the 
degradative pathway of ATP. If ATP utilisation exceeds its production, ADP 
or AMP accumulates and is hydrolysed through a series of steps to 
hypoxanthine. This substance can cross the cell membrane and then be 
further degraded by oxidation in the liver via the enzyme xanthine oxidase 
to xanthine and then uric acid. It has been shown th a t an elevation of 
hypoxanthine correlates to decreased survival in ITU patients (Grum et al. 
1985).
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In the septic stage there may be an inhibition of skeletal muscle's 
ability to oxidise glucose effectively. This abnormality relates to a metabolic 
block of the entry of pyruvate obtained from glucose in the Krebs cycle. 
Pyruvate dehydrogenase can become inactive in septic subjects. As a result 
pyruvate tends to accumulate which in turn equilibrates at increased levels 
vdth lactate. Lactate levels become progressively higher as the septic 
process accelerates. This is the cause of lactic acidemia of sepsis and is 
accompanied by a normal lactate pyruvate ratio in contradistinction to 
states associated with a perfusion deficit.
An im portant feature of this work is the difference in the ability of 
diverse organs to m aintain ATP production. Liver suffers principally from 
hypoxemia, more so than kidney and muscle, a possible reason for the great 
increase in splanchnic blood flow showed in high risk patients. I t also 
demonstrates the vital importance of maintaining hepatic DO2 . A study of 
the relationship of ATP production in various organs to the increase in DO2 
and VO2 in those patients treated vrith high DO2 would be of considerable 
importance.
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Chapter 4
H istological features associated w ith M.S.OJP.
Introduction
Investigation of the ultra-structure of the lungs was undertaken to 
establish the mechanisms involved in the development of this condition. 
Studies were performed on lungs of recently deceased patients, but 
unfortunately their condition did not reflect the mechanisms involved, only 
the degenerative changes th a t occurred before death. Considerable 
confusion has arisen because of these early studies, cause being mistaken 
for effect.
Bachofen and Wiebel in 1977 and Schnells et al. in 1980 were the first 
to perform open lung biopsies on ARDS patients as early as 3 hours after the 
onset of symptoms. From these studies they were able to describe some of the 
early changes and postulate the causes.
Unfortunately, histological studies of human tissue from patients 
with multi-organ damage do not allow the study of the development of the 
condition. Animal models have been developed to mimic the organ changes 
seen in humans. The relevance of these studies m ust be questioned in view 
of the considerable differences between hum ans with sepsis and the 
experimental septic animal. The la tte r is a relatively healthy and intact 
organism which can sustain a massive insult (large doses of live organism 
or endotoxin) and is followed for only a number of hours, rarely a few days. 
Whereas a patient may have had the condition for several days and is 
treated aggressively with therapies that are untestëd.
Considerable work has been done in the non-human primate (baboon) 
as this animal's response to sepsis closely resembles th a t of the human. 
Unfortunately, the baboon is expensive to study, carries hepatitis and can be 
distasteful to work with on ethical grounds due to its primate status.
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Lung Histology
Normal pulmonary ultrastructure
On the gaseous side of the normal alveolar wall are two main cell 
types: epithelium and type II pneumocytes. Epithélium covers 90% of the 
alveolar surface and are a layer of flattened cells with thin cytoplasmic 
extensions less than  1 i^m thick. Junctions between alveolar cells are very 
tight and impermeable to water. When damaged, epithelial cells cannot 
replicate. They are formed by differentiating type II pneumocytes as 
described by Adamson and Bowden (1975). Type 11 cells have numerous 
functions, the most important is the production of surfactant, maintaining 
the alveolar sacs open.
The work of Mason (1978) shows that although type II pneumocytes 
develop into epithelial cells, under adverse conditions they may remain as 
large cuboidal cells. These cells appear relatively inactive in secreting 
surfactant from their lamellar bodies or cytoplasmic microsomes, and their 
thickness prevents oxygen exchange.
Lining the pulmonary capillaries are the endothelial cells shown 
(Mason et al. 1978) to be functionally important, containing large numbers 
of enzymes capable of degrading prostaglandins and vasoactive amines or 
producing prostaglandins. Endothelium is also responsible for the 
conversion of angiotensin 1 to 2 or the inactivation of bradykinin.
The normal ultrastructure of pig lung is shown in the transmission 
electron micrograph (TEM) in Figure 2. Red blood cells and several 
leucocytes are contained within the thin walled pulmonary capillaries. 
Nuclei of endothelial cells are flattened inside the capillary. A normal 
neutrophil in a pulmonary capillary can be seen in the TEM in Figure 3. Its 
azurophilic and specific granules are membrane bound and can be 
distinguished from each other. The three layers of the capillary wall can be 
distinguished, on the alveolar side is the epithelium, in the middle the 
basement membrane and inside is the capillary endothelium.
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Pathological pulmonary ultrastructure
There are several reviews of the electron microscopic features of the 
lung in humans who developed ARDS after traum a (Schnells et al. 1980) 
(Pietra et al. 1981), bum s (Nash et al. 1974), septicaemia (Bachofen and 
Weibel 1982), and pancreatitis (Bachofen and Weibel 1977, 1974). Although 
these conditions are of considerable difference, the pulmonary changes are 
essentially the same.
In humans, two phases develop between the onset of the condition and 
the 21 days tha t often pass before the death of the patient, the acute and 
chronic phases.
The description of Bachofen and Wiebel (1982) is typical of many of the 
reviews. They studied lung tissue from 9 patients dying from ARDS due to 
septicaemia. In the acute phase, up to 4 days after the onset of respiratory 
distress, the alveolae contained erythrocytes, neutrophils, macrophages, 
oedema fluid and strands of fibrin. Epithelium was ruptured with exposure 
of the basement membrane. Twenty-four hours after the onset of symptoms, 
type II pneumocytes proliferated within the alveolar lumina. Hyaline 
membranes comprising a mixture of plasma proteins, fibrin strands, cell 
debris and degenerative changes in elastic fibres were also seen.
There was irregular endothelial cell swelling, vacuolation and 
exposure of basement membrane. The initial injury was to the endothelial 
cells, by aggregates of lymphocytes and degranulating neutrophils (Siegel 
and Cerra 1979). Associated with this development was fibrin deposition in 
the pulmonary lumina and the formation of microthrombi.
Pulmonary oedema either interstitial or intra-alveolar was reported 
in this condition. Intra-alveolar oedema was seen as a terminal event of 
ARDS. The excess fluid in the in terstitia l space is removed by the 
pulmonary lymphatics (Hurley 1978, Cunningham and Hurley 1972) but 
when the capacity of the lymphatics is exceeded, oedema spreads into the 
interstitium  and the alveolar lumina.
107
Not all patients necessarily follow this sequence of diffuse alveolar 
damage, progressing to interstitial and intra-alveolar fibrosis (Bachofen 
and Weibel 1974). Bachofen and Weibel in 1977, quantified the components of 
the alveolar wall in ARDS due to septicaemia. They showed approximately a 
twofold increase in the interstitial volume in the acute phase and up to 10 
times normal in the chronic phase. Similarly there was a two to threefold 
volume increase in the epithelial cells in the acute phase and a further 
doubling in the chronic phase. Both these changes impair gaseous difhision 
with the smallest relative volume changes being those of the endothelial 
cell.
Schnells et al. (1980), took lung biopsies from patients during the 
course of post-traumatic respiratory insufficiency between 3 hours and 19 
days after the onset of shock. There was endothelial and epithelial damage, 
lymphatic dilatation and in te rstitia l as well as intra-alveolar fibrin 
extravasion. In te rs titia l oedema and ex tra vascular m igration of 
granulocytes, lymphocytes and mast cells with fibrinoblastic proliferation 
and fibrosis of the alveolar septa was also seen. Fibroblasts replaced 
capillaries a t the surface where gas exchange takes place, the capillaries 
were thus forced into the depth of the interstitial tissues. At the same time 
the alveolar surface became covered with layers of thick walled proliferating 
epithelia which also render gas exchange increasingly difficult.
Figures 4 and 5 are TEM of lung tissue, removed within minutes of 
the death of a patient with ARDS. Figure 4 shows the total destruction of the 
normal pulmonary architecture. It is difficult to establish where gas 
exchange was taking place. The alveolar space is lined with fibrin and the 
normal structures are totally deranged. Figure 5 shows a single pulmonary 
capillary obstructed by a degranulating neutrophil. The endothelium is 
swollen and interstitial oedema can be seen. The alveolar epithelium is 
separated from the basement membrane which is covered by fibrin.
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Animal studies o f pulmonary ultrastructure in  ARDS like syndrome.
We have studied rabbit (Tighe et al. 1987, 1989) and pig (Tighe et al. 
1990) pulmonary ultrastructure from lung biopsies taken 2 and 5 hours after 
the induction of faecal peritonitis. Two hours after the induction of 
peritonitis there was an increase in the number of neutrophils in the 
pulmonary capillaries, but without apparent damage. After 5 hours of 
peritonitis there was an eightfold increase in the number of neutrophils and 
lymphocytes. The neutrophils were degranulated and the capillaries 
occluded, with very few red blood cells (RBC). The capillary endothelium 
was either swollen, vacuolated or completely disrupted, exposing the 
basement membrane. The alveolar epithelium is vacuolated or detached 
from the basement membrane. Type II pneumocytes did not show the 
presence of lam ellar bodies, suggesting the absence of surfactant 
production.
We demonstrated (Tighe et al. 1990) tha t in pig lung 5 hours after the 
induction of faecal peritonitis, capillary luminal area was much smaller 
than  normal tissue and there was an 8 fold increase in the number of 
intracapillary leucocytes (Tighe et al. 1990). The patent perfusable capillary 
area was reduced and partially occluded by degranulating neutrophils, 
lymphocytes, swollen RBC’s, enlarged endothelium and cell debris. The 
alveolar epithelium is swollen and vacuolated. Some capillaries were 
ruptured as evidenced by the RBC’s and leucocytes in  the alveolar space 
seen in Figure 6. Figure 7 shows a capillary occluded by a degranulating 
neutrophil, appearing to be tightly adherent to the endothelium, which is 
swollen and partly detached from the basement membrane. The epithelium 
is swollen and vacuolated. Figure 8 is a scanning electron micrograph 
(SEM) of a pulmonary capillary containing a neutrophil. Points of adhesion 
can be seen between the neutrophil and the endothelium.
Meyrick et al. (1983) infused E. coli endotoxin into 5 sheep and 
compared them to a control group. After 50 minutes of endotoxin infusion.
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light microscopy revealed margination and accumulation of leucocytes in 
the lung microcirculation. Counts of the number of granulocytes in lung 
biopsy specimens from test animals showed a threefold increase by 15 
minutes and a sixfold increase by 240 minutes. Electron microscopy of the 
leucocytes identified both granulocytes and lymphocytes in  approximately 
equal numbers. Some granulocytes were fragmented and specific granules 
were found free in the vascular lumen. By 60 minutes interstitial oedema 
was seen and there was focal endothelial damage. Correlation of the 
structural and physiological changes showed th a t the initial accumulation 
of leucocytes in  the m icrocirculation occurred when pulm onary 
hypertension developed. The migration of leucocytes into the interstitium  
and the endothelial cell damage preceded the physiological changes that 
were interpreted as increased pulmonary capillary permeability.
Studies of anaesthetised baboons (Coalson et al. 1977) infused slowly 
with live E. coli bacteria demonstrated sequestration, degranulation and 
fragmentation of neutrophils and platelets in the pulmonary capillaries. 
There was characteristic swelling and disruption of the pulmonary 
endothelium. Fibrin was present in the capillary lumen, interstitium  and 
alveolar sac and oedema was also present in the interstitium  and alveolar 
sac.
Shaw et al. (1980) made intra-tracheal injections of C5a in rabbits .to 
induce an acute pulmonary inflammation characterised by intra-alveolar 
accumulation of neutrophils, erythrocytes and oedema fluid. Electron 
microscopy of the rabbit lung revealed degranulated neutrophils in the 
pulmonary capillaries and interstitial spaces. The alveolar spaces, and less 
often, the interstitial compartment contained fibrin deposits with leucocytes 
and erythrocytes enmeshed in the fibrin strands. Injury to the pulmonary 
endothélium consisted of bleb formation and exposure and separation of the 
basem ent membrane, with accumulation of inflammatory cells in the 
capillaries. Epithelial cells were damaged with blebbing and detachment
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from the basement membrane. Endothelial and epithelial cell damage was 
always associated with pulmonary neutrophils continuous with the injured 
structure.
Balis et al. (1978) infused E. coli endotoxin into baboons for up to 22 
hours, and found a rapid margination of neutrophils in the pulmonary 
capillaries tha t progressively degranulated and fragmented. The capillary 
endothelium was swollen and disrupted. There was interstitial and alveolar 
oedema. The alveolar epithelial cells showed blebbing and disruption with 
exposure of the basement membrane.
Attention has been paid to histological changes in the lung of humans 
with ARDS, and lung and liver in animal models of this condition. They are 
considered to give a good indication of the mechanisms causing MSOF. But 
the pathophysiology of this condition is undoubtedly much more complex. 
The work of Beeley et al. (1986) is especially illuminating.
They took 36 rabbits divided into 3 groups and allowed to inhale 
acrolein vapour for 15 minutes. After 30 minutes animals from two of the 
groups received steroid treatm ent and the other group was given a placebo. 
Some animals died during the study, others were killed after 72 hours. 
Histology of the lungs was examined in all the animals and the severity of 
pathological changes graded.
The purpose of the study was to quantify the histopathologic changes 
in  the lung after inhalation injury, and study the effect of steroid treatment 
on mortality and lung histopathology. In the placebo group 8 out of 12 died 
and  in  the steroid group 5 from 24. This difference was significantly 
different. But when histological scores were compared, there was no 
difference between the steroid and placebo treatm ent groups. Steroids failed 
to attenuate the pathological changes studied. In fact pulmonary congestion 
was generally more severe in the steroid treated group. Survival in the 
steroid treated  group was not related to protection of pulmonary 
ultrastructure.
Ill
liv e r  histology.
There have been few studies of liver histology from patients with 
ARDS, due to the danger to life of the patient in taking the necessary tissue
samples. In animal models of the ARDS like condition, few researcher have
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focused on liver ultrastructure. We studied hepatic ultrastructure in rabbits 
(Tighe et al. 1989) and pigs (Tighe et al. 1990) from biopsies taken 2 and 5 
hours after the induction of peritonitis. Figure 9 shows a TEM of tissue 
taken from pig Uver before infection was initiated. Figure 10 shows a SEM 
of similar tissue. The hepatic architecture is clearly defined in both 
pictures. Figure 9 shows a normal sinusoid lined with endothelium and an 
apparent space of Disse. Figure 10 shows open sinusoids and clear bile 
canaliculi.
In both species, after 2 hours there was a 3 fold increase in the 
number of neutrophils in the hepatic sinusoids without any apparent 
damage. But after 5 hours the sinusoids appeared occluded with poorly 
defined architecture as can be seen in the TEM in Figure 11 and the SEM in 
Figure 12. Figure 11 demonstrates a sinusoid 5 hours after infection, 
showing dense occlusion by degranulating neutrophils, lymphocytes, cell 
debris and fibrin deposits. Kupffer and endothelial cells are swollen with 
consequent narrowing of the sinusoidal lumina and the space of Disse, with 
a reduction in sinusoidal luminal area. Figure 12 shows occluded sinusoids 
with poorly defined bile canaliculi.
Figure 13 is an SEM of a normal sinusoid, lined with fenestrated 
endothelium, through which the space of Disse can be seen. Figure 14 is a 
SEM of pig hepatic sinusoid 5 hours after infection, it reveals the sieve plates 
of the sinusoidal endothelium to be disrupted by areas of larger 
fenestrations. Figure 15 is a similar tissue sample as Figure 14, it  shows a 
swollen Kupffer cell obstructing a bifurcation in the sinusoid. Immediately 
adjacent to this cell can be seen swollen endothelium, not observed further
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away from this cell. This suggests tha t the swelling is a result of Kupffer 
cell activation.
Most of the occlusion by leucocytes, Kupffer cells, endothelial cells and 
fibrin deposition occurred in sinusoids of zone 1 of the Rappaport acinus 
system (Rappaport 1973). Sinusoids of zone 2 appeared constricted hut with 
httle damage whilst the sinusoids of zone 3 appeared more patent where 
they enter the hepatic vein. Each acinus defines an area of liver tissue 
organised around the terminal branch of the portal vein in such a way that 
cells at the centre of the acinus, zone 1, are the first to receive blood, followed 
by zone 2, and cells located toward the periphery and collecting vein, zone 3, 
being the last to receive blood (Shaw et al. 1980).
Sinusoidal endothelium is swollen even when not associated with 
leucocytes. These observations suggest tha t the inflammatory response is 
occurring independently of neutrophils. This swelling of the endothelium 
reduces blood flow through the sinusoids, a feature tha t together with 
Kupffer cell swelling may act as a potent control of liver blood flow.
Bahs et al. (1978) infused E. coli endotoxin into Rhesus monkeys for 22 
hours. After 3 hours they noted sequestration of neutrophils into hepatic 
sinusoids. Over the next 19 hours activated Kupffer cells and neutrophils 
were seen in the sinusoids. Lymphocytes, monocytes and fibrin were also 
present in the sinusoids.
Liver function tests are a poor indicator of hepatic dysfunction. The 
liver can show very severe damage a t the histological level without any 
apparent signs of physiological failure. Animal studies have shown that the 
lactic acidosis seen in septic shock may be the result of its poor hepatic 
clearance by the failing liver.
We (Tighe et al. 1989) have shown in pigs that lactic acidosis can be 
reversed in faecal peritonitis by using drugs th a t increase hepatic blood 
flow, without any major increase in oxygen consumption. The lactic 
acidosis was a function of reduced liver blood flow and is an indicator of its
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immanent failure. Daniel et al. (1976) showed that an important feature in 
developing lactic acidosis in endotoxic shock was the reduction in hepatic 
clearance of lactate. Similarly, AlmenofF et al. (1989) showed that in subjects 
with hepatic dysfunction serum lactate levels rose faster and remained 
elevated longer than  normal subjects when undergoing exercise tests. 
Similar results were observed by Connor et al. (1982) when increased blood 
lactate was attributed to its reduced hepatic clearance.
I^leen histology.
Balis et al. (1978) infused E. coli endotoxin into baboons and showed 
fibrin in  the spleen of the monkey. We studied spleen histology in rabbits 
(Tighe et al. 1989) and pigs (Tighe et al. 1990) in which faecal peritonitis was 
induced. The spleen shows degranulating neutrophils in the red pulp, 
arterioles and venous sinuses. Many aggregates of platelets are seen in the 
red pulp although there was no capillary occlusion. Macrophages showed 
evidence of activation and contained large amounts of phagocytosed cell 
debris. Fibrin was also found adjacent to the endothelium of the venous 
sinuses and red pulp. There was no damage to the endothelium.
Renal Histology.
Coalson et al. (1977) showed that the glomeruli contained multiple 
fibrin thrombi, disrupted platelets and the glomeruli capillary endothelium 
was focally oedematous and disrupted in their septic baboons. However, 
when Balis et al. (1978) infused E. coli endotoxin into baboons (1978) they 
were unable to demonstrate fibrin in the kidney of the monkey. We could not 
show any histological changes in the kidney of the rabbit or pig with 
peritonitis.
Heart histology.
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Coalson et al. (1977) reported myocardial capillary endothelial oedema 
and fluid accumulation in interfibre and intrafibre spaces. The studies of 
Balis et al. (1978) and Tighe et al. (1989) were unable to show leucostasis or 
fibrin in the heart.
Miifide histology.
No changes to capillary ultra-structure or aggregates of leucocytes 
have ever been reported in animals or humans with multi-system organ 
failure.
Conclusion.
Animal studies were performed to produce a more controlled 
development of the condition. From these studies it was possible to show that 
the major changes were taking place in the pulmonary capillaries around 
the alveolar spaces. Leucocytes were aggregating in the capillaries, causing 
occlusions, whilst the capillary endothelium and alveolar epithelium 
showed considerable damage.
Researchers such as Coalson et al. in 1977, made the most important 
discovery, not previously found in ultrastructural studies of patient tissue. 
They were able to show tha t/ at the same time ouch ohangoo were taking 
place in the lung, similar destructive changes were occurring in the liver, 
spleen and adrenal glands. ARDS was only the pulmonary aspect of multi­
system organ failure. These other organs showed similar leucostasis and 
endothelial disruption.
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C hapters.
Inflammatory cells.
1. Polym oiphonudear leucocytes.
2. Monocytes.
3. M acrophages
1. Polymorphonuclear leucoçytes (neutrophils).
Introduction
Neutrophils are circulating marrow-derived phagocytes, which are 
short-lived end-stage cells, having a blood half-life of 6-8 hours. According to 
Weiss and Regiani (1984) they have a significant m arginal pool, 
characterised by moving along the vessel wall, instead of through the 
central part of the lumen. The result of this characteristic is th a t when a 
blood sample is taken to estimate the number of neutrophils, many will not 
be counted. When a subject is stimulated and the blood flow rate increased, 
the marginating pool will be decreased, giving the false impression that 
there is an increase in the number of circulating neutrophils.
They are the first myeloid cell to arrive at an inflammatory focus, 
where they modulate the process of inflammation, both by amplification and 
then restriction. In response to specific signals, such as the complement 
fragments C5a and C3a, leukotriene B4, or formyl peptides released from 
bacteria, neutrophils are released from the bone marrow into the 
circulation, where there is then increased neutrophils activation. The 
neutrophils aggregate and adhere to endothelium, migrating into the tissue 
(diapedesis) and then to the site of inflammation (chemotaxis). Once in the 
tissue, they ingest opsonised micro-organisms, destroying them by the 
release of lysosomal granular constituents or by active synthesis of toxic 
oxygen metabolites such as hydrogen peroxide or the hydroxyl radicals.
Dahinden and Fehr (1983) and Wilson (1985) showed that neutrophils 
represent the most im portant inflammatory response to infection. But, 
unfortunately they can produce inflammation amplification, as in septic
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shock, th a t may potentiate host injury. Endotoxin, released in gram 
negative septicaemia can inhibit chemotaxis, augm ent adherence to 
endothelium, promote degranulation and induce synthesis of neutrophil- 
toxic oxygen species.
Work done by Athens et al. (1961) and Boggs et al. (1964) showed that 
there is a dynamic interaction between neutrophils and the endothelial wall 
of blood vessels. About 10% of vascular neutrophils emarginate and move 
across the endothelium but do not re-enter the circulation in any significant 
numbers. Wintrobe and Lee (1981) demonstrated th a t neutrophils were 
removed via the reticulo-endothelial system of the lung, Hver and spleen as 
well as via the urine and the G.I.tract. This interaction occurs only between 
the em argenating pool of neutrophils and endothelium. Meyrich and 
Brigham (1983) showed th a t neutrophils especially em arginate in the 
pulmonary circulation of sheep when challenged by endotoxin, possibly 
because 60% of vessel endothelium is in the lungs. This emarginating pool 
represents about 50% of the total number of blood neutrophils. These can be 
mobilised rapidly into the circulating pool by exercise or an infusion of 
adrenaline. It is unlikely that these emarginating neutrophils are actually 
adherent to the vessel wall, Mayrovitz et al. (1977) found th a t when 
examined by microscopy, neutrophils appear to roll along the endothelial 
surface.
The aggregation of leucocytes in the lung capillaries (leucostasis) and 
their disappearance from the peripheral blood (leucocytopaenia), during 
endotoxic or septic shock were first described by Goldscheider and Jacobs in 
1894 and Webb in 1924. Since this early work many studies have shown these 
phenomena in animal studies, Wittels et al. in 1974, Powe et al. in 1982 and 
Snapper et al. in 1983, resulting in leucocytopaenia and pulmonary 
sequestration in several species. This combination of organ sequestration 
and degranulation by neutrophils appears to be a major cause of 
inappropriate tissue damage in response to septic shock.
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In our laboratory, we (Tighe et al. 1989) have shown similar results, 
using a rabbit faecal peritonitis model of ARDS. Figure 16 shows the blood 
count of neutrophils in two groups of animals, each containing 6 rabbits. 
One group was sham operated and did not receive a faecal peritonitis 
infection, the other received such an infection. Blood samples were taken at 
baseline in both groups. They were then taken hourly for five hours. A 
precipitous fall to 12% of baseline, in the number of circulating neutrophils 
can be seen in the infected group, whereas there was a 30% increase in the 
sham operated group. Lung tissue was taken from both groups at baseHne 
and after five hours, and prepared for electron microscopy. The number of 
neutrophils were counted per alveolae, in each group of rabbits studied. 
Figure 17 shows there was no change in the number of pulmonary 
neutrophils in the sham operated group, but there was a five fold increase 
in the infected group. We (Tighe et al. 1989) have also shown, described in 
the next chapter; th a t neutrophils are sequestered in the liver and spleen 
but not kidneys, heart or muscle.
Fig^ure 16. P e rip h e ra l blood n eu troph il c o w t  in  6 sham  opera ted  and  6 
septic rabbits over a  five hour period. (Tighe et al. 1989)
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Figure 17. Num ber of neutrophils per alveolae in  sham  and septic rabbit 
lung at baseline and after five hours of peritonitis. (T i^e et al. 1989)
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Wittels et al. (1974) challenged monkeys with E. coli endotoxin, and 
found th a t the peripheral leukocyte count fell by more than 50% in 30 
seconds. Lung sections taken one hour after endotoxin infusion, showed 
large numbers of leucocytes in the pulmonary capillaries. At the end of the 
study considerable pulmonary damage was observed. Begley et al. (1984) 
found a fall in circulating neutrophils in sheep, from a control value of 8,000 
XIO^/L to 2,000 XIO^/L, after 30 minutes of endotoxin infusion. He also found 
tha t neutrophils in the pulmonary alveolae rose from a control value of 1 to 
3.75 after 30 minutes, and to 6 after 4 hours.
The number of neutrophils in bronchial lavage has been shown to be 
predictive of abnormalities in gas exchange and lung protein permeability. 
Weiland et al. in 1986 demonstrated that, in ARDS patients, neutrophils 
constituted 67% of recovered lavage cells, whereas in control mechanically 
ventilated patients they were only 4%, and in normal volunteers 0.8%. These 
data suggest that the neutrophils seen in the pulmonary capillaries migrate 
through to the alveolar sac.
119
Although it m ight be attractive to assume th a t the migrating 
neutrophils cause pulmonary damage and increase capillary permeability, 
it is unlikely. Movement of neutrophils through a capillary wall do not 
usually cause increased permeability. Work performed by Renaldo and 
Rogers 1982 dissociated the change in permeability caused by endotoxemia, 
from the migration of neutrophils out of the pulmonary capillaries into the 
air spaces. They injected endotoxin into the peritoneum of rats, finding the 
usual immediate increase in capillary sequestration of neutrophils and an 
increase in the retention of albumen in the lungs after 6 hours. But, by 
24 hours the iodinated albumen retention levels in the lung had returned to 
normal. Bronchial lavage showed only a small increase in neutrophils a t 15 
hours, and a t 24 hours there was a marked increase in their number. The 
recovery of neutrophils remained significantly elevated for 3 days and only 
returned to normal values at day 6.
Two phase response o f pulmonary dynamics.
Snapper et al. (1983) studied the effect of an infusion of E. coli 
endotoxin in  sheep. They a ttenuated  its effects, by infusing the 
prostaglandin inhibitors, meclofenamate or ibuprofen. They were able to 
show th a t pulmonary changes occurred in two phases. The first phase was 
characterised by pulmonary hypertension and could be inhibited by the 
action of meclofenamate or ibuprofen. From these data, they inferred that it 
was mediated by thromboxane, causing vascular constriction. The second 
phase showed an increase in lymph flow and was associated with 
leucostasis, but could not be inhibited by these drugs. The initial phase of 
pulmonary hypertension is separate from the pulmonary leucostasis that 
occurs later. Begley et al. (1984) in a sheep model of ARDS similar to that of 
Snapper et al. (1983) studied the effects of steroid and non-steroidal anti­
inflammatory drugs on the pulmonary responses to E. coli endotoxin 
infusion. They found that steroid pre-treatment could prevent the increased
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pulmonary capillary permeability associated with leucostasis, by preventing 
the pulmonary leucostasis from occurring.
Leukocytopaenia.
Although leucocytes may be important in organ damage, the work 
described above does not confirm whether these changes were causes or 
effects. Further work was performed on neutropaenic animals to establish 
the importance of neutrophils in pulmonary dysfunction. Pingleton et al. 
(1975) compared the pulmonary ultrastructure of endotoxic shocked rhesus 
monkeys made neutropaenic by whole body irradiation, with similarly 
trea ted  non-irradiated anim als. Electron microscopy dem onstrated 
pulmonary capillary sequestered neutrophils in the non-irradiated group, 
but a complete absence in the irradiated group. Both groups had significant 
endothelial swelling and perivascular oedema. Leucocytopaenia provided no 
protection from the histological damage induced by endotoxin. Gaynor (1973 
) also showed th a t damage to the pulmonary vessel walls arose after the 
adm inistration of endotoxin, even in animals made leukocytopaenic by 
nitrogen mustard treatment.
Brigham et al. (1979) and Heflin and Brigham (1981), who measured 
lung lymph flow as an index of pulmonary damage in sheep, found that 
leucocytopaenia significantly reduced lymph flow. But neither performed 
any histological studies in their sheep and therefore do not know what 
changes occurred in the endothelium. Both of these groups, using dogs or 
sheep, found th a t the increase in pulmonary vascular resistance was 
independent of the presence of neutrophils. This supports the contention of 
Snapper et al. (1983) regarding the two phase response of pulmonary 
hypertension mediated by prostaglandins and increased lymph flow 
mediated by neutrophils. But this contention obscures the involvement of 
neutrophils in causing endothelial disruption and pulmonary degradation. 
None of the studies completely remove all of the neutrophils and none of
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them continued for sufficient length of time to establish the degree of 
damage th a t could occur in the presence of very small numbers of 
neutrophils. There could be a third phase, in the pulmonary response to E. 
coli endotoxin infusion, involving endothelial swelling and perivascular 
oedema, tha t is independent of neutrophil action. This characteristic could 
be more widespread than the lungs and liver, where neutrophils aggregate. 
It could mean tha t endothelial damage is occurring in other organs, such 
as muscle, heart and kidney.
Patients with ARDS have characteristics similar to experimental 
animals with neutropaenia, tha t is, the disappearance of neutrophils from 
the peripheral circulation and pulm onary leucostasis, the static 
accumulation of neutrophils in the pulmonary capillaries. But, there is a 
group of patients who develop ARDS, with the commonly accepted clinical 
and X-ray criteria for this syndrome, who are also neutropaenic. Patients 
receiving suppressive or cytotoxic drugs, such as patients with leukaemia, 
become neutropaenic, but many also develop ARDS. Neutropaenia provides 
no protection against developing the condition. M aunder et al. (1986) 
described 4 neutropaenic patients who developed ARDS and showed typical 
histological changes associated with the condition. Rinaldo and Borovetz 
(1985) described 6 neutropaenic patients who developed ARDS. In four 
patients, there was a worsening of the condition with a fall in arterial 
oxygenation, when their neutrophil count returned to normal values.
Neutrophil role in  endotoxin induced endothelial cell iigury.
Endotoxin induced endothelial cell injury has been implicated in the 
pathogenesis of different diseases such as septicaemia. But whether 
endotoxin can cause injury directly to endothelial cells or whether 
mediators are necessary for the injury to occur is uncertain. Harlan et al.
(1983) studied bovine pulmonary endothelial monolayers using electron 
microscopy. They brought them into contact, in vitrOy with endotoxins and
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showed dilatation in their intracellular junction and cellular changes 
representing contractions. Two hours after incubation with endotoxin cell 
death was found. These findings show that endotoxin mediates directly or 
complements independent endothelial cell cytotoxicity and this injury is not 
prevented by inhibitors of protein and prostaglandin synthesis. However, 
according to Meyrick et al. (1986) and Yamada et al. (1981) this endothelial 
injury observed after incubation of endotoxin with endothelial cells in 
culture can only be observed with bovine endothelial cells but not with 
human cells. Harlan et al. showed (1983) that if human endothelial cells in 
culture are incubated with endotoxin in the presence of granulocytes, these 
cells adhere to and significantly injure cultured endothelial cells. This 
injury can be reduced by suppression of granulocyte adhesiveness or by free 
radical scavengers. Human endothelial cells were seen by Morel et al. (1986) 
to become susceptible to endotoxin-induced cell toxicity when low density 
lipoproteins (LDL) are present, forming a complex with LDL, endotoxin can 
enter endothelial cells and kill them.
Workers have shown tha t although endotoxin can damage bovine 
endothelium, it  does not directly injure human endothelium. Injury to 
human endothelium, in response to endotoxin, requires the presence of an 
intermediate such as neutrophils or LPL.
Pulmonary leucostasis w ithout damage.
Pulmonary leucostasis has been shown by Webster et al. (1982) to 
occur without functional lung changes. They administered cobra venom 
factor, zymosan or C5a to rabbits without surgery, anaesthesia or any other 
intervention. They discovered th a t although all these factors cause 
periphera l leucocytopaenia and pulm onary leucostasis, no lung 
inflammation occurred, as measured by vascular permeability, neutrophil 
diapedesis into the alveolae or increased pulmonary vascular resistance. 
After 24 hours, the neutrophils started to move out of the lungs. When
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combined with traum atic interventions, such as surgery or anaesthesia, 
pulmonary damage did occur. Pulmonary leucostasis alone does not 
inevitably produce pulmonary damage. Work performed in -v itro , by 
O 'Flaherty et al. (1979) showed th a t although arachidonic acid can 
stim ulate neutrophils to aggregate, it does not cause any lysosomal 
degranulation, as measured by lactic acid dehydrogenase and lysozyme. 
Clearly there are two phases to the damage that results from the action of 
neutrophils. F irst they congregate in the organ's capillaries in close 
proximity to the endothelium, then they become activated to damage the 
endothelium and move into the tissue. It is possible tha t the neutrophil has 
two separate receptors, one for aggregation and one for degranulation.
Leukocyte adhesion.
When Tonneson et al. (1984) reduced neutrophil adherence to cultured 
endothelium either pharmacologically or mechanically, cell injury by 
activated neutrophils was reduced. When Boogaerts et al. in 1982, increased 
neutrophil adherence to cultured endothelium, endothelial cell cytotoxicity 
was increased.
Close proximity between the neutrophil and endothelial cell appears 
to be required for cytotoxicity, reflecting the need for a micro-environment at 
the cell-cell interface, which is protected from exogenous scavengers. This 
neutrophil/endothelial in teraction is radically altered  when acute 
inflammation occurs, as shown by Grant (1973). This adherence is therefore 
a prerequisite for extravascular migration to the site of inflammation. But it 
may also be of greater importance in the pathogenesis of vascular and tissue 
injury with acute inflammation.
Influence of leucostasis
The mechanism of leucostasis was initially investigated by looking at 
the adhesiveness of neutrophils in patients with ARDS and sepsis.
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Zimmerman et al. (1984) assayed granulocyte adherence to nylon fibres 
using whole blood collected from the pulmonary artery of 14 patients within 
24 hours of satisfying the criteria for ARDS. The mean value of adherence 
was 83% of tha t of normal subjects. In 10 of the 14 patients it was equal to or 
less than controls. A similar method was used by Venezio et al. (1982) who 
looked a t bacteraemic patients with and without shock and compared them 
to normal controls. The neutrophil adhesiveness of bacteraemic non­
shocked patients was similar to controls, but in bacteraemic shocked 
patients it was raised by 20%. Enhanced adhesiveness was demonstrated 
when normal neutrophils were suspended in  plasm a from shocked 
hypotensive patients. M ethylprednisolone significantly reduced the 
adherence of neutrophils. These data were collected at an earlier time in the 
course of the syndrome than  those of Zimmerman et al (1984). The 
bacteraemic patients had not yet developed ARDS, and pretreatm ent with 
steroids is known to prevent pulmonary damage associated with endotoxin. 
It is possible th a t there is an early short term  increase in neutrophil 
adhesiveness. But our work using two separate techniques to measure 
adhesiveness in  rabbits and pigs showed no significant changes in 
adhesiveness (Tighe et al. 1990,1989).
Tighe et al (1989) and Baylis et al. (1978) showed tha t neutrophils 
aggregate in the sinusoids of the liver and spleen. Tighe et al (1989) and 
Baylis et al. (1978) further showed that neutrophils do not sequestrate in the 
heart, kidney or muscle. If leucostasis was due merely to an increased 
adhesiveness, then neutrophils would be expected to adhere to all 
endothelium in all organs. That neutrophils selectively aggregate in the 
lungs, liver and spleen suggests tha t there is a neutrophil and endotheUal 
interaction.
These three organs are also part of the reticulo-endothelial system (RES), 
raising the possibility tha t damaged or eccentric neutrophils are being
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cleared from the circulation, but their numbers being so great, overwhelm 
the RES and cause organ damage.
Endothelial-leukocyte adhesion m olecule (ELAM) and leukocyte adhesion  
inhibitor (LAI).
Bevilacqua et al. in 1987 discovered that monokines play an active role 
in neutrophil endothelial adhesion. They reported th a t purified natural 
human monocyte derived interleukin 1 can act directly on cultured human 
endothelial cells (HEC) to increase dramatically the adhesiveness of their 
surfaces for human neutrophils, monocytes and their cell lines HL-60 and 
U937. This effect was shown to require protein/RNA-synthesis and be 
mediated primarily through the endothelial cell. They developed a series of 
murine monoclonal antibodies directed against monokine-stimulated HEC 
surfaces. One of these antibodies (H4/18) recognises an endothelial cell 
surface structure which is induced by IL-1 and certain other cytokines in a 
similar fashion to the pro-adhesive surface changes for leucocytes. H4/18 
partially blocks HL-60 cell adhesion to monokine treated HEC, and, in vivo, 
labels hum an vascular endothelial sites of delayed hypersensitivity 
reactions. A second monoclonal antibody (H18/7) significantly blocked the 
adhesion of both HL-60 cells and neutrophils to monokine treated HEC. 
Thus H4/18 and H18/7 appear to recognise the cell surface structures on 
HEC responsible for adhesion. They designated this surface structure, 
"endothelial-leukocyte adhesion molecule" (E-LAM-1). IL-1 treated HEC 
cultures generate a leukocyte adhesion inhibitor (LAI). LAI acts on 
neutrophils to inhibit the ir adhesion to hyperadhesive endothelial 
monolayers, bu t does not inhibit neutrophil activation by chemotactic 
stimuli. LAI appears to inhibit adhesion of peripheral neutrophils and 
monocytes, but not lymphocytes, to hyperadhesive HEC. This endothelial 
derived inhibitory activity blocks leucocyte adhesion without suppressing 
leukocyte function.
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The work of Gimbrone et al. (1987) showed that the endothelium is the 
source of neutrophil adhesion, generating proteins th a t either enable 
adhesion to take place or inhibit their adhesion. What this work does not 
address is why pulmonary and hepatic endothelium should allow leucocytes 
to adhere in cases of septicaemia and multiple trauma. It is possible tha t 
the endothelium of differing organs have variable enzyme systems 
producing different levels of E-LAM and LAI.
Neutrophil m ediated tissue iigury
Three classes of mediators are likely to be involved in the pathogenesis 
of neutrophil/endothelial damage: granular enzymes, reactive oxygen 
metabolites and membrane phospholipases.
1. Grfimday enzymes.
G ranular enzymes are produced in the azurophilic and secondary 
granules. Lysosomes contain a number of substances capable of mediating 
vascular injury. Cationic lysosomal proteins increase vascular permeability 
in vivo as shown by Janoff et al. in 1965 and 1968 and Cockrane and Aiken in 
1966.
Elastase is a major granular enzyme secreted by neutrophils capable 
of dissolving elastin, reported by Harlan et al. in 1981 to detach cultured 
endothelium from culture substrate in vitro. Endothelial membrane 
components or the subendothelial matrix can be degraded by elastase in the 
presence of plasm a protease inhibitors due to the protected micro­
environment a t the interface between the neutrophil and the endothelium. 
Endogenous plasma alpha-1-protease, the elastase inhibitor, was shown by 
Weiss and Regiani in 1984 to be inactivated by neutrophil derived oxidants, 
allowing damage to occur. Bronchial lavage from patients with ARDS has 
been found by Lee et al. in 1981 to contain free neutrophil elastase, 
suggesting it may be involved in the pathogenesis of vascular injury in vivo.
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Fowler et al. in 1984, compared lysosomal enzyme release of neutrophils 
isolated from control and ARDS patients. The neutrophils from ARDS 
patients showed a fourfold increase. He further showed th a t normal 
neutrophils exposed to the plasma of ARDS patients did not show raised 
activation or enzyme secretion level, suggesting tha t the activating agent 
was not blood-bome but of cellular origin.
2a. Reactive oxvgen metabolites.
Oxidants or toxic oxygen metabolites according to Sachs et al. in 1978
could be m ediators of cellular injury. These were shown to include
superoxide anion, hydrogen peroxide and hydroxyl ion by Wiess and
LoBulgio in  1982. These oxygen metabolites can in itiate membrane
peroxidation and damage intracellular components. Work performed in
vitro by Wiess et al. (1981) and in vivo by Till et al. (1982) showed that toxic
oxygen metabolites derived from neutrophils, particularly  hydrogen
peroxide or its products, induce endothelial cell lysis. Zimmerman et al.
(1984) looked at the production of superoxides, ex vivo in neutrophils from
eight patients suffering from ARDS. Four patients had raised super oxide
levels, and four had normal or reduced levels.
The work of Hinshaw et al (1989) has shown th a t oxidants are 
unstable oxygen metabolites such as 0"g, H^Og, and OH', having potent
oxidising properties which can alter cell function. Most oxidant induced
direct cell injury appears to be caused by OH". The OH" is in large part 
produced by conversion from 0^' and H^Og which occurs in the presence of
free iron (Fe^^). Tissue damage can be measured a t several levels. At the 
subcellular level, DNA alteration  is seen. At the cellular level, a 
peroxidation of the lipid moiety of the cell membrane occurs, which alters 
m em brane and m em brane enzyme function. Increased  vascular 
permeability can also result, although this process may be as much related 
to the oxidant-decreasing antiprotease defenses ra ther than  direct OH"
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attack on the microvascnlar membrane. Oxidants, in particular OH", also 
activate complement with additional activation of other cascades, in 
particular the arachidonic acid cascade. Lipid hydroperoxides generated by 
oxidants are extremely potent activators of the cydo-oxygenase enzymes.
2b. Other sources of oxidants.
Although neutrophils and macrophages are an important source of 
oxidants through in tracellu lar myeloperoxidase activity, it  m ust be 
remembered tha t the endothelium also produces oxidants in response to 
reperfusion after tissue ischemia, by the action of xanthine oxidase (McCord 
1985). The concentration of xanthine oxidase in tissue is usually low, but it 
is converted from xanthine dehydrogenase, during cell ischemia. On 
reperfusion, xanthine oxidase acts on the large cellular content of 
hypoxanthine in the presence of oxygen to produce and H2O2, which in 
tu rn  can result in further oxidant reactions. This factor produces a major 
clinical problem. If blood flow to major organs is decreased during shock, 
causing damage through ischemia, then when blood flow is restored to an 
organ the potential damage to the organ is even greater. It should also be 
emphasised tha t this mechanism of superoxide production, could cause 
tissue damage in the absence of neutrophils, and could cause injury in 
those organs that do not show leukocyte aggregation.
3. Membrane phospholipases.
Harlan (1984) showed that phospholipase A2 provokes endothelium to 
release the arachidonic acid metabolites prostacyclin, prostaglandin E2, 
thromboxane, leukotrienes B, C and D. and platelet activating factor. The 
considerable importance of these inflam matory m ediators w ill be discussed  
in a later chapter.
There is little doubt th a t neutrophils have the ability to cause 
considerable tissue destruction and either release or induce the release of
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numerous active inflammatory agents, by the three mechanisms mentioned 
above.
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Figure 18; Summary o f possible m echanism  o f vascular ipjury caused by 
neutrophil activation.
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Monocytes
Monocytes are circulating marrow-derived phagocytes, with a blood 
half-life of 71 hours and apparently do not have a significant marginal pool 
according to Weiss and Regiani (1984). Most importantly blood monocytes 
are destined to become long-lived tissue macrophages.
Like neutrophils, monocytes must first adhere to endothehum before 
m igrating from the blood stream  to extravascular sites. Complement 
activation in vivo induces a transient monocytopaenia as shown by McGuire 
and Spragg in 1982. Sacks et al. showed in 1978 tha t isolated monocytes in 
vitro aggregate to chemotactic factors. It is likely tha t the monocytes behave 
like the neutrophils in vivo by undergoing aggregation and margination. 
The process by which adherent monocytes diapedese across in tact 
endothelium in vivo is similar to that observed in neutrophils according to 
Huttemeier et al. (1982). Weiss and Regiani (1984), showed that monocytes 
accumulate in skin windows more slowly than neutrophils, but are the 
predominant cell after 12-24 hours. Monocytes, like neutrophils, secrete 
factors th a t are potentially cytotoxic or which may alter endothelial 
function. There are no reports of mononuclear phagocyte-mediated 
endothelial injury. Based on studies of neutrophil-mediated endothelial 
iiyury, it is likely that mononuclear phagocyte-derived toxic oxygen radicals 
or proteases will also induce endothelial injury. Like neutrophils, 
monocytes, also produce a number of lipoxygenases and cyclo-oxygenases 
capable of altering vascular permeability and vasomotor tone.
In addition to toxic oxygen radicals, proteases, lipoxygenases and 
cyclo-oxygenases, mononuclear phagocytes release several monokines that 
affect the vessel wall: tumour necrosis factor and interleukin-1. Tumour 
necrosis factor, interleukin-1 and alpha interferon production is now 
considered to be among the most important functions of monocytes in ARDS 
and MSOF.
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Macrophages
Macrophages are derived from the circulating pool of monocytes and 
are part of the reticulo-endothelial system distributed throughout the body. 
They are present in the interstitium  and alveolae of the lung, peritoneum, 
liver (Kupffer cells), spleen, bone marrow and lymph nodes. The monocyte 
moves into the tissue and further differentiates into tissue macrophages. 
These cells remove and destroy bacteria, damaged tissue cells, neoplastic 
cells and macromolecules such as antigen-antibody complexes. But 
macrophages are also more than a non-specific phagocyte. They also inhibit 
bacterial function, facilitate viral destruction, produce chemotactic factors 
and most importantly produce tumour necrosis factor and interleukin-1.
Conclusion.
Neutrophils are certadnly important in the development of ARDS and 
MSOF. They have the destructive ability to cause considerable tissue 
damage. In animal models, of ARDS, there is a precipitous fall in the 
num ber of peripheral neutrophils when challenged by endotoxin or 
infection. They are sequestered in the lungs, liver and spleen but not kidney, 
h ea rt or muscle. There appears to be an interaction between the 
endothelium of certain organs and neutrophils th a t causes leucostasis. 
Pulmonary leucostasis can occur without lung damage.
The oedema formation seen in animal models of ARDS although 
associated with leucostasis is not the cause. Oedema formation occurs in 
neutropaenic anim als and its time course does not coincide with 
leucostasis.
Although neutropaenia attenuates pulmonary damage in animal 
models of ARDS, neutropaenic patients develop ARDS which is often lethal. 
It is possible tha t these patients are never totally neutropaenic and have a 
small number of neutrophils in the circulation. This possibility seems 
unlikely because there would be no quantitive association between the
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number of neutrophils and the degree of tissue damage, i.e. a very small 
number causes the same injury as large numbers.
A major problem in looking at blood borne inflammatory cells, is to 
consider that the behaviour of cells in the blood during ARDS is the same as 
those cells causing damage in the tissue. There could be two populations of 
neutrophils or monocytes: one group of cells causing damage in the tissue, 
while the other is inactive and does not cause such damage.
This evidence suggests th a t although neutrophils are important in 
the inflammatory process, they are not the principle cause of whole body 
inflammation and the development of ARDS and MSOF, although they 
undoubtedly accentuate tissue damage. The importance of macrophages is 
in their production of tumour necrosis factor discussed in detail in chapter 
6, section lb.
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Introduction
The inflammatory cascade shown in Figure 19 is initiated by a wide 
variety of stimuli. They include tissue damage, hypoxemia and ischemia, 
endotoxin, and exogenous pathogens such as bacteria, virus and fungi. The 
first part of the process involves the protein elements of plasma, such as 
k inins and complement. In addition, tum our necrosis factor and 
interleukin-1 are released from stimulated inflammatory cells, such as 
neutrophils, monocytes and tissue macrophages. Although other mediators 
such as histamine and 5-HT are undoubtedly released, they are non-spedflc 
in  the development of ARDS and MSOF.
When the inactive protein elements of the kinin and complement 
systems in  the plasma contact the inflammatory stimuli they become 
activated. The kinins and complement stimulate both the endothelium and 
a fu rther number of circulating inflam matory cells. The circulating 
inflammatory cells have two sources of activation.
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Figure 19. Mediator response to tissue damage involved in  MSOF
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When monocytes, tissue macrophages and neutrophils (Yoshinaga et al. 
1987) are stimulated, they also produce the cytokines; TNF and the 
interleukins. These cytokines further activate the endothelium. This system 
of activation can result in a whole body inflammatory reaction to the initial 
insult, by blood-bome mediators.
The endothelium and circulating inflammatory cells are stimulated 
through the ceU membrane constituent, phospholipase, to initiate the lipid 
inflammatory cascade. These lipid mediators, unlike complement and 
kinins, are thought to act locally. They include platelet activating factor, 
thromboxane, prostacyclin and the leukotrienes. These inflam matory 
mediators actually cause tissue damage, this tissue damage causes further 
mediator activation and further damage. This system of inflammatory 
ampliflcation causes organ disfunction to occurr. Even when the initial 
insult is removed or blocked, tissue damage caused by the inflammatory 
response can maintain and further amplify the organ damage. If the initial 
insult is quickly removed then the cascade can be stopped, but if allowed to 
continue, fresh tissue damage will be caused, further stim ulating the 
system to whole body inflammation. Once this level of activity has been 
reached it is unlikely to be stopped by any of the body's natural systems.
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Section 1.
Protein mediators of inflammation, 
la . K inins.
Introduction 
Bradykinin Blockade.
Wilson et al. in 1989, tested the hypothesis tha t bradykinin (BK) plays 
an important role in the pathology of endotoxic shock by studying the effect 
of a BK an tagon ist NPC 567 in  ra ts  trea ted  w ith endotoxin. 
Lipopolysaccharide (LPS) administration resulted in an increase of plasma 
BK from < 23 pg/ml to 144 pg/ml at one hour. The mean arterial blood 
pressure fell 38%, while the breakdown product of prostacyclin, 6-keto- 
prostaglandin-Fl-alpha (GkPGFla) rose from 289 pg/ml to 7,927 pg/ml. NPC 
567 partially reversed the fall in MABP and reduced the rise in GkPGFla by 
42%, suggesting a reduction in prostacyclin production. Most importantly it 
reduced the mortality .from 100% to 50%. These results strongly suggest that 
BK plays a significant role in the pathology of shock.
Background
Kinins are a family of small peptides formed in blood and biological 
fluids of mammals by the actions of kallikreins on large protein substrates, 
the kininogens. In general, the concentration of kinins in circulating blood 
and tissue is fairly low, since kallikreins are coupled to inhibitors and kept 
as inactive precursors, prekallikreins. When an appropriate physiological 
or pathological stimulus activates the prekallikreins, plasm a kallikreins  
are formed. Bradykinin is formed in the blood by the action of plasma 
kallikreins on the kininogens. Kallidin (KD) is released in tissue by the 
action of tissue kallikreins on kininogens (Roche and Silver 1980). Kinins 
are inactivated by kininase II which is particularly abundant in the lung 
and kidney, and appears to be localised in  the plasm a membrane of 
endothelial cells (Erdos 1979, Palmiere et al. 1986).
138
F igure 20. Schem e o f IQ nin generation  
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The metabolites desaturated Argenine (des arg) BK and des Arg KD 
are generated by the enzyme kininase 1, found in endothelium. Inactivation 
of kinins is quite efficient at the site of release. The kinins which escape into 
the circulation are broken down to inactive fragments in the lung, BK by 80- 
95%, KD by 70%, while des Arg BK, des Arg KD are resistant to degradation 
(Ferreira and Vane 1967).
Kinins are also inactivated in  the kidney and other organs, 
consequentially their concentration in arterial blood is less than 30pg/ml. 
(Carretero et al. 1981).
Biological actioua of bi’adykinin and related kinins.
Kinins are naturally  occurring peptides, exerting a number of 
biological actions in vivo and in vitro. Intravenous BK induce an acute fall 
in blood pressure which is dose dependant, and rapidly reversible (Kegoli 
1984). The hypotension is partly due to peripheral vasodilatation, which is 
brought about by relaxant effects (endothelium dependent) of BK on 
resistance vessels. The capillary endothelium and the veins are contracted
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by the kinins, similar to other smooth muscles from the uterus, the trachea 
and bronchi, the stomach and the intestine, the bladder and the urethra. 
(RegoliD. 1984)
Several biological effects of BK are mediated by endogenous agents 
such as prostaglandins, histamine, 5 hydroxytryptamine, catecholamine 
and renin (Regoh D. 1980) The release of prostaglandins, can cause an 
increase in  vascular perm eability, and hypotension through the ir 
vasodilation properties. Among the most significant biological actions of 
kinins is the activation of neural circuits by the stimulation of sensory nerve 
endings in various tissues. In dogs and rabbits, BK induces rapid changes 
in blood pressure through the stimulation of sensory afferents in the rabbit 
ear or dog splanchnic or carotid arteries (Ferreira et al. 1973). Applied to the 
portal vein of rats, BK induces the release of vasopressin (Stoppini L, Baija 
F, Mathison R, Baertchi J. Spinal substance P transm its bradykinin but not 
osmotic stim uli from hepatic portal vein to hypothalam us in rat. 
Neuroscience 1984: 11: 903-912) These biological actions of the kinins are due 
to the activation of at least two different receptor types.
Bradykinin receptor sites
The biological actions of kinins are due to the activation of at least two 
different receptor types. The B1 receptor mediates the contractile effect of 
kinins in the rabbit aorta and mesenteric vein, and shows high sensitivity to 
des Arg BK and des Arg KD. The B2 receptor mediates both the relaxation of 
the dog carotid artery and the contraction of the rabbit jugular vein, with a 
high sensitivity to BK and KD.
In vivo y B1 receptors are activated in rabbits by the intravenous 
injection of E. coli endotoxin. In rabbits treated with this endotoxin, des Arg 
BK (inactive in  normal animals) becomes a potent vasodilator and 
hypotensive agent.
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Most of the pathological actions of kinins, such as peripheral 
vasodilation, have been attributed to activation of the B2 receptors in the 
endothelium of large and small vessels. The major physiological events of 
the inflammatory reaction, vasodilation, increase in vascular permeability, 
venoconstriction and mobilisation of blood and tissue cells, are generally 
activated more efidciently by BK than by des Arg BK and are not modified by 
B1 receptor antagonists.
Mechanisms of action of kinins.
Kinins are one of the most potent activators of prostaglandin release 
(Marceau et al. 1983); for instance endothelium mediated vasodilatation, the 
smooth muscle contraction or relaxation in various organs, are associated 
with the release of prostaglandins. Kinins promote the release of 
prostacyclin from blood vessels of the heart and kidney, from cell cultures 
(such as ra t adipocytes and human endothelial cells), possibly by interacting 
w ith m em brane phospholipases. This stim ulation  of prostacyclin 
production, especially thromboxane and prostacyclin can have a profound 
effect in the development of MSOF, as will be discussed later in this section.
Involvem ent o f kinins in  inflammation.
Acute inflammation was induced in rats by intraperitoneal injection 
of endotoxin by Kageyama et al. in 1985. The livers of injured rats released 
twice as much kininogen into the perfusing physiological medium as the 
livers of normal animals. Once released into peripheral tissue, kinins act 
on blood vessels, particularly the endothelium through which they produce 
both peripheral vasodilatation by promoting the release of a smooth muscle 
relaxing factor and increase of capillary permeability by contracting the 
capillary endothelium. Kinins may increase intracapillary and venous 
pressure by contracting the venous smooth muscle. They are therefore
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blood-borne pro-inflammatory agents exerting potent actions on blood 
vessels.
Kinins find specific receptors on leucocytes, and inhibit the neutrophil 
chemotactic response. Once they enter the inflammed area, leucocytes may 
perpetuate the production of kinins since they have been shown to contain 
kallikreins and kinins (Zachariae et al. 1986).
The mechanisms by which kinins exert all these actions are 
unknown. I t is possible th a t the activation of phospholipase could be 
involved in some but not all pro-inflammatory effects of these peptides. Over 
90% of the biological activity of bradykinin is lost on a single passage 
through the pulmonary circulation (Ryan et al. 1968). The inactivation is 
due to metabolism of BK, notably by angiotensin 1 converting enzyme 
(kininase II) which is localised in the pulmonary endothelium (Ryan et al. 
1975, Seager et al. 1983). Angiotensin converting enzyme is responsible for 
terminating the biological actions of BK and for converting angiotensin 1 
into angiotensin 2. These two actions; inactivation of a substance that tends 
to lower blood pressure and the formation of a potent hypertensive hormone 
released directly into the systemic circulation from the endothelial cells of 
the pulmonary vascular bed, play a prominent role in the control of blood 
pressure (Cochley et al. 1978).
The work of Cochley et al. (1978) shows th a t BK exerts an hormonal 
effect on specific receptors possessed by vascular endothehal cells to release 
20 fold levels of thromboxane or prostacyclin from bovine pulmonary artery 
endothelial cells. No platelets are necessary for this action.
Normally plasma contains bradykinin in the order of 1 ng or less per 
ml, but potentially several thousand times more may be released from the 
precursor protein kininogen. But as BK is rapidly removed from the 
circulation, i t  is very difficult to measure its plasma concentration. The 
turnover of bradykinin may therefore, be more important. Measurement of 
kininogen in septic patients, was undertaken by Hirsch et al. in 1974. They
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showed tha t the levels of kininogen fell to low values in  those patients who 
died of septic shock. In contrast, the kininogen levels rose toward normal in 
those patients who survived. It was thought tha t the decrease in kininogen 
was associated with the liberation of kinins by activated plasma kallikrein 
and the exhaustion of available substrate.
Martinez-Brotons et al. (1987) compared plasma kinin in patients 
suffering septic shock with those having cardiogenic shock. Patients with 
septic shock, especially in fatal cases, showed a highly significant decrease 
in levels of factor XII, prekallikrein, high molecular weight kininogen, 
alpha macroglobulin and anti thrombin. Components and inhibitors of the 
kallikrein-kinin system were within normal lim its in  patients with 
cardiogenic shock. These findings further demonstrate the importance of 
this system in mediating some of the changes seen in septic shock, and in 
demonstrating the difference between septic and cardiogenic shock.
Condusion.
The work on the involvement of bradykinins in ARDS is hampered by 
measurement difficulties. It is quickly removed from the circulation by just 
one circuit through the body. Its blood concentration is the result of its rate 
of production and clearance. The body of work performed to investigate its 
involvement in ARDS is consequently very limited. The work of Wilson et al. 
is therefore of considerable interest showing that an inhibitor of bradykinin 
reduces mortality by 50% in endotoxic treated rats. But further work needs 
to bo performed to fully evaluate the importance of bradykinin in ARDS and 
MSOF.
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Section 1.
Protein mediators 
lb . Cytokines
TNF/cachectin and interleukin.
Introduction
Cachectin was discovered during studies of rabbits infected with 
Trypanosom a hrucei in an experimental model of cachexia, a condition 
associated with extreme weight loss, depletion of lean body mass and 
hypertriglyceridaemia (Kawakami and Cerami 1981).
Kawakami and Cerami (1981) showed tha t when mice were injected 
with endotoxin, a transferable serum factor causing lipoprotein lipase (LPL) 
suppression and lipaemia was produced. LPL is a membrane bound 
enzyme th a t normally mediates the clearance of circulating lipids. 
Lipopolysaccharide (LPS) or endotoxin resistant mice, used as controls, did 
not exhibit this response. However LPL suppression and lipaemia could be 
induced in endotoxin resistant animals when they were injected with the 
serum of endotoxin treated normal mice. This study showed that the active 
agent in promoting LPL suppression and lipaemia was blood borne.
This factor was isolated from the supernatant of endotoxin stimulated 
murine macrophages by Beutler et al. (1985) and named cachectin, because 
of its suspected role as the mediator of cachexia. Beutler et al. purified 
cachectin and found it to be a polypeptide hormone with a subunit size of 
approximately 17 kilodaltons.
A link  betw een shock and tumour regression was observed in  1962 
when O'Malley et al. reported that serum obtained from mice with endotoxic 
shock was capable of producing haemorrhagic necrosis of a tumour in other 
animals. This tumour necrosis factor (TNF) when injected into animals 
produced shock like symptoms, discussed below.
Beutler’s research group (1986) established tha t TNF and cachectin 
were the same substance. Early in 1985, Beutler et al. noticed cachectin and
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TNF produced an identical spectrum  of bioactivities and were 
immunologically similar. A single injection of endotoxin into rabbits can 
produce about 1 mg of the hormone, far in excess of the 0.3 mMol Abe and 
co-workers (1985) found in serum during shock.
After the injection of endotoxin, TNF appears in the circulation 
within minutes, reaches a peak level after 2 hours and then rapidly declines 
in concentration until a t 4 hours it  is not detectable. Macrophages and 
monocytes do not continue to release TNF, even in the presence of persistent 
endotoxic stimulus. TNF secreting cells in vitro  become refractory to 
further production and after subsequent endotoxic exposure produce a 
markedly attenuated secondary response. The half hfe of the hormone in the 
circulation is approximately 6 minutes.
TNF induces the release of another cytokine, interleukin 1 by 
monocytes, macrophages and endothelial cells. IL-1 is also known to 
activate neutrophils, stimulating their adhesion to endothelial cell surfaces 
and enhancing their phagocytic activity. Its effect on endothelial cells is to 
promote neutrophil adhesion (Nawroth et al. 1986).
Highly purified IL-1 was isolated in the late 1970s and extensive 
investigation focused on the biological activities of the peptide. I t has 
recently become clear, through the use of pure IL-1 th a t many of these 
responses characteristically observed during endotoxaemia are not solely 
mediated by EL-1 but, rather, occur in response to cachectin /TNF. The TNF 
NH2 term inal amino acid sequence binds to specific receptors th a t are 
distinct from those of IL-1.
Neutrophil and endothelial activation by R rl and TNF alpha
In vitro  studies indicate th a t both cytokines have an effect on 
neutrophils and endothelial cells, the two major participants in neutrophil 
emargination. Chemotaxis has been dem onstrated in neutrophils and
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monocytes with IL-1. Chemoattraction of lymphocytes by EL-1 has also been 
reported (Miossec et al. 1984).
IL-1 induces release of the specific granules from human neutrophils 
(Klamper et al. 1978), and TNF alpha induces the adhesion of neutrophils to 
endothelium in vitro (Gamble et al. 1985). The adhesion process is complex. 
When endothelium monolayers, in vitro, were stimulated by cytokines, no 
enhancement of adherence of neutrophils to the endothelial monolayer was 
observed, until Hoover et al. (1984) introduced leukotriene B4. Subsequently a 
number of investigators demonstrated tha t IL-1, TNF alpha and endotoxin 
have a similar effect and tha t the adhesion process can be blocked by 
inhibitors of protein synthesis (Bevilacqua et al. 1985, Schleimer and 
Rutlidge 1986). The involvement of lipoxygenases in MSOF will be discussed 
later in this chapter, in section 2f.
Endothelial leukocyte adhesion molecule (ELAM)
Bevilacqua et al. (1987) demonstrated the existence of endothelial 
leukocyte adhesion molecules (ELAM), produced in response to stimulation 
by cytokines. They developed monoclonal antibodies against IL-1 and TNF 
treated endothelial monolayers. The antibody was found to recognise 
cytokine treated, but not untreated monolayers (Bevilacqua et al. 1985,1987, 
Pober et al. 1986), suggesting that the monclonal antibody was recognising 
the ELAM binding site. Peak neutrophil adhesion is observed after a 3-4 
hour stimulation of the monolayer with the cytokines. The adhesion is 
blocked by cyclohexamine or actinomycin D. Unlike EL-1, TNF alpha can 
induce rapid adhesion of neutrophils to the endothelial monolayer, this 
effect is on the neutrophil and is protein synthesis and RNA independent. 
The neutrophil dependant and endothelium dependant mechanism of 
neutrophil adhesion require a functional CD 11 to CD 18 (CD cluster of 
differentiation) complex on the neutrophil membrane. Neutrophils of 
patients with congenital absence of the CD 11 to CD 18 complex or normal
146
neutrophils in  which the complex is inhibited by a monoclonal antibody 
cannot be stimulated to adhere to endothelium (Pohlman et al. 1986, Harlan 
et al. 1985). The effect of TNF on neutrophil adhesion is maximally induced 
within 5 min and does not require protein or RNA synthesis. In contrast, 
maximum effects of TNF on human umbilical vein endothelial cells take 4 
hours to develop and required RNA synthesis (Gamble et al. 1985). The 
rapidity of the effects suggests the induction of surface expression of 
adhesion promotion molecules.
Sources of TNF and IL-1.
Monocytes and macrophages were considered the main, if not unique 
source of IL-1 and TNF alpha. Although neutrophils secrete less than the 
monocyte on a per cell basis, they release a considerable amount 
considering the large number of these cells in the circulating, marginal 
and bone marrow pools and in acute inflammation exudate (Yoshinaga et 
al. 1987). Recently, it has been shown th a t IL-1 induces the synthesis of 
prostacyclin (Rossi et al. 1985, Albrightson et al. 1985), and stimulates 
platelet activation factor production by endothelial cells (Bussolino et al. 
1986).
Endothelial cells treated with endotoxin can synthesise interleukin-1 
(Stem et al. 1985, Miossec et al. 1986) 1 hour after incubation of endotoxin, so 
are both origin and target for EL-1.
Tissue receptors of TNF.
Beutler et al. (1985) showed that when labelled TNF is injected into 
mice it is concentrated by several tissues, shown in Table 33. Eight minutes 
after injection, liver, kidney, skin, lung and gastrointestinal tract together 
contain nearly 80% total extra vascular label. Liver, kidney, spleen and 
gastrointestinal tract have specific TNF receptors. When administration of 
radio-iodinated TNF is preceded by unlabelled TNF the amount of labelled
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TNF is reduced. But the lung and skin receptors cannot be saturated in this 
way, suggesting th a t they are not so specific. The hormone is degraded 
rapidly in these tissues without formation of detectable interm ediate 
products. Only 10% of the administered radioactivity was observed in the 
urine despite the fact th a t a large fraction of the injected hormone was 
recovered firom the kidney itself.
Table 33. Fractional distribution of labelled IN F  in  tissue of mice, 8 minutes 
after iiqection. (Beutler et al. 1985)
Organ % of bound label
Liver 31
Skin 30
G.I. tract 8.8
Kidney 7.8
Lung 1.8
Spleen 0.9
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TSF  produ cû aain  vivo in  response to LPS or bacteria.
Hesse et ai. (1988) gave bolus injections of endotoxin, 20 units/kg of 
body wt, to 4 volunteers. (It should be emphasised tha t 4 subjects is a very 
low number on which to base an hypotheis). On Figures 21-25 the endotoxin 
is given a t time 0. Peak TNF levels of 358 ±166 pg/ml in serum were observed 
within 1.5 hours of the challenge, falling to undetectable levels a t 5 hours, 
seen in Figure 21.
F igure 21. Serum  TNF concentrations in  hum an volunteers, over 6 hours, 
challenged w ith 20 units/kg E, coli endotoxin. (Hesse et al. 1988)
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Peak serum IL-1 levels of 2.14 ±.0.89 u/ml were seen within 2 hours of 
challenge, falling to undetectable levels at 5 hours, as can be seen in Figure 
22.
Figure 22. Serum  interleukin-1 concentrations in  hum an volunteers, over 6 
hours, challenged w ith 20 units/kg F. coli endotoxin. (Hesse et al. 1988)
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By contrast, the infusion of a lethal dose of live E. coli in  to 4 baboons 
revealed peak serum TNF levels of 20,500 ±9890 pg/ml within 1.5 hours of 
infusion, falling to undetectable levels a t 9 hours, as can be seen in Figure 
23.
Figure 23. Serum TNF concentrations, over 12 hours, in  baboons challenged 
w ith a  lethal dose of live E, coli. (Hesse et al. 1988)
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Peak IL-1 levels of 14.2 ±10 u/ml, can be seen 3 hours after challenge, falling 
to undetectable levels at 10 hours, seen in Figure 24.
Figure 24. Serum interleukin-1 concentrations, over 12 hours, in baboons 
challenged with a lethal dose of live E. coli. (Hesse et al. 1988)
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Interferon gamma levels reached a peak of 2.67 ±1.66 ng/ml in baboon sera 8 
hours after infusion, but was not detectable by 12 hours, seen in Figure 25. 
Gamma Interferon was not detected in the sera of humans.
F igure 25. Serum  Interferon-g concentrations, over 12 hours, in  baboons 
challenged w ith a  lethal dose of live E, coli, (Hesse et al. 1988)
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These results suggest that the transient release of TNF followed by IL- 
1 and interferon gamma may participate in a cascade of events noted in 
overwhelming bacterial invasion. Although the time course of the cytokine 
appearance was similar in both models, lethality appeared to correlate only 
with its magnitude.
These data show that serum TNF levels of 300-400 pg/ml and IL-1 
levels of 2-3 p/ml are well tolerated in healthy normal volunteers, as they did 
not show any adverse symptoms of endotoxemia. Elevated circulating levels 
of TNF and IL-1 appear to be transient events in acute sepsis. Therefore the 
early TNF and IL-1 response to the infection may represent an important 
but transitory triggering signal in the host response to invasive infection. 
Interferon g production appeared to be a transient phenomenon reaching 
peak levels 8 hour after bacterial challenge in baboons. No interferon g was 
found in the serum of human volunteers challenged with endotoxin. These
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data suggest tha t circulating levels of interferon g may depend on the scope 
and duration of the initial bacterial insult or alternately on the magnitude of 
the cytokine response to bacterial stimuli.
Lymphotoxin, a product of activated T cells with a spectrum of 
biological activities similar to TNF, could not be detected in humans or 
baboons.
TNF stim ulates endothelium or macrophages to produce IL-1. 
Although the infusion of IL-1 has been reported to induce fever and 
hypotension, unlike TNF, IL-1 does not appear to induce irreversible shock 
and death. Extremely low tissue levels of TNF and IL-1 are known to elicit 
several cellular responses in the presence of other cytokines. Many 
investigators have shown tha t interferon g acts synergistically with TNF 
and IL-1 in several biological systems. W hether or not the delayed 
appearance of circulating interferon g synergises the very low levels of TNF 
and so perpetuates the injurious bacterial state or alternately mediates the 
action of other cytokines in the lethal host response requires further 
investigation.
Shock in  response to TNF infusion.
TNF was administered (Tracey et al. 1987) by infusion in two groups of 
beagle dogs at a lethal dose of 100 pg/kg and sublethal dose of 10 pg/kg, seen 
in Table 34. The infusion produced serum TNF levels 1-50 nmol/1 similar to 
those achieved after experimental endotoxaemia. The lethal response to 
TNF was characterised by progressive hypotension, shock and death within 
three hours. TNF infusion precipitated significant increases of plasma 
catecholamines in a dose dependant manner. TNF infused directly into the 
isolated hindlim b m ediated reductions of skeletal muscle resting  
transmembrane potential and stimulated lactate production efflux.
Histopathological findings after the lethal dose of TNF showed gross 
abnormalities in the lung, kidneys and adrenal glands, with multiple
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haemorrhagic lesions in the pulmonary parenchyma. The kidneys also 
contained multiple haemorrhagic foci and the adrenal glands were grossly 
necrotic. Leucocytes and thrombi were aggregated in  the pulmonary 
vessels.
Acute tubular necrosis and acute in terstitia l inflammation was 
apparent throughout the kidneys. Haemorrhagic medullary necrosis was
Table 34. H aem odynam ic and  neurohorm onal response o f dogs to  TNF 
infusion. (Tracey et al. 1987)
Time MAP PCWP
Hrs mmHg mmHg
0 0
L/min
SVR
units
AD NorAD
pg/ml
TNF Dose 0 pg/kg
-1 139 6 2.3 4626 33 223
0 128 6 1.8 5422
1 123 5 1.7 5552
2 133 5 1.8 5688 55 359
3 127 4 1.8 5466 57 273
TNF Dose 10 pg/kg
-1 145 5 2.6 4307 36 307
0 143 6 2.1 5219
1 113 4 2.1 4152
2 130 3 2.3 4417 62 32
3 124 5 1.8 5288 145 565
TNF Dose 100 pg/kg
-1 141 5 2.5 4320 58 282
0 113 1 1.8 4977
1 98 0 1,9 4126
2 93 3 1.5 4800 11481400
3 45 2 1.5 2293 16231982
MAP mean arteria l blood pressure, PCWP pulmonary capillary wedge 
pressure (reflected left atrial pressure), CO cardiac output, SVR systemic 
vascular resistance, AD adrenaline, Nor AD noradrenaline.
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The falling PCWP, seen in Table 34, in  the high dose group 
necessitated the adm inistration of intravenous fluid a t a ra te  which 
significantly exceeded the fluid requirem ent of the other two groups, 
showing tha t TNF participates in the development of tissue oedema and 
increased permeability oedema, typically seen during the development of 
shock. CO and SVR fell causing a fall in MAP, The reduction in SVR shows 
th a t systemic vasodilatation occurred, w ith a reduction in  PCWP 
contributing to the development of the shock syndrome. Profound shock and 
falling blood pressure were associated with progressively falling cardiac 
output, in spite of markedly increased levels of circulating catecholamines.
In some studies by this group, the hind limb was isolated from the 
rest of the circulation of the dogs, by use of an extracorporeal circulation 
machine. When TNF was infused into the isolated hind limb lactate was 
released. The control dogs tha t had a placebo infusion did not produce 
lactate. These data suggest tha t TNF contributes to the development of a 
profound lactemia by an unknown mechanism. When TNF alone is infused, 
many of the features associated with shock are produced. These features 
show many similarities to those produced by the infusion of endotoxin.
Tracey et al. (1986) found similar results when they infused TNF into 
rats. They found histological damage to the lungs, kidney and G.I.tract and 
hypotension, metabolic acidosis, haemo-concentration and death within 
several hours.
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Tracey et al. (1987) produced lethal hacteraemia in baboons, blocking 
the endogenous TNF by passive immunisation with monoclonal anti-TNF , 
shown in Table 35 below.
Table 35. A ttenuation of haemodynamic responses to TNF infusion, by TNF
antibodies, in  baboons. (Tracey et al. 1987)
Time TNF MAP WBC CO AD NorAD
H rs ng/ml mmHg xlOOO L/min pg/ml
Controls-Iive E, coli
-2 <0.04 120 13.2 2.2 165 382
2 16.7 65 1.1 2.8 973 2344
8 <0.04 0 1.2 0 3012 3411
Antibody 1 hour before infection
-2 <0.04 120 9.3 2.4 129 958
2 1.2 110 1.0 3.0 1785 2591
8 <0.04 115 1.4 2.8 3202 3934
Antibody 2 hour before inEection
-2 <0.04 120 12.1 2.1 191 419
2 <0.04 110 3.6 2.4 550 491
8 <0.04 115 8.2 2.3 160 372
Baboons were given monoclonal anti-TNF intravenously, 1 and 2 
hours before the LDioo dose of live E coli. Maximum plasma TNF levels of 
22 ng/ml in the controls were observed for 1.5-2.5 hours following the E.coli 
infusion. Serum TNF fell from nanom olar concentrations to below 
detectable levels of 34 pg/ml, 4-6 hours after bacterial infusion. Control 
animals rapidly succumbed to the lethal effects of hacteraemia, with an 
acute decrease in both blood pressure and the PCWP and a decline in 
cardiac output, vital organ injury and anuric renal failure. There was a 2 
fold increase in serum creatinine followed by death from pulmonary
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oedema. These pathophysiological events are characteristic of lethal 
haemodynamic sepsis.
Passive immunisation of baboons with anti-TNF antibody infused 1 
hour before bacterial challenge conferred beneficial cardiovascular effects, 
but not complete protection, against critical organ injury. Although systemic 
vascular resistance foil, blood pressure was maintained by a compensatory 
increase in heart rate and cardiac output. Although acute cardiovascular 
collapse and shock were not observed serious renal injury did occur, a 
twofold increase of serum creatinine was seen a t 8 hours with the 
development of anuria. Each of the baboons immunised 1 hour before 
bacterial challenge developed fatal pulmonary oedema.
The antibody when administered 2 hours before the E. coli. infusion 
was associated with maintaining normal blood pressure and preventing the 
development of shock. Vital organ dysfunction did not occur or renal failure 
develop. There was no evidence of pulmonary oedema. These results with 
TNF antibodies were unlikely to be due to increased bacterial clearance in 
the immunised animals or to bacteriocidal properties of the antibody 
solution. Antibody adm inistration is associated with improved cardiac 
output, suggesting th a t the well known sepsis associated myocardial 
depression is also in part due to TNF.
The role of TNF as a mediator of endotoxic shock was further 
established by studies in which mice (Beutler et al. 1985) were immunised 
against the hormone and found to be protected against the lethal effects of 
endotoxin.
Prostaid^indins and TNF.
Kettelhut et al. (1987) suggested tha t prostaglandins participate as 
second messengers of TNF induced systemic toxicity. After intravenous 
injection of human recombinant TNF (4 mg/g) into rats, all died within 2-4 
hours. In 1 hour TNF caused a sharp fall in body temperature and a large
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increase in plasm a prostaglandin E2 levels. Blood glucose initially 
increased but then a profound hypoglycemia developed by 2 hours. The TNF 
treated animals developed cyanosis and severe metabolic acidosis. A single 
injection of the the cyclo-oxygenase inhibitor indomethacin or ibuprofen 
before the TNF treatm ent completely prevented the rapid killing and 
reduced lethality by 70%.
A single dose of cyclo-oxygenase inhibitors (indomethacine or 
ibuprofen) prevented lethality, acidosis, hypothermia and biphasic changes 
of blood glucose concentration. These data suggest tha t prostaglandins are 
direct mediators of the cellular responses, seen during septic shock, that 
are triggered in part, by the appearance of TNF. It must be emphasised that 
there am 't any papers in the literature showing cyclo-oxygenase inhibitors 
have these effects in septic animal models of ARDS. This work suggests that 
there should be some doubt concerning the pivotal role of TNF in 
septicaemia.
Hum an TNF
Waage et al. (1986) measured TNF in serum from 23 cancer patients, 
23 patients with hacteraemia and 25 normal controls. The serum from 
normal controls and cancer patients did not show the presence of TNF. Only 
3 of the infected group showed the presence of TNF: two on admission but 
not later; the third patient developed hacteraemia in hospital and only 
showed an increased TNF on one day. Waage et al. (1986) does not describe 
whether the patients had shock, whether the TNF positive patients were in  
any way different to the other infected patients, or how many died. Waage et 
al. (1986) also showed one patient with TNF was infected with non-endotoxin 
producing Gram-positive pneumococci, suggesting tha t factors other than 
lipopolysaccharides may stimulate production of TNF.
Waage et al. (1987) looked at TNF serum concentrations in 79 patients 
on admission with meningococcal meningitis, septicaemia or both. The
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information is summarised in Table 36, but does not give the plasma 
concentrations of TNF, only its presence or absence.
TNF was present in 18 of the patients, 10 of whom died. Thirteen of the 
patients with TNF had septic shock on admission, and hypotension 
developed in a further 4 of the TNF patients. He also showed a high 
correlation between TNF and granulocytopaenia. The patients with the 
highest level, greater than O.lng/ml eventually died.
Although Waage et al. (1987) has shown a strong correlation between 
the presence of TNF in the initial stages of shock and a fatal outcome, he 
(Waage et al. 1987) was unable to show the presence of TNF in the serum of 
shock patients after the initial phase. His findings that TNF concentrations 
in excess of 100 pg/ml are predictive of death throw some doubt on the 
importance of TNF measurements as a predictor of shock and outcome. 
Higher serum levels have been shown in non-lethal conditions. Human 
volunteers receiving E.coli endotoxin a t sublethal doses had serum TNF 
concentrations of 350 pg/ml (Hesse et al. 1988). Scuderi (1986) showed that in 
patients with visceral Leischmania or malaria TNF levels of 188pg/ml were 
present in the serum.
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Table 36. Association of serum  TNF w ith clinical outcome of 79 septicaemic 
patients. (Waage et al. 1987)
Category on admission Survived Died TNF (positive)
Positive meningitis with no 
hypotension or bruises. 26 0 2
Septicaemia with hypotension 
but no meningitis. 12 8 11
Septicaemia with hypotension 
and meningitis. 15 2 2
Septicaemia with or without 
meningitis with no hypotension 
or bruises. 15 1 3
Hypotension: < 100 mmHg
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Conclusion.
Although TNF and IL-1 are important mediators in shock and MSOF, 
it is likely tha t TNF is only involved in the initial stages of the process. It 
should also be emphasised that serum levels do not necessarily reflect the 
level of TNF involvement. A more exact measurement of TNF activity might 
be the measurement of messenger RNA for TNF in monocytes.
Monoclonal anti bodies to TNF, given after endotoxin infusion, do not 
prevent death, and even when given an hour before infusion, they do not 
prevent severe organ damage.
When cyclo-oxygenase inhibitors are given before TNF infusion, they 
considerably attenuate the haemodynamic, histological and biochemical 
changes. But cyclo-oxygenase inhibitors have little effect on animal models 
of ARDS and MSOF.
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Section 1.
Protein mediators, 
le . Complement.
Introduction
The complement system consists of a t least 20 chemically and 
inimunologically distinct serum proteins which are capable of interacting 
w ith each other, with antibodies, and w ith cell membranes. These 
interactions lead to the generation of complement activity. The biological 
sequelae of activation of this system range from lysis of a spectrum of 
different kinds of eukaryotic cells, bacteria and viruses to direct mediation of 
inflam m atory processes. The individual proteins of th is system are 
normally present in the circulation as functionally inactive precursor 
molecules. Together they comprise approximately 15% (w/w) of the plasma 
globulin fraction.
Biological actions of complement cleavage products.
Two peptides are principally involved in inflammation th a t are 
chemically distinct from each other. C3a is a peptide with a molecular 
weight of 8,900. C5a is larger, molecular weight 17,000 kD. C3a and C5a are 
also biologically distinct in that they react with different cellular receptors, 
since tissue rendered unresponsive to C3a will continue to respond to C5a, 
and vice versa. C5a also has chemotactic activity, for leucocytes. Binding 
C5a to leukocyte membranes, particularly neutrophils, causes migration of 
the cells towards the area of complement activation.
Complement activation via tiie classical and alternative pathways
The classical pathway is activated by antibody/antigen complexes» and 
is thought to be of relatively little importance in the development of MSOF. 
Activation of the alternative pathway occurrs in the absence of antibodies, it 
occurrs in  response to such factors as bacterial polysaccharides.
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Complement activation in the presence of leucocytes, leads to the release of 
leukocyte lysosomal enzymes. This is a specific reaction, as other 
compartments of the cell are not affected and lysis does not occur. The active 
principle in the clinical aspects of complement activation is C5a.
Complement activation in  haem odialysis.
When haemodialysis was first introduced, i t  was associated with 
pulmonary dysfunction and hypoxemia and cardiopulmonary dysfunction, 
including angina pectoris, dispnoea, cardiac dysrhythmia and even sudden 
death (Hampers et al. 1973).
In 1968, Caplow and Gochinet (1969) discovered tha t sudden severe 
leucocytopaenia occurs in the first few minutes of haemodialysis. Although 
profound, this reduction in the number of leucocytes in the blood of humans, 
usually occurred for less than 30 minutes. Initially, the leucocytopaenia 
was presumed to be the result of brief sequestration of leucocytes in the 
cellophane coils of the the haemodialysis apparatus. However, when 
autologous plasm a devoid of leucocytes was incubated with dialyser 
cellophane, and infused into dogs, leucocytopaenia also developed (Jenson et 
al. 1973). These results demonstrated that plasma incubated with dialysing 
cellophane, generates a factor producing sudden and dramatic changes in 
the behaviour of leucocytes.
Craddock et al. (1979) showed th a t leucocytopaenia was due to 
complement activation. This occurred when plasm a contacted the 
cellophane membrane of the dialyser, via the alternative pathway. 
Pulmonary dysfunction was found in both patients and animals (Craddock 
et al. 1977). Leukocytes, predominantly neutrophils and monocytes were 
sequestered mainly in the lungs of patients (Craddock et al. 1979), 
undergoing dialysis. In rabbits leucostasis was accompanied by increased 
pulmonary lymph flow.
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Neutrophil activation by complem ent
Endotoxin and zymosan activate complement by the alternative 
pathway. Electron microscopy of neutrophils exposed to activated 
complement showed rapid  surface changes including m em brane 
spreading, pseudopod development and extrusion. These features suggested 
th a t such neutrophils might adhere more readily to the endothelium 
(Craddock et al. 1977).
Sachs et al. (1978) studied the mechanism by which the combination of 
activated  complement and neutrophils, dam aged the pulm onary 
endothelium. He exposed endothelial cells cultured from human umbilical 
veins to granulocytes activated by C5a. These granulocytes adhered to the 
endothelial cells and reloasod toxic oxygon species such as superoxides and 
hydrogen peroxide. Substantial endothelial damage resulted, but he found 
that this damage could be prevented by the addition of the oxide detoxifier 
enzyme, superoxide dism utase. Neutrophils exposed to endotoxin also 
damaged the endothelial cells in vitrOy a finding th a t seems particularly 
relevant to patients with sepsis and ARDS (Craddock et al. 1977).
Craddock et al. (1977) found that activated plasma complement will 
induce aggregation of hum an granulocytes. He thought the active 
component was C5a because anti-C5a could ablate this response but not 
anti-C3a antibodies. C5a fragments prepared by trypsinisation of purified 
C5a reproduced the aggregating activity of the whole activated plasma, 
whereas plasm a from C5a deficient donors did not produce this 
aggregation. Granulocyte aggregation and activation was induced by either 
injecting zymosan or exposing plasma to cellophane.
Webster et al. (1982) investigated the action of C5a infusion, systemic 
complement activation by cobra venom factor (CVF) and intravascularly 
administered zymosan-activated (ZAP) rabbit plasma in rabbits. They were 
interested in measuring the degree of lung injury in these animals. They 
found that C5a, CVF and ZAP all caused an acute neutropaenia, th ta t with
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sequestration of neutrophils within the pulmonary vasculature. However no 
significant lung infiammation, as measured by neutrophil emigration from 
the pulmonary capillaries, or increased vascular permeability, occurred 
with any of the three stimuli. Only when these agents were combined with 
anaesthesia , surgical m anipulation and intubation, did significant 
neutrophil emigration into alveoli occur, but there was no change in 
vascular perm eability. One m ust conclude from these data , th a t 
complement activation alone is not enough to cause symptoms of ARDS. 
Additionally, they showed tha t pulmonary leucostasis can occur without 
pulmonary damage.
Cardiopulmonary by-pass activation of complement.
It has also been shown, that patients undergoing heart lung by-pass 
surgery, show what is called post pump syndrome,' similar to ARDS. 
Chenoweth et al. (1981) concluded, th a t the complement derived 
inflammatory mediators, C3a and C5a, produced during extracorporeal 
circulation, may contribute to the pathogenesis of th is post by-pass 
syndrome. He measured levels of C3a and C5a, during cardio pulmonary 
by-pass in 15 adults. Plasma levels of C3a were significantly elevated at the 
beginning of the procedure, and continued to increase steadily thereafter. At 
the end of the procedure, C3a levels were more than 5 times higher than the 
pre-operative levels. Plasma levels of C5a did not change significantly 
during cardio pulmonary by-pass, instead, there was a significant 
neutrophilia during the by pass, and significant transitory neutropaenia 
occurred when cardio-pulmonary circulation was re-established with 
partial by-pass. Chenoweth et al. (1981) found that incubation of blood with 
the nylon mesh liners of bubble oxygenators, as well as vigorous 
oxygenation of whole blood, promotes the activation of complement.
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Aoaphylatoxm s.
The vaso-reactive products of complement activation are termed 
anaphylatoxins, since on injection they produce a syndrome similar to that 
seen in anaphylactic shock. This effect was shown as long ago as 1917 in 
humans, although they were ignorant of complement as the activator at 
that time, as complement was unknown (Noble and Kruph 1917 ).
The anaphylatoxins have been characterised as low molecular weight 
polypeptides released during activation of C3, C4, C5. These peptides termed 
C3a, C4a and C5a are characterised by the ability to enhance vascular 
permeability when injected subcutaneously and to release histamine from 
m ast cells causing smooth muscle contraction. In addition C5a is a potent 
chemoattractor of neutrophils (Fernandez et al. 1978). It is significant that 
complement activation in humans with gram negative sepsis is associated 
with the development of shock and high mortality (Fernandez et al. 1978).
Neutropaenia.
Hosea et al. (1980) found that the infusion of activated C5 into guinea 
pigs increased alveolar capillary permeability to serum proteins, but rabbits 
made neutropaenic did not alter their capillary permeability. Activation of 
complement through C5a in the presence of neutrophils induces alterations 
in pulmonary alveolar capillary permeability.
Tvedten et al. (1985) found th a t acute lung injury was produced in 
mice by intravenous injection of cobra venom factor, an activator of C5. He 
also found tha t depletion of neutrophils and platelets resulted in marked 
reduction in the degree of lung injury. Lipoxygenase and thromboxane 
synthetase inhibitors afforded some protection against cobra venom factor 
induced acute lung injury, while cyclo-oxygenase inhibitors gave variable 
results. His data suggested th a t acute lung injury in mice following 
systemic activation of complement had an absolute requirement for C6a and
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was dependant on the role of neutrophils as well as platelets and can be 
linked to the generation of lipoxygenases (Tvedten et al. 1985).
Tvedten et al. (1985) showed by transmission electron microscopy that 
after the injection of cobra venom factor and production of C5a, pulmonary 
vascular injury developed with extensive swelling of endothelial cells. These 
changes were associated with in travascular aggregation of platelets, 
neutrophils and fibrin and occlusion of pulmonary capillaries.
C5a desaturated arginine.
Larson (1980) compared C5a and C5a desatu rated  arginine 
(C5adesArg). Because C5a is rapidly converted to C5adesArg in vivo, he 
looked a t fragments most effective in producing pulmonary inflammation. 
In rabbit C5adesArg consistently produced marked inflammation. This was 
characterised by neutrophil accumulation, oedema, haemorrhage, fibrin 
formation and damage to alveolar epithelium. The time course of the 
inflammatory reaction initiated by C5adesArg showed pulmonary vascular 
sequestration of neutrophils but no intra-alveolar migration 30 minutes 
after injection. After 2 hours interstitial and alveolar neutrophils were 
numerous with accumulation of neutrophils in the alveolae, increasing to a 
maximum a t 6 hours. At 24 and 48 hours the predominant cells were 
mononuclear macrophages. In contrast, inhalation of C5a induced either 
no inflammation or milder more focal response than C5adesArg. Infusions 
of C5a produced little inflammation. A prolonged intrapulmonary infusion 
of C5a over 20 minutes in contrast to the bolus infusion of 1 minute, did 
initiate an inflammatory response which may reflect the conversion of C5a 
to C5adesArg in the lungs. His study suggested th a t intrapulm onary 
cleavage of C5 plays an im portant roll in the initiation of pulmonary 
inflammation (Larson et al. 1980).
The same group then looked at the effect of circulating C5a and 
C5adesArg in adult rabbits, using the labelled mediators I^ ^® C5a or I^ ^®
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CôadesArg. CôadesArg persisted in the circulation longer than  C5a. 
Inhalation caused an acute neutropaenia whereas with CSadesArg it  was 
less severe but more prolonged. Changes were primarily seen in the highly 
vascularised organs, lung, spleen, liver and kidney. The time dependant 
accumulation was seen initially in the lung followed by the spleen, liver and 
kidney. Histological examination showed a marked increase in the number 
of neutrophils w ithin the lung and spleen. Depletion of circulating 
neutrophils by nitrogen mustard pre-treatment in rabbits showed no change 
in the amount of labelled mediator (I^^  ^C5a or I^ ^® C5adesArg)bound in the 
lung. Whereas splenic accumulation of labelled mediator depended on the 
presence of neutrophils. These results indicate tha t C6a and C5adesArg are 
rapidly removed from the circulation. Specific accumulation in the highly 
vascularised organs and clearance from the circulation of more than 50% of 
the radio activity was seen within 2 minutes for both mediators i.e. . These 
studies show neutrophil dependant and independent mechanisms are 
involved in the removal of C5a and C5adesArg from the circulation. Binding 
of G5 fragments in the pulmonary vasculature may precede and then 
induce neutrophil sequestration. The aggregation of neutrophils in 
response to activated complement might contribute to the genesis of ARDS.
Hammerschmidt et al. (1980) looked at 61 patients at risk of developing 
ARDS. He found a significant correlation between the presence of 
complement and neutrophil aggregating activity with the development of 
ARDS. This correlation was also significant when patients with sepsis were 
excluded from analysis. When patients with ARDS were studied, 31 of S3 
had abnormal plasma C5a levels on the day of diagnosis or during the 
following 72 hours. In contrast only 5 of the 28 high risk patients who did not 
develop ARDS had excess plasma C5a.
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Complément activation in  the development of ARDS.
It seems paradoxical that within 30 minutes of beginning infusion of 
complement, activated by zymosan, cobra venom factor, haemodialysis or 
leukophoresis, pulmonary dysfunction and increased pulmonary lymph 
flow were observed. Yet, circulating C5a in patients with adult respiratory 
distress syndrome may be detected hours or days before pulmonary 
dysfunction is noted. The acute pulmonary dysfunction th a t has been 
reported was mild and was detected by standard techniques. In contrast, the 
dysfunction in ARDS is severe. I t is possible tha t this severe pulmonary 
dysfunction will be detected if sought in the hours preceding the 
devolopment of the cyndromo. Furthormoro» noutrophils repeatedly exposed 
to activated complement become unresponsive to the chemotactic and 
aggregating effects of C5a. Thus with prolonged circulation of C5a, 
neutrophils may become insensitive to this complement component and 
may take longer to damage endothelium (Hammerschmit et al. 1978).
In 1984, Duchateau et al. studied 50 patients, 36 of whom developed 
ARDS, and found an early intense complement activity. These patients were 
a t risk of ARDS because of multiple injuries, major abdominal surgery, 
acute pancreatitis, bum s, or disseminated intravascular coagulation. The 
C3d fraction, a breakdown product from 03 activation, was measured as 
well as 03. Absolute levels of 03d were correlated with total 03 content of 
normal plasma; therefore the ratio of 03d to total 03 concentration (03d:03 
ratio) was calculated in  order to assess true in vivo  com plem ent 
consumption. Abnormal 03 consumption, measured by the C3d:03 ratio, 
and elevated plasma C5a activity were associated with respectively, 84% and 
86% of cases of ARDS. The 03d:03 ratio was increased in 12 control patients 
after minor surgery. C5a activity was found only in patients at risk of ARDS. 
It was highly associated with conditions that predisposed to the development 
of ARDS but it did not show any consistent increase of correlation with the 
occurrence of ARDS. Sequential samples from both sides of the pulmonary
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circulation showed initial pulmonary clearance followed by the release of 
C5a like activity. No simultaneous changes in C3 levels were found 
suggesting the possible presence of modulation factors. These observations 
suggested that other factors may influence the development of ARDS.
Similar flndings of a lack of correlation between the presence of 
serum complement and the development of ARDS have been shown by 
Weinberg et al. in 1983 and Parsons et al. in 1989. These flndings suggest 
that whatever its involvement» complement activation alone cannot account 
for the development of ARDS.
Reduction of complement tætivity.
Flick et al. (1986) studied the effects of reducing the total haemolytic 
complement activity in sheep by N aja haja  cobra venom factor. They 
infused E. coli endotoxin into 5 normal sheep and 5 pretreated with N aja  
haja and measured lung lymph flow. They showed th a t complement 
reduction did not prevent lung injury caused by endotoxin and did not 
prevent the appearance in plasma and lung lymph of chemotactic activity. 
One must conclude tha t an intact complement system is not necessary for 
endotoxin-induced lung injury.
C onclusion.
Complement is an important blood-home mediator of inflammation, 
stimulating neutrophils, endothelial cells and the arachidonic acid cascade. 
But the development of ARDS is not only dependant on complement 
activation. Complement infusion into animals does not produce ARDS. 
Reduction of the complement component does not prevent pulmonary 
damage in animal models of ARDS. Additionally patients with ARDS do not 
show consistent correlation with complement concentration.
Complement is most likely important in the development of ARDS 
when associated with other inflammatory mediators. Complement is one
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part of the inflammatory response seen in Figure 19, but the other blood- 
borne mediators are associated with the development of ARDS in the 
absence of complement.
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2a. Phospholipids.
Introduction.
Prostaglandins (PG), thromboxane (TXA2), prostacyclin (PGI) and 
leukotrienes (LT) collectively termed eicosanoids, are derived from the 
substrate arachidonic acid, a constituent of cell membrane phospholipid. A 
variety  of inflam m atory stim uli can directly or indirectly activate 
phospholipase A2 or C, resulting in the release of arachidonic acid from 
specific phospholipid pools. (Flower and Blackwell 1976). Phospholipase A2 
is the rate limiting enzyme for the formation of eicosanoids. Once released, 
arachidonic acid is oxidatively metabolised via two major routes, the cyclo- 
oxygenase and lipoxygenase pathways, as can be seen in Figure 26. The 
enzyme fatty acid cyclo-oxygenase converts arachidonic acid to the unstable 
endoperoxide m etabolites PGG2 and PGH2, which are metabolised 
enzymically to TXA2, PG (PGD2, PGE2, PGF2) and PGI2. Although all 
eicosanoids are derived from arachidonic acid, the relative amounts of 
TXA2 and PGI2 vary with different cell types. These two cyclo-oxygenases 
are of particular interest because of their opposing haemodynamic and 
haematologic actions (Moncada and Vane 1979). Of the other cyclo- 
oxygenase products PGE2 is a vasodilator, considerably less potent than 
PGI2, and PGF2 is a vasoconstrictor less potent than TXA2 (Armstrong et 
al. 1978).
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The other major pathway of arachidonic acid metabolism gives rise to 
the lipoxygenase products (Samuelson et al. 1979). Two classes of 
leukotrienes are derived from enzymatic conversion of the LTA4 precursor: 
the sulphidopeptide leukotrienes, LTC4, LTD4 and LTE4, and the 
nonpeptide metabolite LTB4.
Prostaglandins, thromboxanes and leukotrienes can produce a 
variety of haemodynamic, haematologic and inflammatory actions that are 
characteristic of many features of circulatory shock. These eicosanoids have 
been increasingly implicated as significant pathophysiologic mediators in 
endotoxic and septic shock (Ball et al. 1986).
Figure 26. lip id  cascade in  response to tissue damage in  MSOF.
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2b. Phospholipase.
Introduction
Phospholipases are a heterogenous group of enzymes distributed 
throughout eukaryotic cells with molecular weights ranging from 5,000- 
100,000 kD depending on the organ and species in which they are found.
Figure 27. Structure of phosphatides and the action of pho^holipase.
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R is a fatty acid residue. 
P is phosphate. 
B is a choline, etholamine, inositol or serine group.
Phospholipids are composed of a 3-carbon glycerol backbone to which 
various functional groups are attached by an ester linkage to the glycerol 
alcohols. The 3 glycerol carbons are referred to as 1, 2 and 3, shown in 
Figure 27. Fatty acids are esterifîed in the 1 and 2 positions. The products of 
phospholipase A1 (PLAI) and phospholipase A2 (PLA2) hydrolysis are the 1 
and 2 lysophosphatides, these include lysophosphatydic acid and platelet 
activation factor. Phospholipase C (PLA C) hydrolyses the glyceryl- 
phosphate bond on the 3 position to phosphoric acid giving phosphatidic 
acid, or more usually a phosphorylated base (i.e. inositol, choline, 
ethanolamine or serine) and a diacylglycerol, (diacylglycerol is a potent
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stimulator of neutrophils that is independent of calcium ions). Arachidonic 
acid can be liberated from a phosphatide by PLA C if the enzyme is coupled 
with a diglyceride lipase. Coupled enzyme systems of this type have been 
described in platelets.
Thus PLA2 is an im portant regulatory enzyme for the entire 
eicosanoid cascade. PLA2 is found as two distinct types, either membrane- 
bound or soluble. Enzymes of the former group are strongly bound to the 
plasma, Golgi or mitochondrial membranes, generally requiring the 
presence of calcium ions and a neutral pH for optimal activity. The latter 
type of enzymes are soluble, found in cellular lysosomes, calcium 
independent and function at an optimal pH of 4. However soluble PLA2 with 
an optimum neutral pH and calcium dependence has been shown to be 
secreted during activation of phagocytes.
It is possible tha t the membrane bound enzyme can be stimulated 
when certain receptors on the cell surface are occupied. This could explain 
why certain agents such as bradykinin or an antigen-antibody combination 
can cause cells to generate large amounts of prostaglandins.
Clinical significance of serum PLA2 activity.
Vadas (1984) looked at serum PLA2 activity in patients suffering gram 
negative septic shock, non-septic shocked patients during the hypotensive 
phase, and normal volunteers.
All septic shock patients had elevated serum PLA2 activity as high as 
434% compared to non-septic shock levels, and sixteen fold compared to 
control levels. But those patients with ARDS had a serum PLA activity 20 
fold greater than controls, and 70% greater than septic non-ARDS patients. 
Patients with the highest levels of circulating PLA2 appear to be a t greater 
risk of developing ARDS. Those patients surviving the hypotensive episode, 
showed decreasing phospholipase A2 levels, returning to baseline during 
their convalescence.
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Vadas (1984) found that the PLA2 activity had an optimum pH of 7.5. 
This pH is typical of the membrane bound form, unlike the lysosomal form 
released on the degranulation of phagocytes, which has an optimum pH of 
4.0. Vadas (1984) suggested th a t th is biochemical characterisation 
implicated macrophages of the reticulo-endothelial system as the main 
source of this enzyme.
The adm inistration of PLA2 is associated with hypotension. The 
intravenous injection of PLA2 purified from snake venom causes a rapid 
and profound drop in mean arterial blood pressure in dogs. Similarly PLA2 
isolated from honey bee venom caused a marked hypotensive response in 
cats, dogs and rats. Vadas also showed tha t the intravenous administration 
of plasm a from shocked rabbits thought to contain PLA2, produced a 
profound and sustained drop in MABP when injected into other normal 
rabbits. This hypotension was blocked by treatm ent with the phospholipase 
A2 inhibitor P-Bromophenylacylbromide.
Steroids have been shown to attenuate the severity of clinical Gram 
negative septic shock or experimental endotoxic shock. The mechanism of 
action of steroids is thought to lie in their ability to induce the synthesis of a 
protein inhibitor of soluble PLA2, termed lipomodulin or macrocortin. 
Alveolar macrophages are sources of PLA2 th a t can modify pulmonary 
surfactant. Further stimulation of reticulo-endothelial system macrophages 
may further enhance the secretion of this enzyme playing an important role 
in promoting tissue damage.
Vallee (1979) determined that the inhibition of PLA2 activity by non­
steroidal anti-inflammatory drugs (NSAID) resulted in protection against 
inflammation and platelet aggregation. He used the PLA2 inhibitors, 
mepacrine, P-bromophenylbromide and papaverine to assess their ability to 
prevent or decrease the release of arachidonic acid from platelets in the 
presence of thrombin. While the three agents could not all be considered sole 
PLA2 inhibitors, they all reduced the release of arachidonic acid from
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platelets. BPB847 and CB874 were also used as they are direct inhibitors of 
PLA2 since they inhibit the in vitro hydrolysis of phopholipids by PLA2.
Vallee (1979) injected carageenan into the paws of rats treated with a 
drug or placebo. Measurements were taken by plethysmography after 2, 3 
and 5 hours to gauge the intensity of the resulting oedema. Papaverine did 
not produce much inhibition, but mepacrine and the two numbered 
inhibitors gave considerable inhibition, and only 20% inflam mation 
occurred. Mepacrine and the two numbered inhibitors caused inhibition of 
platelet aggregation when stimulated by thrombin. PLA2 inhibition reduced 
inflammation when stimulated by carageenan, showing its importance in 
the development of inflammation. It is assumed tha t this inhibition would 
prevent arachidonic acid release, lysophosphatide production and 
eicosanoid synthesis.
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2c. Arachidonic acid.
Introduction
In man, the precursors of AA are usually ingested as dietary linoleic 
acid, a constituent in many meats. It is then esterifîed as a component of the 
phospholipid of the cell membrane or is found in ester linkage in  other 
complex lipids.
AA is released from membrane phospholipids by the action of PLA2. 
The concentration of free AA is low, and it is believed th a t endogenous 
biosynthesis of prostaglandins and related compounds depends on the PLA2 
release of precursor acid from cellular phospholipid stores.
Once released, AA is rapidly metabolised to oxygenated products by 
two distinct enzymic mechanisms, a cyclo-oxygenase and a lipoxygenase 
system. Both pathways of the arachidonic acid cascade may be activated by 
numerous mediators and appear closely linked to the pathophysiology of 
septic shock.
Eioosanoid substrate
Most mammalian cells generate eicosanoids in response to a wide 
variety of physiological, pharmacological or pathological stimuli and, since 
these compounds are not stored within cells, biosynthesis must immediately 
precede release. The substrate, usually arachidonic acid, must be in a non- 
esterified form, but the intracellular level of free precursor acid is extremely 
low. Although precursor fatty acids could arise from the hydrolytic cleavage 
of a number of intracellular lipid pools, eicosanoid release follows so rapidly 
on stimulation, tha t hydrolysis of dietary lipid is too slow to constitute a 
viable mechanism. Most cells and tissue types use phospholipids to produce 
AA.
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2d. Platelet activating factor.
Introduction
The term platelet activating factor (PAF) proposed by Benveniste et al. 
(1973) originally defined the most prominent biological activity of a new 
class of phospholipids released from basophils by immune (IgE) stimuli. 
The chemical nature of these phospholipids has been identified as 1-0-alkyl- 
2-acetyl-sn-glyceryl-3-phosphatidylcholine (Demopuolos et al. 1979). This 
group of compounds have far more diverse actions than the stimulation of 
platelets. Endothelial cells and neutrophils are stimulated by PAF (Snyder 
1985).
This vasoactive phospholipid produces severe hypotension, shock and 
death when infused into guinea pigs, rats, rabbits, dogs and pigs (Braquet et 
al. 1987). It is thought to be the single most potent agent to cause shock when 
adm inistered systemically. Shock syndrome produced by PAF involves 
several mechanisms and sites of action.
F irst, the pulmonary circulation is affected by an increase in 
pulmonary vascular resistance and bronchoconstriction, both of which 
contribute to the development of hypoxemia, with the increase in pulmonary 
vascular resistance contributing to right heart failure (Bessin et al. 1983). 
Secondly, the heart is also affected by reduction in cardiac output due to 
coronary constriction (Feuerstein et al. 1983), reduction in myocardial 
contractility (Benveniste et al. 1983), and reduced cardiac preload. However 
some controversy exists as to whether PAF directly affects the myocardium 
or whether reduction in oxygen transport to the myocardium leads to a 
secondary effect, stemming from coronary vasoconstriction. Also, the PAF 
induced coronary vaso-constriction and cardiac failure seem to be mediated, 
a t lea st in  part by TXA2, since much of the cardiac effect of PAF can be 
blocked by the prostaglandin inhibitor indomethacin (Feuerstein et al. 1983). 
Third, the peripheral circulation is affected by vasodilatation which might 
also contribute to the hypotensive effect of PAF. The vasodilation effect of
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PAF is not mediated by eicoSanoids (Feuerstein et al. 1983). Fourth, there is 
an increase in vascular permeability with extravasation of plasma into the 
tissue, contributing to the reduction in cardiac output and causing 
pulmonary oedema (Bessin et al. 1983). Fifthly, leucocytes and platelets are 
activated, primarily in the lungs and liver, contributing to endothelial 
damage and micro thrombi in these organs. Finally PAF stim ulates 
neutrophils and endothelium to produce secondary inflammatory mediators 
such as leukotrienes (Voelkel et al. 1982), thus confusing their direct affect 
on physiological and haemodynamic parameters.
Doses of 3 nmol/kg of PAF (a very low dose) reduce blood pressure and 
flow in ra t mesentery, kidney and hind limbs. The blood pressure normally 
rises a short time after the infusion of PAF is stopped, but the blood flow in 
these organs remains low (Feuerstein and Hallenbeck 1987). Although 
infusion of PAF can cause the shocked state in animals, only a small 
number of studies have been performed on infection patients or animals to 
measure PAF levels. Elevated PAF levels were found in rats infused with E. 
coli endotoxin (Doebbler et al. 1985). PAF was also found to be released by 
macrophages and spleen lymphocytes in  ra ts  suffering from bacterial 
peritonitis (Inarrea et al. 1985). Antagonists of PAF such as kadsurenone, 
ÇV 3988, and BN 52021 have been shown to reverse hypotension (Doebbler et 
al. 1985), and increase survival in rats challenged with endotoxin.
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2e. Cyclo-oxygenases; Thromboxane and Prostacyclin.
Introduction
TXA2 has a very short half life, of 30 seconds a t 37°C and pH 7.4, 
therefore TXB2, a stable and virtually nonactive metabolite of TXA2 is used 
to monitor TXA2 levels. Several lines of evidence support a role for TXA2 as 
a mediator of shock. Elevated plasma and lymph levels of TXB2 are 
consistently found in a variety of animal shock models, such as endotoxic 
(Cook et al. 1980), traum atic (Hock and Lefer 1984) or haemorrhagic 
(Feuerstein and Hallenbeck 1987). Moreover, increased plasma levels of 
TXB2 in  hum ans suffering from severe septic shock were also 
reported (Reines et al. 1982).
Two major pathophysiological processes can be attributed to TXA2, 
First, it is a potent vasoconstrictor of small and large blood vessels; second, 
it is an extremely potent aggregating factor of neutrophils and platelets. 
These two primary actions of TXA2 are believed to act together to interfere 
with organ blood flow and promote ischaemia in several shock states.
Antagonists or synthesis inhibitors of TXA2 also demonstrate its 
pathophysiology in various shocked states. The receptor antagonist EP 092 
blocks the development of pulmonary hypertension in  endotoxemia 
(Armstrong et al. 1985). However the TXA2 antagonists are also PGH2 
antagonists, therefore it is not yet possible to evaluate the relative roles of 
PGH2 and TXA2 in shock, although TXA2 synthesis inhibitors have 
therapeutic efficacy in several shock and traum a models. UK 37248 is 
effective in ra t endotoxic shock (Halushka et al. 1983) and U 63,557A is 
protective in ra t trauma (Reines et al. 1982). However it must be emphasised 
tha t TXA2 inhibition fails to modify the outcome of gram negative septic 
shock (Fletcher et al. 1983). Inhibitors also act by increasing the availability 
of endoperoxides for the PGI2 synthetase pathway to produce more PGI2 
(Casey et al. 1982).
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Biosynthesis of thromboxane has been described in a range of tissues 
and cells including platelets, pulmonary endothelium, gastric mucosa, 
kidney, fibroblasts and leucocytes. Although it has recently been shown that 
all vascular endothelium can produce TXA2, platelet and the action of 
thromboxane synthetase in platelets has been the most studied.
Prostacylin, has a half life of 3 minutes at 37°C centigrade and pH 7.5, 
activated by the enzyme prostacyclin synthetase. It has been shown to be a 
major cyclo-oxygenase pathway metabolite of arachidonic acid in vascular 
tissue. Recent data from bovine aorta (Feuerstein and Hallenbeck 1987) 
shows th a t the enzyme responsible for the formation of PGI2, prostacylin 
synthetase, is found principally in endothelium and smooth muscle cells, 
although, the level of cyclo-oxygenase activity is several times higher in the 
endothelium. Histamine and bradykinin stimulate prostacylin biosynthesis 
by human umbilical endothelial cells, whereas agents such as angiotensin 
2 , vasopressins, and adrenalin were without effect.
Thromboxane and prostacyclin exhibit a reciprocal relationship in 
blood capillaries. TXA2 acts as a positive feedback to increase platelet and 
neutrophil aggregation and is a potent vasoconstrictor and lysosomal 
membrane destabiliser. Prostacyclin is a vasodilator and prevents platelet 
and neutrophil aggregation and causes the ir disaggregation. The 
TXA2/PGI2 balance is disturbed when endothelial cells are disrupted. 
Suppression of PGI2 and augm entation of TXA2 synthesis has been 
demonstrated in rabbit septic shock (Carmona et al. 1984).
Lung lymph was examined for prostanoids (Adams and Traber 1982) 
in sheep infused with endotoxin to produce ARDS. Thromboxane B2 and 6- 
keto-Fl, were both elevated, but pretreatment with Ibuprofen abolished these 
early increases and prevented the resulting pulmonary hypertension. 
Prostaglandins could also be reduced by depleting the animal of their 
neutrophils (Huttemeier et al. 1982). I t appears th a t in response to 
endotoxin, neutrophils release TXA2, causing venoconstriction. The
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microvascular hydrostatic pressure is raised, causing transvascular fluid 
movement and an elevation in lung lymph flow. The importance of PGI2 is 
unclear, although PGI2 antagonises most of the actions of TXA2, it may not 
necessarily provide a protective effect.
Dupont et al. (1987) found a significant production of prostanoids in 
ARDS patients particularly those with sepsis. They found a disturbance in 
the balance of the prostacyclin and throm boxane relationship . 
Thromboxane and prostacyclin were measured in 84 patients a t risk of 
developing ARDS, 44 patients following multiple traum a, 29 abdominal 
surgery and 11 with acute pancreatitis. ARDS developed in 49 patients, as 
can be seen in Table 37.
Table 37. Diagnostic distribution of 84 patients a t risk  of developing ARDS.
(Dupont et al. 1987)
Diagnosis Patient number ARDS patients
Multiple injuries 44 26
Abdominal surgery 29 14
Acute surgery 11 9
Total 84 49
Plasma thromboxane and prostacyclin levels can be seen in Table 38. High 
thromboxane levels were found in 52 of the patients. The median values of 
TXA2 were 360 pg/ml in multiple trauma, 250 pg/ml in abdominal surgery 
and 410 pg/ml in acute pancreatitis. The median TXA2 concentration was 
575 pg/ml in patients developing ARDS, significantly higher than  the 
140pg/ml in those without this development. Median values of prostacyclin 
were 55 pg/ml in multiple injured, 25 pg/ml in abdominal surgery and 120 
pg/ml in acute pancreatitis. The median PGI values was 122  pg/ ml in 
ARDS patients significantly higher than the 25pg/ml in non-ARDS patients.
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High TXA2 and PGI values were particularly related to sepsis in abdominal 
surgery patients and were significantly raised.
Table 38. P lasm a concen tra tion  of throm boxane an d  p rostacyclin  in  84 
patients, in  3 diagnostic groups, a t risk  of deve loph^  ARDS. (Dupont et al. 
1987)
Diagnosis Thromboxane pg^ml Prostacyclin p^m l
Multiple injuries 00 55
Abdominal surgery 250 25
Acute surgery 410 120
ARDS patients 575 122
Non-ARDS patients 140 25
In multiple injured patients they were also significantly raised. No 
relationship could be established between abnormal TXA2 or PGI values 
and death. High TXA2 values often persisted for several days and were 
observed particularly at the time ARDS diagnostic criteria were fulfilled. An 
imbalance between TXA2 and PGI was observed. PGI values were always 
lower than TXA2 values and did not persist more than 24 hours.
Huttemeier (1982) examined TXA2 and PGI levels in sheep infused 
with E. coli endotoxin. Group 1 were control sheep, group 2 were rendered 
leucopaenic by nitrogen mustard, and group 3 received ibuprofen before the 
endotoxin infusion. The control sheep showed an increase in pulmonary 
vascular resistance and a high level of thromboxane release. The second 
group showed only half the increase in pulmonary vascular resistance and 
thromboxane levels. The third group showed only minimal increases of 
pulm onary a rte ry  pressure and pulm onary vascu lar resistance. 
Prostacyclin, on the other hand showed a 10 fold increase in group 1 . But in 
group 2 and 3 there was no change. The production of prostacyclin seems to 
be dependant on the presence of leucocytes. In group 3 the prostaglandin
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inhibition prevented the release of prostacyclin. Neutrophils appear to be 
unnecessary for the production of thromboxane when stim ulated by 
endotoxin. Thromboxane, it  should be emphasised, can be produced by the 
pulmonary endothelium, without the involvement of platelets.
There is varied production of eicosanoids by the endothelium of 
differing vital organs, explaining some of the regional blood flow variations 
occurring in shock. Cook et al. (1982) in  1982 showed th a t the 
hepatosplanchnic circulation is a region of increased eicosanoid production 
during endotoxemia in the rat. Venous TXB2 and i6-keto-PGElalpha levels 
are increased relative to arterial levels, with the highest levels occurring in 
the portal or hepatic vein. High portal TXB2 during endotoxemia correlates 
temporally with reduced splanchnic blood flow and small bowel infarction 
(Halushka et al. 1983, Frolich et al. 1980, Tempel et al. 1986).
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2£ Lipoxygenases; Leukotrienes 
Introduction.
The first animal lipoxygenases were not described until 1974, and it is 
only in the last ten years th a t they have been recognised as sources of 
biologically im portant molecules. Studies w ith fatty  acids such as 
arachidonic acid or eicosapentanoic add  indicated the presence of a family 
of biologically important molecules which are derived from individual fatty 
acids.
Samuelson et al. (1983) introduced the term  leukotriene in 1983 
because of their initial discovery in leucocytes and their conjugated triene 
structure, to describe the compounds produced by this metabolic pathway. A 
subscript was used to describe the total number of double bonds in the 
molecule.
Production of leukotrienes in acute anaphylaxis is considered to play 
a major role in the cardio respiratory derangements tha t lead to shock and 
death (Samuelson 1983). But the role of LT in other forms of shock such as 
sepsis, traum a, or haemorrhage is still unclear. This is primarily due to 
their rapid elimination fi*om the circulation making the assay in biological 
tissues or fluids unreliable. Leukotriene metabolites m ust be measured, 
therefore in bile, urine or through bronchial lavage fluid.
Some recent evidence supports the generation of LT in bum s and 
traum a by following the levels of LT in the bile. Large increments of LTE4 
and N-acetyl-LTE4 are found in the plasma and bile of rats exposed to 
various traum atic injuries such as burns, bone fracture, abdominal 
surgery (Denzlinger et al. 1985) and endotoxemia (Hagman et al. 1985). 
Leukotrienes are considered to be rapidly cleared from the blood, and 
metabolised by the liver and excreted in the bile as nonactive metabolites. 
Recent experim ents indicate th a t LTs have an enterohepatic cycle 
(Denzlinger et al. 1986) in species where N-acetyl-LTE^ is the major LT 
metabolite to re-enter the circulation from the gut, although little biological
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activity can be anticipated, since N-acetyl-LTE^, is less than 1% as effective 
as LTE4.
Leukotrienes have been shown to have effects on the cardio­
respiratory system, the blood vessels and the microcirculation (Denzlinger 
et al. 1985). The principal pathophysiological actions of LT include, 
reduction in cardiac output, constriction of the blood vessels and reduction 
in organ blood flow, bronchoconstriction, reduced lung compliance and 
increased pulmonary vascular resistance (Piper 1982). An increase in post­
capillary venular perm eability and venoconstriction th a t leads to a 
pronounced plasma extravasation and reduction in blood volume (Piper 
1982) is also observed. LT compounds have also been shown to aggregate and 
activate p la te le ts , leucocytes and m acrophages re leasing  th e ir  
inflammatory mediators and contributing to the development of circulatory 
shock. This process also leads to the formation of microthrombi in the 
lungs.
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Summary
Chapter 1 is a broad introduction to ARDS, showing the clinical 
picture and scientific background.
Chapter 2 describes the historic background and brings together the 
differing causes of ARDS. Most deaths medically described from ARDS were 
caused by sepsis, but with the improvement in medical practice, the 
condition was seen in traumatised but non-septic patients who would have 
previously died from their original condition such as traum a, bum s or 
major abdominal surgery.
The Vietnam war allowed a comprehensive study of traum a victims 
who had immediate access to sophisticated medical treatment, who would 
previously have died shortly after injury. These studies showed tha t even 
when patients were treated quickly with volume replacement therapy, renal 
dialysis and mechanical ventilation, they still died, but not from their 
original injury. The lungs were normal in casualties with non-thoracic 
injuries who died within 8 hours of injury, but heavily congested in those 
who died later. All subjects with tissue traum a had some degree of 
pulmonary dysfunction, rarely associated with infection. This dysfunction 
appears to be a pulmonary response to tissue trauma.
This chapter additionally shows tha t ARDS is rarely seen without 
MSOF. Most patients die from organ failure or circulatory collapse, not 
hypoxemia. ARDS is only the more obvious pulmonary damage tha t occurs 
in association with other less clinically obvious organ dysfunction.
An analysis of the causes of MSOF suggests that it occurs as a result 
of a whole body inflammatory reaction. Any condition th a t produces a 
substantial inflammatory reaction can cause MSOF to develop. A better 
name for MSOF would be severe inflammatory cascade activation or SICA.
Chapter 3 looks a t the major causes of MSOF and shows the common 
factors among them. Section 1 deals with sepsis. It shows tha t there is 
considerable confusion concerning the concept of sepsis among the medical
189
establishment. A number of terms in common usage such as septicaemia, 
septic syndrome, septic shock and bacteraemia are ambiguous, overlapping, 
imprecise and vague.
Sepsis is typically diagnosed in a patient by the symptoms of their 
condition, not the presence of micro-organisms. Micro-organisms are 
assumed to be present if the symptoms fit the clinical picture. The concept of 
septic syndrome has been established to describe the presence of symptoms 
in a patient, but the absence of a positive culture.
The science of microbiology seems to study the behaviour of a micro­
organism in infections such as typhoid or cholera, but not their clinical 
implications in sepsis and MSOF. The medical fraternity  is principally 
concerned with identifying the micro-organism so tha t the most appropriate 
antibiotic can be used in its treatm ent. Although antibiotics can cure 
bacteraemia, they make little impact on the high mortality of patients with 
septicaemia.
The symptoms seen in the septic syndrome are the patient’s response 
to tissue injury. Although infection can cause tha t injury, there are many 
other causes of tissue injury not involved with micro-organisms. The 
underlying condition must be treated or the focus of inflammatory response 
removed if the patient is to have any chance of survival.
A similar pattern is seen in the treatment of severe trauma. Attention 
is focused on treating the symptoms of fracture and resetting the bone. Most 
traum a results in pulmonary dysfunction, usually a t a subclinical level. 
Only when organ damage becomes evident is therapy initiated. There is a 
preference to respond only to a patient’s deterioration, not to initiate therapy 
preventing such deterioration. There is little attem pt to predict and prevent 
the development of MSOF in multi-trauma patients.
Injury to the quadraceps and femur is associated with the highest 
incidence of complications and MSOF. The mechanism by which MSOF 
develops in such patients involves severe inflammatory cascade activation in
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response to tissue contusion. Substantial injury to the large muscle mass of 
the quadraceps allows a profound development of the inflammatory process. 
In most cases the high energy required to break the femur guarantees 
considerable muscle contusion. The bone m ust be reset and the tissue 
debrided within 24 hours. The use of traction and plaster should be 
abandoned as it  delays therapy designed to reduce inflammatory cascade 
activation.
These two causes of MSOF are responses to a specific incident such as 
the start of an infection or the clinical developments after a car crash. But 
there is a third factor tha t is more insidious, tha t of tissue damage due to 
oxygen deprivation.
Oxygen deprivation and reduced energy metabolism are currently 
thought to be central to the development of MSOF. Tissue damage due to 
oxygen deprivation manifests itself at several levels. There is an increased 
metabolic ra te  due to sepsis, traum a, burns and other predisposing 
conditions. When this increased rate is limited by an inadequate oxygen 
supply then a relative tissue hypoxemia occurs.
In sepsis syndrome there may be a high tissue oxygen delivery, but the 
distribution of blood to organs and within the organs becomes inappropriate. 
Additionally a high oxygen delivery may be maintained in organs with a low 
oxygen extraction, such as the kidney or skin, a t the expense of organs with 
a high oxygen extraction such as the brain and heart. The organ also loses 
the ability to distribute flow equally within itself, resulting in tissue 
hypoxemia.
Tissue hypoxemia allows the production of xanthine oxidase, an 
enzyme that allows the conversion of oxygen into super oxides. These super 
oxides can cause local tissue damage. It has also been shown that in septic 
syndrome the production of ATP is im paired due to mitochondrial 
derangem ent and dislocation of oxidative phosphorylation. Pyruvate 
dehydrogenase is inactivated, preventing the entry of pyruvate into the
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mitochondria. Inadequate pyruvate concentrations in the mitochondria 
reduce the production of acetyl co-A, needed in the Krebs cycle.
Chapter 4 reflects on the histological changes seen by electron 
microscopy. These studies have chiefly involved the examination of lung 
ultrastructure in humans with ARDS and in animal models.
The acute changes in the lungs, seen up to 3 days after injury are: 
capillary leucostasis, endothelial swelling and disruption, in terstitia l 
oedema, epithelial vacuolation and disruption and alveolar oedema. The 
chronic changes are those of repair, seen up to 3 weeks after injury. They 
include fibrin deposition, proliferation of type two pneumocytes and the 
development of an alveolar hyaline membrane.
Several animal, but no human studies, have been performed on other 
organs. U ltrastructural studies of the liver and spleen in animals has 
shown profound leucostasis. Liver studies have shown swelling of the 
sinusoidal endothelium and Kupffer cells, and occlusion of the sinusoidal 
lumen. But there is an absence of leucostasis in the heart, kidney and 
muscle capillaries. There are few reports about the condition of the 
endothelium in these organs. This may prove to be an important area of 
research. If there is endothelial swelling in these leucostasis free organs, 
then the damage will be due to some as yet unknown factor.
Little work has been done on the u ltrastructural changes of cell 
organelles such as mitochondria or endoplasmic reticulum in MSOF. It is 
im portant to know the effect of the inflammatory reaction on these 
organelles. It is possible that damage to these organelles causes many of the 
changes seen in MSOF. Liver, kidney, heart and muscle are of particular 
interest and further study, especially in humans, is needed.
Chapter 5 is concerned with the behaviour of inflammatory cells, 
especially neutrophils. They are closely involved in the process of tissue 
damage, especially in the lungs liver and spleen. In these organs tissue 
damage is seen in close association with the inflammatory cells. It is
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difficult to establish why they aggregate in these organs, although it is 
possible th a t the reticulo-endothelial system is clearing the activated 
neutrophils from the circulation.
Pulmonary damage does occur in patients with a very low circulating 
neutrophil count, although its severity increases with any rise in blood 
neutrophil count. Tissue damage has been seen in animal models of ARDS 
th a t have been rendered leukocytopaenic. Additionally, pulmonary 
leucostasis has been demonstrated in animals in the absence of tissue 
damage. Neutrophils are undoubtably important in causing organ damage 
in MSOF, but pulmonary damage occurs in the absence of neutrophils and 
they are not responsible for the failure of the heart and kidney seen in this 
condition.
Chapter 6 is concerned with the chemical mediators involved in whole 
body inflammation. They are divided into two groups, the protein and the 
lipid mediators. The diagram on page 148 shows that there are many such 
mediators and their interaction is very complex.
Protein mediators are the kinins, the cytokines, such as tumour 
necrosis factor (TNF) and the interleukins, and the complement system. 
These are blood borne agents having a generalised whole body effect. The 
kinins are of particular interest because, in rats infused with endotoxin, the 
death rate was reduced significantly when they were inhibited. The study of 
kinins in MSOF has been limited, partly by the difficulty of assaying them. 
Further investigation is clearly necessary to elucidate their involvement in 
MSOF.
Cytokines, especially TNF, are of great current scientific interest. This 
thesis tries to show that, a t the present time, their clinical importance is 
exaggerated. When measured in the blood of patients with MSOF they show 
a daily pulse, rising to a peak after several hours and falling back to baseline 
values. Concentrations of TNF during the peaks is similar to tha t shown in 
human volunteers injected with low doses of endotoxin.
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Endotoxin causes the release of TNF from monocytes, which causes 
the symptoms of endotoxemia. But many patients with MSOF either are not 
infected with exogenous micro-organisms or have Gram-positive or viral 
infections that do not produce endotoxin. In these patients TNF has not been 
shown to be present. TNF antibodies can prevent all of the symptoms of 
endotoxemia when given before an endotoxin infusion; or some of the 
symptoms when given 2 hours before infusion. But when TNF antibodies are 
given later than this, they do not have a protective effect. TNF appears to be 
an agent th a t initiates the inflammatory response in Gram negative 
infection, but has a reduced involvement as the process continues. 
Interleukin 1 is not crucial in the development of MSOF.
The complement system is the th ird  protein m ediator of the 
inflammatory response involved in MSOF, especially the fragment C5a. This 
complement fragment stimulates neutrophil activity and is important in the 
leucostasis of MSOF. There is no correlation between the occurrence or 
severity of MSOF and increases in C5a concentration. Although C5a can 
cause leucostasis when administered alone, it  does not cause degranulation 
or tissue damage. Reduction of the complement component of the blood does 
not reduce pulmonary damage. Complement activation, although an 
important component of severe inflammatory cascade activation is not the 
cause.
Section 2 is concerned with the lipid mediators of severe inflammatory 
activation. These agents have a local effect a t the site of production. They are 
not stored, and are fonned by the lipid membrane of a cell as needed. They 
are p latelet activating factor, the cyclo-oxygenases, prostacylin and 
thromboxane, and the lipoxygenases, leukotrienes. The important enzyme 
in controlling the production of all these compounds is phospholipase.
Serum phospholipase activity measured in patients with ARDS and 
sepsis is raised. But it is unlikely that its measurement can be used as an 
index of the development and severity of ARDS. This enzyme is membrane
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bound and acts locally to control the formation of the lipid mediators. 
Consequently its serum concentration depends on the amount th a t leaks 
away from the tissue in which it is formed. The serum concentration will be 
higher when vasodilation has occurred and lower in vasoconstriction. 
Inhibitors of phospholipase could be important in controlling the production 
of lipid mediators. Unfortunately most phospholipase inhibitors tend to be 
toxic, or steroidal, and have little effect when given 2 hours after the 
initiation of the inflammatory cascade. A non-toxic inhibitor of PLA may be 
very important in the treatm ent of MSOF, and further research needs to be 
undertaken.
The lipid mediators are each responsible for certain symptoms of 
MSOF and may be a mechanism by which other mediators control the 
development of the condition. But their production is so interactive that the 
production of one mediator affects the formation of others. Blockade of cyclo- 
oxygenases could increase the production of lipoxygenases. It seems highly 
unlikely th a t pharmaceutical intervention to reduce the activity of these 
mediators will improve the prognosis for patients with MSOF.
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